University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Publications for Norris Cancer Center Members in the Developmental Therapeutics Program

  • If you want to only view publications for one year, enter the 4 digit Year (e.g., 2001) and click Filter.
  • Authors who are Program members appear in bold.
  • Authors who are CC members from other programs are underlined.

Filter by Publication Year: 

Total Number of Publications: 1072
Inter Programmatic Publications: 240
Intra Programmatic Publications: 127

1: Kumar PG
Impact of Anemia in Patients With Head and Neck Cancer.
Oncologist 5 Suppl 2: 13-18 ()
PM ID: 10889270
2: Franklin JL, Finlay J
Leukemias and Lymphomas: Treatment and Prophylaxis of the Central Nervous System.
Curr Treat Options Neurol 8: 335-345 ()
PM ID: 16942676
3: Carlo T, Petasis NA, Levy BD
Activation of Polyisoprenyl Diphosphate Phosphatase 1 Remodels Cellular Presqualene Diphosphate (dagger).
Biochemistry 48: 2997-3004 ()
PM ID: 19220020
4: Grande F, Yamada R, Cao X, Aiello F, Garofalo A, Neamati N
Synthesis and biological evaluation of novel hydrazide based cytotoxic agents.
Expert Opin Investig Drugs 18: 555-68 ()
PM ID: 19388873
5: Burnett AF, Roman LD, Garcia AA, Muderspach LI, Brader KR, Morrow CP
A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix.
Gynecol Oncol 76: 63-6 (2000)
PM ID: 10620443
6: Perez CA, Matthay KK, Atkinson JB, Seeger RC, Shimada H, Haase GM, Stram DO, Gerbing RB, Lukens JN
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
J Clin Oncol 18: 18-26 (2000)
PM ID: 10623689
7: Keshelava N, Groshen S, Reynolds CP
Cross-resistance of topoisomerase I and II inhibitors in neuroblastoma cell lines.
Cancer Chemother Pharmacol 45: 1-8 (2000)
PM ID: 10647494
8: Nickerson HJ, Matthay KK, Seeger RC, Brodeur GM, Shimada H, Perez C, Atkinson JB, Selch M, Gerbing RB, Stram DO, Lukens JN
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
J Clin Oncol 18: 477-86 (2000)
PM ID: 10653863
9: Packer RJ, Raffel C, Villablanca JG, Tonn JC, Burdach SE, Burger K, LaFond D, McComb JG, Cogen PH, Vezina G, Kapcala LP
Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration.
J Neurosurg 92: 249-54 (2000)
PM ID: 10659011
10: Chen RL, Reynolds CP, Seeger RC
Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating.
Cancer Immunol Immunother 48: 603-12 (2000)
PM ID: 10663607
11: Lehman NL, Danenberg PV
Modulation of RTX cytotoxicity by thymidine and dipyridamole in vitro: implications for chemotherapy.
Cancer Chemother Pharmacol 45: 142-8 (2000)
PM ID: 10663629
12: Erdreich-Epstein A, Shimada H, Groshen S, Liu M, Metelitsa LS, Kim KS, Stins MF, Seeger RC, Durden DL
Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.
Cancer Res 60: 712-21 (2000)
PM ID: 10676658
13: Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR
Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages.
J Immunol 164: 1663-7 (2000)
PM ID: 10657608
14: Hornick JL, Sharifi J, Khawli LA, Hu P, Bai WG, Alauddin MM, Mizokami MM, Epstein AL
Single amino acid substitution in the Fc region of chimeric TNT-3 antibody accelerates clearance and improves immunoscintigraphy of solid tumors.
J Nucl Med 41: 355-62 (2000)
PM ID: 10688122
15: Wang Y, Einhorn PA, Triche TJ, Seeger RC, Reynolds CP
Expression of protein gene product 9.5 and tyrosine hydroxylase in childhood small round cell tumors.
Clin Cancer Res 6: 551-8 (2000)
PM ID: 10690538
16: Sirotnak FM, Danenberg KD, Chen J, Fritz F, Danenberg PV
Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms.
Biochem Biophys Res Commun 269: 21-4 (2000)
PM ID: 10694470
17: Taktakishvili M, Neamati N, Pommier Y, Nair V
Recognition and inhibition of HIV integrase by a novel dinucleotide.
Bioorg Med Chem Lett 10: 249-51 (2000)
PM ID: 10698446
18: Zhou Q, Hu P, Ritter MR, Swenson SD, Argounova S, Epstein AL, Markland FS
Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom.
Arch Biochem Biophys 375: 278-88 (2000)
PM ID: 10700384
19: Schmidt ML, Lukens JN, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Perez C, Haase GM, Matthay KK
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study.
J Clin Oncol 18: 1260-8 (2000)
PM ID: 10715296
20: Chandrasoma PT, Lokuhetty DM, DeMeester TR, Bremmer CG, Peters JH, Oberg S, Groshen S
Definition of histopathologic changes in gastroesophageal reflux disease.
Am J Surg Pathol 24: 344-51 (2000)
PM ID: 10716147
21: Wu BW, Lu J, Gallaher TK, Anderson WF, Cannon PM
Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.
Virology 269: 7-17 (2000)
PM ID: 10725193
22: Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW
MethyLight: a high-throughput assay to measure DNA methylation.
Nucleic Acids Res 28: E32 (2000)
PM ID: 10734209 PMC102836
23: Hoffman DM, Gitlitz BJ, Belldegrun AS, Figlin RA
Adoptive cellular therapy.
Semin Oncol 27: 221-33 (2000)
PM ID: 10768601
24: Hinkel A, Tso CL, Gitlitz BJ, Neagos N, Schmid I, Paik SH, deKernion JB, Figlin R, Belldegrun AS
Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
J Immunother 23: 83-93 (2000)
PM ID: 10687141
25: Bridge JA, Liu JF, Weibolt V, Baker KS, Perry D, Kruger R, Qualman SJ, Barr FG, Sorensen PH, Triche TJ, Suijkerbuijk R
Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study.
Genes Chromosomes Cancer 27: 337-44 (2000)
PM ID: 10719362
26: Quinn DI, Henshall SM, Head DR, Golovsky D, Wilson JD, Brenner PC, Turner JJ, Delprado W, Finlayson JF, Stricker PD, Grygiel JJ, Sutherland RL
Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy.
Cancer Res 60: 1585-94 (2000)
PM ID: 10749127
27: Luna MC, Ferrario A, Wong SG, Fisher AM, Gomer CJ
Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter.
Cancer Res 60: 1637-44 (2000)
PM ID: 10749134
28: Roth MD, Gitlitz BJ, Kiertscher SM, Park AN, Mendenhall M, Moldawer N, Figlin RA
Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.
Cancer Res 60: 1934-41 (2000)
PM ID: 10766183
29: Ortega JA, Rowland JH, Monforte HL, Malogolowkin MH, Triche TJ
Presence of well-differentiated rhabdomyoblasts at the end of therapy for pelvic rhabdomyosarcoma: implications for the outcome.
J Pediatr Hematol Oncol 22: 106-11 (2000)
PM ID: 10779022
30: Rodger A, Sanders KJ, Hannon MJ, Meistermann I, Parkinson A, Vidler DS, Haworth IS
DNA structure control by polycationic species: polyamine, cobalt ammines, and di-metallo transition metal chelates.
Chirality 12: 221-36 (2000)
PM ID: 10790193
31: Leder GH, Pillasch J, Kornmann M, Danenberg PV, Link KH
Theoretical considerations and in vitro concentration response studies with two human colorectal carcinoma cell lines. The rational experimental base for clinical studies in regional chemotherapy.
Gan To Kagaku Ryoho 27: 565-77 (2000)
PM ID: 10790999
32: Conti PS, Keppler JS
New indications give PET a lift after struggle over regulatory and reimbursement issues.
Diagn Imaging (San Franc) 22: 40-7 (2000)
PM ID: 10848425
33: Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM, Johansson J, Skinner KA, Chandrasoma PT, DeMeester SR, Bremner CG, Tsai PI, Danenberg PV
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.
J Gastrointest Surg 4: 135-42 (2000)
PM ID: 10675236
34: Pouliot M, Clish CB, Petasis NA, Van Dyke TE, Serhan CN
Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease.
Biochemistry 39: 4761-8 (2000)
PM ID: 10769133
35: Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
J Clin Oncol 18: 1888-99 (2000)
PM ID: 10784629
36: Liang GS, Loevner LA, Kumar PG
Laryngeal rhabdomyoma involving the paraglottic space.
AJR Am J Roentgenol 174: 1285-7 (2000)
PM ID: 10789777
37: Banerjee D, Gorlick R, Liefshitz A, Danenberg K, Danenberg PC, Danenberg PV, Klimstra D, Jhanwar S, Cordon-Cardo C, Fong Y, Kemeny N, Bertino JR
Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase.
Cancer Res 60: 2365-7 (2000)
PM ID: 10811110
38: Salem C, Liang G, Tsai YC, Coulter J, Knowles MA, Feng AC, Groshen S, Nichols PW, Jones PA
Progressive increases in de novo methylation of CpG islands in bladder cancer.
Cancer Res 60: 2473-6 (2000)
PM ID: 10811126
39: Gururangan S, Sposto R, Cairo MS, Meadows AT, Finlay JL
Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study.
J Clin Oncol 18: 2017-25 (2000)
PM ID: 10811665
40: Liu D, Naritoku WY, Tsao-Wei DD, Groshen S, Neville MA, Taylor CR, Cote RJ, Imam SA
LEA.135 expression: an independent and favorable prognostic biomarker for patients with primary invasive breast cancer.
Int J Cancer 89: 224-9 (2000)
PM ID: 10861497
41: Hoffmann S, Masood R, Zhang Y, He S, Ryan SJ, Gill P, Hinton DR
Selective killing of RPE with a vascular endothelial growth factor chimeric toxin.
Invest Ophthalmol Vis Sci 41: 2389-93 (2000)
PM ID: 10892888
42: Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB, Danenberg PV
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
Clin Cancer Res 6: 1322-7 (2000)
PM ID: 10778957
43: Zhang L, da Costa SR, Yarber FA, Runnegar M, Hamm-Alvarez SF
Protein phosphatase inhibitors alter cellular microtubules and reduce carbachol-dependent protein secretion in lacrimal acini.
Curr Eye Res 20: 373-83 (2000)
PM ID: 10855032
44: Sands SA, Van Gorp WG, Finlay JL
A dramatic loss of non-verbal intelligence following a right parietal ependymoma: brief case report.
Psychooncology 9: 259-66 (2000)
PM ID: 10871722
45: Gordon EM, Liu PX, Chen ZH, Liu L, Whitley MD, Gee C, Groshen S, Hinton DR, Beart RW, Hall FL
Inhibition of metastatic tumor growth in nude mice by portal vein infusions of matrix-targeted retroviral vectors bearing a cytocidal cyclin G1 construct.
Cancer Res 60: 3343-7 (2000)
PM ID: 10910035
46: Ladner RD, Lynch FJ, Groshen S, Xiong YP, Sherrod AE, Caradonna SJ, Stoehlmacher J, Lenz HJ
dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
Cancer Res 60: 3493-503 (2000)
PM ID: 10910061
47: Link KH, Kornmann M, Butzer U, Leder G, Sunelaitis E, Pillasch J, Salonga D, Danenberg KD, Danenberg PV, Beger HG
Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy.
Cancer 89: 288-96 (2000)
PM ID: 10918158
48: Israel VP, Garcia AA, Roman LD, Muderspach L, Burnett A, Jeffers S, Muggia FM
Phase II study of liposomal doxorubicin in advanced gynecologic cancers.
Gynecol Oncol 78: 143-7 (2000)
PM ID: 10926793
49: Bodey B, Bodey B, Siegel SE, Kaiser HE
Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors.
Anticancer Res 20: 1759-68 (2000)
PM ID: 10928105
50: Bodey B, Bodey B, Siegel SE, Kaiser HE
Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors.
Anticancer Res 20: 1769-80 (2000)
PM ID: 10928106
51: Bodey B, Bodey B, Siegel SE, Kaiser HE
The role of the reticulo-epithelial (RE) cell network in the immuno-neuroendocrine regulation of intrathymic lymphopoiesis.
Anticancer Res 20: 1871-88 (2000)
PM ID: 10928121
52: Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ
Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Cancer Res 60: 4066-9 (2000)
PM ID: 10945611
53: Bodey B, Bodey B, Gröger AM, Siegel SE, Kaiser HE
Immunocytochemical detection of homeobox B3, B4, and C6 gene product expression in lung carcinomas.
Anticancer Res 20: 2711-6 (2000)
PM ID: 10953348
54: Bodey B, Bodey B, Siegel SE, Luck JV, Kaiser HE
Homeobox B3, B4, and C6 gene product expression in osteosarcomas as detected by immunocytochemistry.
Anticancer Res 20: 2717-21 (2000)
PM ID: 10953349
55: Antunes NL, Khakoo Y, Matthay KK, Seeger RC, Stram DO, Gerstner E, Abrey LE, Dalmau J
Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.
J Pediatr Hematol Oncol 22: 315-20 (2000)
PM ID: 10959901
56: Meng WS, von Grafenstein H, Haworth IS
Water dynamics at the binding interface of four different HLA-A2-peptide complexes.
Int Immunol 12: 949-57 (2000)
PM ID: 10882406
57: Stripecke R, Cardoso AA, Pepper KA, Skelton DC, Yu XJ, Mascarenhas L, Weinberg KI, Nadler LM, Kohn DB
Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage- colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses.
Blood 96: 1317-26 (2000)
PM ID: 10942373
58: Thomas PR, Deutsch M, Kepner JL, Boyett JM, Krischer JP, Aronin P, Albright L, Allen JC, Packer RJ, Linggood R, Mulhern R, Stehbens JA, Langston J, Stanley P, Duffner P, Rorke LB, Cherlow J, Friedman HS, Finlay JL, Vietti TJ, Kun LE
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.
J Clin Oncol 18: 3004-11 (2000)
PM ID: 10944134
59: Pluymers W, Neamati N, Pannecouque C, Fikkert V, Marchand C, Burke TR, Pommier Y, Schols D, De Clercq E, Debyser Z, Witvrouw M
Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters.
Mol Pharmacol 58: 641-8 (2000)
PM ID: 10953059
60: Formenti SC, Lieskovsky G, Skinner DG, Tsao-Wei DD, Groshen S, Petrovich Z
Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparing prostatectomy.
Urology 56: 453-8 (2000)
PM ID: 10962314
61: Umehara S, Nakagawa A, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Shimada H
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.
Cancer 89: 1150-61 (2000)
PM ID: 10964346
62: Bading JR, Shahinian AH, Bathija P, Conti PS
Pharmacokinetics of the thymidine analog 2'-fluoro-5-[(14)C]-methyl-1-beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells.
Nucl Med Biol 27: 361-8 (2000)
PM ID: 10938471
63: Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, Peters JH, DeMeester TR, Danenberg KD, Danenberg PV, Laird PW, Skinner KA
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.
Cancer Res 60: 5021-6 (2000)
PM ID: 11016622
64: Moore JD, Dezube BJ, Gill P, Zhou XJ, Acosta EP, Sommadossi JP
Phase I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl) fumagillol (TNP-470) and its metabolites in AIDS patients with Kaposi's sarcoma.
Cancer Chemother Pharmacol 46: 173-9 (2000)
PM ID: 11021733
65: Crockard A, Kumar PG, Tinker J
Medicine in the millennium: confronting the issues.
Ann R Coll Surg Engl 82: 257-9 (2000)
PM ID: 11045079
66: Kumar PG
Impact of anemia in patients with head and neck cancer.
Oncologist 5 Suppl 2: 13-8 (2000)
PM ID: 10896324
67: Papadakis V, Dunkel IJ, Cramer LD, Kramer E, Papadopoulos E, Goldman S, Packer RJ, Willoughby M, Baker D, Garvin J, Strandjord S, Coccia P, Kaplan AM, Klemperer M, Finlay JL
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors.
Bone Marrow Transplant 26: 153-60 (2000)
PM ID: 10918425
68: Pommier Y, Marchand C, Neamati N
Retroviral integrase inhibitors year 2000: update and perspectives.
Antiviral Res 47: 139-48 (2000)
PM ID: 10974366
69: Robbins KT, Kumar PG, Wong FS, Hartsell WF, Flick P, Palmer RF, Weir AB, Neill HB, Murry T, Ferguson R, Hanchett C, Vieira F, Bush A, Howell SB
Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients.
Head Neck 22: 687-93 (2000)
PM ID: 11002324
70: Prakash GK, Mandal M, Schweizer S, Petasis NA, Olah GA
A facile stereocontrolled synthesis of anti-alpha-(trifluoromethyl)-beta-amino alcohols.
Org Lett 2: 3173-6 (2000)
PM ID: 11009374
71: Bading JR, Alauddin MM, Fissekis JD, Shahinian AH, Joung J, Spector T, Conti PS
Blocking catabolism with eniluracil enhances PET studies of 5-[18F]fluorouracil pharmacokinetics.
J Nucl Med 41: 1714-24 (2000)
PM ID: 11038003
72: Bodey B, Bodey B, Siegel SE, Kaiser HE
Immunocytochemical detection of the homeobox B3, B4, and C6 gene products within the human thymic cellular microenvironment.
In Vivo 14: 419-24 (2000)
PM ID: 10904875
73: Roebuck DJ, Villablanca JG, Maher K, Nelson MD
Surveillance imaging in children with medulloblastoma (posterior fossa PNET).
Pediatr Radiol 30: 447-50 (2000)
PM ID: 10929362
74: Rosenthal MA, Gruber ML, Glass J, Nirenberg A, Finlay J, Hochster HS, Muggia FM
Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme.
J Neurooncol 47: 59-63 (2000)
PM ID: 10930101
75: Zhou Q, Sherwin RP, Parrish C, Richters V, Groshen SG, Tsao-Wei DD, Markland FS
Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression.
Breast Cancer Res Treat 61: 249-60 (2000)
PM ID: 10966001
76: Wang Y, Duncan R, Ann DK, Hamm-Alvarez SF
Identification of a novel taxol-sensitive kinase activity associated with the cytoskeleton.
Biochem Biophys Res Commun 277: 525-30 (2000)
PM ID: 11061987
77: Bodey B, Bodey B, Siegel SE, Kaiser HE
Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in breast carcinomas.
Anticancer Res 20: 3281-6 (2000)
PM ID: 11062754
78: Bodey B, Bodey B, Siegel SE, Kaiser HE
Matrix metalloproteinase expression in childhood astrocytomas.
Anticancer Res 20: 3287-92 (2000)
PM ID: 11062755
79: Dunkel IJ, Aledo A, Kernan NA, Kushner B, Bayer L, Gollamudi SV, Finlay JL, Abramson DH
Successful treatment of metastatic retinoblastoma.
Cancer 89: 2117-21 (2000)
PM ID: 11066053
80: Yang Q, Olshan AF, Bondy ML, Shah NR, Pollock BH, Seeger RC, Look AT, Cohn SL
Parental smoking and alcohol consumption and risk of neuroblastoma.
Cancer Epidemiol Biomarkers Prev 9: 967-72 (2001)
PM ID: 11008916
81: Neamati N, Marchand C, Pommier Y
HIV-1 integrase inhibitors: past, present, and future.
Adv Pharmacol 49: 147-65 (2001)
PM ID: 11013763
82: Albright AL, Sposto R, Holmes EJ, Zeltzer PM, Finlay JL, Wisoff JH, Berger MS, Packer RJ, Pollack IF
Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors.
Neurosurgery 47: 879-85; discussion 885-7 (2001)
PM ID: 11014428
83: da Costa SR, Wang Y, Vilalta PM, Schönthal AH, Hamm-Alvarez SF
Changes in cytoskeletal organization in polyoma middle T antigen-transformed fibroblasts: involvement of protein phosphatase 2A and src tyrosine kinases.
Cell Motil Cytoskeleton 47: 253-68 (2001)
PM ID: 11093247
84: Wu L, Chen PC, Shum CH, Chen CS, Barsky LW, Weinberg KI, Jong A, Triche TJ
MAT1-modulated CAK activity regulates cell cycle G(1) exit.
Mol Cell Biol 21: 260-70 (2001)
PM ID: 11113200 PMC88799
85: Seeger RC, Reynolds CP, Gallego R, Stram DO, Gerbing RB, Matthay KK
Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.
J Clin Oncol 18: 4067-76 (2001)
PM ID: 11118468
86: Ozkaynak MF, Sondel PM, Krailo MD, Gan J, Javorsky B, Reisfeld RA, Matthay KK, Reaman GH, Seeger RC
Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study.
J Clin Oncol 18: 4077-85 (2001)
PM ID: 11118469
87: Buckley JD, Meadows AT, Kadin ME, Le Beau MM, Siegel SE, Robison LL
Pesticide exposures in children with non-Hodgkin lymphoma.
Cancer 89: 2315-21 (2001)
PM ID: 11147603
88: Greaves TS, Olvera M, Florentine BD, Raza AS, Cobb CJ, Tsao-Wei DD, Groshen S, Singer P, Lopresti J, Martin SE
Follicular lesions of thyroid: a 5-year fine-needle aspiration experience.
Cancer 90: 335-41 (2001)
PM ID: 11156516
89: Kumar PG, Orton CI, McWilliam LJ, Watson S
Incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit.
Br J Plast Surg 53: 563-6 (2001)
PM ID: 11000071
90: Safra T, Muggia FM, Jeffers S, Tsao-Wei DD, Groshen S, Lyass O, Henderson R, Berry G, Gabizon A
Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.
Ann Oncol 11: 1029-33 (2001)
PM ID: 11038041
91: Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion JB, Belldegrun AS
Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Cancer J 6: 220-33 (2001)
PM ID: 11038142
92: Chen IJ, Neamati N, Nicklaus MC, Orr A, Anderson LA, Barchi JJ, Kelley JA, Pommier Y, MacKerell AD
Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targets.
Bioorg Med Chem 8: 2385-98 (2001)
PM ID: 11058033
93: Kumar PG
Tumor hypoxia and anemia: impact on the efficacy of radiation therapy.
Semin Hematol 37: 4-8 (2001)
PM ID: 11068949
94: Keshelava N, Zuo JJ, Waidyaratne NS, Triche TJ, Reynolds CP
p53 mutations and loss of p53 function confer multidrug resistance in neuroblastoma.
Med Pediatr Oncol 35: 563-8 (2001)
PM ID: 11107118
95: Goto H, Keshelava N, Matthay KK, Lukens JN, Gerbing RB, Stram DO, Seeger RC, Reynolds CP
Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors.
Med Pediatr Oncol 35: 619-22 (2001)
PM ID: 11107131
96: Choi LM, Kim NW, Zuo JJ, Gerbing RB, Stram D, Lukens JN, Matthay KK, Seeger RC, Reynolds CP
Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma.
Med Pediatr Oncol 35: 647-50 (2001)
PM ID: 11107138
97: Park JR, Slattery JT, Gooley T, Hawkins D, Lindsley KL, Villablanca JG, Matthay KK, Sanders JE
Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors.
Med Pediatr Oncol 35: 719-23 (2001)
PM ID: 11107155
98: Daniels JL, Olshan AF, Teschke K, Hertz-Picciotto I, Savitz DA, Blatt J, Bondy ML, Neglia JP, Pollock BH, Cohn SL, Look AT, Seeger RC, Castleberry RP
Residential pesticide exposure and neuroblastoma.
Epidemiology 12: 20-7 (2001)
PM ID: 11138814
99: Der R, Tsao-Wei DD, DeMeester TR, Peters JH, Groshen S, Lord RV, Chandrasoma PT
Carditis: a manifestation of gastroesophageal reflux disease.
Am J Surg Pathol 25: 245-52 (2001)
PM ID: 11176074
100: Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, Brenner PC, Delprado W, Stricker PD, Grygiel JJ, Sutherland RL
Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer.
Cancer Res 61: 423-7 (2001)
PM ID: 11212224
101: Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM, White PS
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Cancer Res 61: 679-86 (2001)
PM ID: 11212268
102: Bodey B, Bodey B, Siegel SE, Kaiser HE
Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas.
In Vivo 14: 659-66 (2001)
PM ID: 11212843
103: Bodey B, Bodey B, Siegel SE, Kaiser HE
Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors.
In Vivo 14: 667-73 (2001)
PM ID: 11212844
104: Bodey B, Bodey B, Siegel SE, Kaiser HE
Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
In Vivo 14: 675-82 (2001)
PM ID: 11212845
105: Stein JP, Lieskovsky G, Cote RJ, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.
J Clin Oncol 19: 666-75 (2001)
PM ID: 11157016
106: Brabender J, Lenz HJ, Danenberg PV
[Molecular markers as basis for chemotherapy?]
Chirurg 71: 1433-9 (2001)
PM ID: 11195061
107: Kaiser HE, Bodey B, Siegel SE, Gröger AM, Bodey B
Spontaneous neoplastic regression: the significance of apoptosis.
In Vivo 14: 773-88 (2001)
PM ID: 11212857
108: Ward BK, Kumar PG, Turbett GR, Edmondston JE, Papadimitriou JM, Laing NG, Ingram DM, Minchin RF, Ratajczak T
Allelic loss of cyclophilin 40, an estrogen receptor-associated immunophilin, in breast carcinomas.
J Cancer Res Clin Oncol 127: 109-15 (2001)
PM ID: 11216911
109: Quinn DI
The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.
N Engl J Med 344: 686; author reply 687-8 (2001)
PM ID: 11229338
110: Formenti SC, Felix J, Salonga D, Danenberg K, Pike MC, Danenberg P
Expression of metastases-associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle.
Clin Cancer Res 6: 4653-7 (2001)
PM ID: 11156216
111: Gordon EM, Chen ZH, Liu L, Whitley MD, Liu L, Wei D, Groshen S, Hinton DR, Anderson WF, Beart RW, Hall FL
Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice.
Hum Gene Ther 12: 193-204 (2001)
PM ID: 11177556
112: Iqbal S, Lenz HJ
Determinants of prognosis and response to therapy in colorectal cancer.
Curr Oncol Rep 3: 102-8 (2001)
PM ID: 11177741
113: DiPaola RS, Kumar PG, Hait WN, Weiss RE
State-of-the-art prostate cancer treatment and research. A report from the Cancer Institute of New Jersey.
N J Med 98: 23-33 (2001)
PM ID: 11221439
114: Lord RV, Tsai PI, Danenberg KD, Peters JH, DeMeester TR, Tsao-Wei DD, Groshen S, Salonga D, Park JM, Crookes PF, Kiyabu M, Chandrasoma PT, Danenberg PV
Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence.
Surgery 129: 267-76 (2001)
PM ID: 11231454
115: Zisman A, Pantuck AJ, Dorey F, Said JW, Shvarts O, Quintana D, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS
Improved prognostication of renal cell carcinoma using an integrated staging system.
J Clin Oncol 19: 1649-57 (2001)
PM ID: 11250993
116: Reynolds CP, Seeger RC
Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma.
J Pediatr Hematol Oncol 23: 150-2 (2001)
PM ID: 11305717
117: Kuehne J, Biernacki P, Kleisli T, Streeter O, Beart RW
Continence Preservation in the Management of Recurrent Rectal Cancer: Booth P25.
Dis Colon Rectum 44: A27-A59 (2001)
PM ID: 11373539
118: Kawakami K, Brabender J, Lord RV, Groshen S, Greenwald BD, Krasna MJ, Yin J, Fleisher AS, Abraham JM, Beer DG, Sidransky D, Huss HT, DeMeester TR, Eads CA, Laird PW, Ilson DH, Kelsen DP, Harpole DH, Moore MB, Danenberg KD, Danenberg PV, Meltzer SJ
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.
J Natl Cancer Inst 92: 1805-11 (2001)
PM ID: 11078757
119: Chirayil PT, Jayaraj J, Kumar PG
Infantile digital fibromatosis - a case report.
Burns 27: 89-90 (2001)
PM ID: 11164672
120: Lin AH, Kasahara N, Wu W, Stripecke R, Empig CL, Anderson WF, Cannon PM
Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein.
Hum Gene Ther 12: 323-32 (2001)
PM ID: 11242525
121: Triche TJ, Schofield D, Buckley JD
DNA microarrays in pediatric cancer.
Cancer J 7: 2-15 (2001)
PM ID: 11269644
122: Christodoulopoulos I, Cannon PM
Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors.
J Virol 75: 4129-38 (2001)
PM ID: 11287562 PMC114158
123: Grem JL, Danenberg KD, Behan K, Parr A, Young L, Danenberg PV, Nguyen D, Drake JA, Monks A, Allegra CJ
Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
Clin Cancer Res 7: 999-1009 (2001)
PM ID: 11309351
124: Rudnick E, Khakoo Y, Antunes NL, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Matthay KK
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
Med Pediatr Oncol 36: 612-22 (2001)
PM ID: 11344492
125: Cooper RM, Khakoo Y, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Nakagawa A, Shimada H
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
Med Pediatr Oncol 36: 623-9 (2001)
PM ID: 11344493
126: Hamm-Alvarez SF, Chang A, Wang Y, Jerdeva G, Lin HH, Kim KJ, Ann DK
Etk/Bmx activation modulates barrier function in epithelial cells.
Am J Physiol Cell Physiol 280: C1657-68 (2001)
PM ID: 11350762
127: Romero RM, Rojsitthisak P, Haworth IS
DNA interstrand crosslink formation by mechlorethamine at a cytosine-cytosine mismatch pair: kinetics and sequence dependence.
Arch Biochem Biophys 386: 143-53 (2001)
PM ID: 11368336
128: Brabender J, Lord RV, Danenberg KD, Metzger R, Schneider PM, Uetake H, Kawakami K, Park JM, Salonga D, Peters JH, DeMeester TR, Hölscher AH, Danenberg PV
Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
J Gastrointest Surg 5: 174-81; discussion 182 (2001)
PM ID: 11331481
129: Gan Y, Mo Y, Kalns JE, Lu J, Danenberg K, Danenberg P, Wientjes MG, Au JL
Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors.
Clin Cancer Res 7: 1313-9 (2001)
PM ID: 11350900
130: Kumar PG, Mark PJ, Ward BK, Minchin RF, Ratajczak T
Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells.
Biochem Biophys Res Commun 284: 219-25 (2001)
PM ID: 11374893
131: Brabender J, Usadel H, Danenberg KD, Metzger R, Schneider PM, Lord RV, Wickramasinghe K, Lum CE, Park JM, Salonga D, Singer JB, Sidransky D, Hölscher AH, Meltzer SJ, Danenberg PV
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
Oncogene 20: 3528-32 (2001)
PM ID: 11429699
132: Simon J, Salzbrunn S, Prakash GK, Petasis NA, Olah GA
Regioselective conversion of arylboronic acids to phenols and subsequent coupling to symmetrical diaryl ethers.
J Org Chem 66: 633-4 (2001)
PM ID: 11429844
133: Neamati N
Structure-based HIV-1 integrase inhibitor design: a future perspective.
Expert Opin Investig Drugs 10: 281-96 (2001)
PM ID: 11178341
134: Bodey B, Bodey B, Siegel SE, Kaiser HE
Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
In Vivo 15: 57-64 (2001)
PM ID: 11286131
135: Bodey B, Bodey B, Siegel SE, Kaiser HE
Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas.
In Vivo 15: 71-6 (2001)
PM ID: 11286133
136: Gitlitz BJ, Hoffman DM, Moldawer N, Belldegrun AS, Figlin RA
Treatment of metastatic renal cell carcinoma with high-dose bolus interleukin-2 in a non-intensive care unit: an analysis of 124 consecutively treated patients.
Cancer J 7: 112-20 (2001)
PM ID: 11324764
137: Khadilkar UN, Pai RR, Lahiri R, Kumar PG
Ovarian strumal carcinoid--report of a case that matastasized.
Indian J Pathol Microbiol 43: 459-61 (2001)
PM ID: 11344613
138: Anton PA, Poles MA, Elliott J, Mao SH, McGowan I, Lenz HJ, Chen IS
Sensitive and reproducible quantitation of mucosal HIV-1 RNA and DNA viral burden in patients with detectable and undetectable plasma viral HIV-1 RNA using endoscopic biopsies.
J Virol Methods 95: 65-79 (2001)
PM ID: 11377714
139: Keppler JS, Conti PS
A cost analysis of positron emission tomography.
AJR Am J Roentgenol 177: 31-40 (2001)
PM ID: 11418393
140: Logg CR, Logg A, Tai CK, Cannon PM, Kasahara N
Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.
J Virol 75: 6989-98 (2001)
PM ID: 11435579 PMC114427
141: Zisman A, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, de Kernion JB, Figlin RA, Belldegrun AS
Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome.
J Urol 166: 54-8 (2001)
PM ID: 11435822
142: Kannan R, Stolz A, Ji Q, Prasad PD, Ganapathy V
Vitamin C transport in human lens epithelial cells: evidence for the presence of SVCT2.
Exp Eye Res 73: 159-65 (2001)
PM ID: 11446766
143: Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL
Frequent loss of estrogen receptor-beta expression in prostate cancer.
Cancer Res 61: 5331-5 (2001)
PM ID: 11454669
144: Isogai C, Laug WE, Shimada H, Declerck PJ, Stins MF, Durden DL, Erdreich-Epstein A, Declerck YA
Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin.
Cancer Res 61: 5587-94 (2001)
PM ID: 11454712
145: Ghosh S, Weiss M, Streeter O, Sinha U, Commins D, Chen TC
Drop metastasis from sinonasal undifferentiated carcinoma: clinical implications.
Spine (Phila Pa 1976) 26: 1486-91 (2001)
PM ID: 11458156
146: Garcia AA, Leichman CG, Lenz HJ, Baranda J, Lujan R, Casagrande Y, Leichman L
Phase II trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic, measurable adenocarcinoma of the stomach.
Jpn J Clin Oncol 31: 275-8 (2001)
PM ID: 11463806
147: Maris JM, Guo C, White PS, Hogarty MD, Thompson PM, Stram DO, Gerbing RB, Matthay KK, Seeger RC, Brodeur GM
Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.
Med Pediatr Oncol 36: 24-7 (2001)
PM ID: 11464895
148: Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM, Brodeur GM, Stram DO, Seeger RC, Gerbing RB, Matthay KK, Matise TC, White PS
Loss of heterozygosity for chromosome 14q in neuroblastoma.
Med Pediatr Oncol 36: 28-31 (2001)
PM ID: 11464899
149: Maris JM, Guo C, Blake DR, White PS, Hogarty MD, Thompson PM, Rajalingam V, Gerbing RB, Stram DO, Matthay KK, Seeger RC, Brodeur GM
Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Med Pediatr Oncol 36: 32-6 (2001)
PM ID: 11464900
150: Brabender J, Lord RV, Danenberg KD, Metzger R, Schneider PM, Park JM, Salonga D, Groshen S, Tsao-Wei DD, DeMeester TR, Hölscher AH, Danenberg PV
Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
J Surg Res 99: 301-6 (2001)
PM ID: 11469901
151: Lara PN, Gandara DR, Longmate J, Gumerlock PH, Lau DH, Edelman MJ, Gandour-Edwards R, Mack PC, Israel V, Raschko J, Frankel P, Perez EA, Lenz HJ, Doroshow JH
Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial.
Cancer Chemother Pharmacol 48: 22-8 (2001)
PM ID: 11488520
152: Gitlitz BJ, Belldegrun AS, Figlin RA
Vaccine and gene therapy of renal cell carcinoma.
Semin Urol Oncol 19: 141-7 (2001)
PM ID: 11354534
153: Taktakishvili M, Neamati N, Pommier Y, Nair V
Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV-1 integrase.
Bioorg Med Chem Lett 11: 1433-5 (2001)
PM ID: 11378371
154: Tetef ML, Synold TW, Chow WA, Leong LA, Margolin K, Morgan RJ, Raschko J, Shibata SI, Somlo G, Yen Y, Groshen S, Johnson KC, Lenz HJ, Gandara D, Doroshow JH
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.
Clin Cancer Res 7: 1569-76 (2001)
PM ID: 11410492
155: Zhang XK, Neamati N, Lee YK, Orr A, Brown RD, Whitaker N, Pommier Y, Burke TR
Arylisothiocyanate-containing esters of caffeic acid designed as affinity ligands for HIV-1 integrase.
Bioorg Med Chem 9: 1649-57 (2001)
PM ID: 11425564
156: Hoon DS, Kuo CT, Wen S, Wang H, Metelitsa LS, Reynolds CP, Seeger RC
Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow.
Am J Pathol 159: 493-500 (2001)
PM ID: 11485908 PMC1850569
157: Marchand C, Neamati N, Pommier Y
In vitro human immunodeficiency virus type 1 integrase assays.
Methods Enzymol 340: 624-33 (2001)
PM ID: 11494874
158: Bodey B, Bodey B, Siegel SE, Kaiser HE
Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.
Anticancer Res 21: 2021-8 (2001)
PM ID: 11497292
159: Quinn DI, Henshall SM, Haynes AM, Brenner PC, Kooner R, Golovsky D, Mathews J, O'Neill GF, Turner JJ, Delprado W, Finlayson JF, Sutherland RL, Grygiel JJ, Stricker PD
Prognostic significance of pathologic features in localized prostate cancer treated with radical prostatectomy: implications for staging systems and predictive models.
J Clin Oncol 19: 3692-705 (2001)
PM ID: 11504751
160: Keshelava N, Zuo JJ, Chen PC, Waidyaratne SN, Luna MC, Gomer CJ, Triche TJ, Reynolds CP
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.
Cancer Res 61: 6185-93 (2001)
PM ID: 11507071
161: Fu CH, Martin-Aragon S, Weinberg KI, Ardi VC, Danenberg PV, Avramis VI
Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein.
Cancer Chemother Pharmacol 48: 123-33 (2001)
PM ID: 11561778
162: Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, Brenner PC, Delprado W, Stricker PD, Grygiel JJ, Sutherland RL
Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients.
Clin Cancer Res 7: 544-50 (2001)
PM ID: 11297246
163: Brabender J, Danenberg KD, Metzger R, Schneider PM, Park JM, Salonga D, Hölscher AH, Danenberg PV
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.
Clin Cancer Res 7: 1850-5 (2001)
PM ID: 11448895
164: Ladanyi M, Chan WC, Triche TJ, Gerald WL
Expression profiling of human tumors: the end of surgical pathology?
J Mol Diagn 3: 92-7 (2001)
PM ID: 11486047 PMC1906955
165: Mark PJ, Ward BK, Kumar PG, Lahooti H, Minchin RF, Ratajczak T
Human cyclophilin 40 is a heat shock protein that exhibits altered intracellular localization following heat shock.
Cell Stress Chaperones 6: 59-70 (2001)
PM ID: 11525244 PMC434384
166: Wang W, Xue S, Ingles SA, Chen QR, Diep AT, Frankl HD, Stolz A, Haile RW
An association between genetic polymorphisms in the ileal sodium-dependent bile acid transporter gene and the risk of colorectal adenomas.
Cancer Epidemiol Biomarkers Prev 10: 931-6 (2001)
PM ID: 11535543
167: Lee PJ, Wang FF, Kuniyoshi J, Rubio V, Stuges T, Groshen S, Gee C, Lau RL, Jeffery GG, Margolin K, Marty V, Weber JS
Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma.
J Clin Oncol 19: 3836-47 (2001)
PM ID: 11559721
168: Safra T, Groshen S, Jeffers S, Tsao-Wei DD, Zhou L, Muderspach L, Roman LD, Morrow CP, Burnett A, Muggia FM
Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome.
Cancer 91: 90-100 (2001)
PM ID: 11148564
169: Bodey B, Bodey B, Siegel SE, Kaiser HE
Immunocytochemical detection of leukocyte-associated and apoptosis-related antigen expression in childhood brain tumors.
Crit Rev Oncol Hematol 39: 3-16 (2001)
PM ID: 11418297
170: Sands SA, Kellie SJ, Davidow AL, Diez B, Villablanca JG, Weiner HL, Pietanza MC, Balmaceda C, Finlay JL
Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: from the First International CNS Germ-Cell Tumor Study.
Neuro Oncol 3: 174-83 (2001)
PM ID: 11465398 PMC1920620
171: Goh J, Baird AW, O'Keane C, Watson RW, Cottell D, Bernasconi G, Petasis NA, Godson C, Brady HR, MacMathuna P
Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo.
J Immunol 167: 2772-80 (2001)
PM ID: 11509622
172: Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, Perussia B, Kronenberg M, Seeger RC
Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
J Immunol 167: 3114-22 (2001)
PM ID: 11544296
173: Shi Y, Brands FH, Chatterjee SJ, Feng AC, Groshen S, Schewe J, Lieskovsky G, Cote RJ
Her-2/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease.
J Urol 166: 1514-9 (2001)
PM ID: 11547123
174: Masood R, Gordon EM, Whitley MD, Wu BW, Cannon PM, Evans L, Anderson WF, Gill P, Hall FL
Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors.
Int J Mol Med 8: 335-43 (2001)
PM ID: 11562769
175: Bhattacharya R, Rao PV, Pant SC, Kumar PG, Tulsawani RK, Pathak U, Kulkarni AA, Vijayaraghavan R
Protective effects of amifostine and its analogues on sulfur mustard toxicity in vitro and in vivo.
Toxicol Appl Pharmacol 176: 24-33 (2001)
PM ID: 11578146
176: Nguyen C, Liang G, Nguyen TT, Tsao-Wei DD, Groshen S, Lübbert M, Zhou JH, Benedict WF, Jones PA
Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
J Natl Cancer Inst 93: 1465-72 (2001)
PM ID: 11584062
177: Dimmock JR, Kumar PG, Jha A, Quail JW
Synthesis and cytotoxicity of 1-phenyl-3,3-diacetoxy-1-propene.
Pharmazie 56: 744-5 (2001)
PM ID: 11593998
178: Pollack IF, Finkelstein SD, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Finlay JL, Sposto R, Children's Cancer Group
Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.
Cancer Res 61: 7404-7 (2001)
PM ID: 11606370
179: Borok Z, Harboe-Schmidt JE, Brody SL, You Y, Zhou B, Li X, Cannon PM, Kim KJ, Crandall ED, Kasahara N
Vesicular stomatitis virus G-pseudotyped lentivirus vectors mediate efficient apical transduction of polarized quiescent primary alveolar epithelial cells.
J Virol 75: 11747-54 (2001)
PM ID: 11689655 PMC114760
180: Tso CL, Zisman A, Pantuck AJ, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun AS
Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Cancer Res 61: 7925-33 (2001)
PM ID: 11691814
181: Alauddin MM, Shahinian A, Gordon EM, Bading JR, Conti PS
Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET.
J Nucl Med 42: 1682-90 (2001)
PM ID: 11696640
182: Sinha UK, Zim S, Maceri D
Frontotemporal reconstruction with hydroxyapatite cement and the radial forearm free flap.
Arch Facial Plast Surg 3: 271-6 (2001)
PM ID: 11710865
183: Stoehlmacher J, Ghaderi V, Iobal S, Groshen S, Tsao-Wei DD, Park DJ, Lenz HJ
A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer.
Anticancer Res 21: 3075-9 (2001)
PM ID: 11712813
184: Shirota Y, Stoehlmacher J, Brabender J, Xiong YP, Uetake H, Danenberg KD, Groshen S, Tsao-Wei DD, Danenberg PV, Lenz HJ
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.
J Clin Oncol 19: 4298-304 (2001)
PM ID: 11731512
185: Melek M, Jones JM, O'Dea MH, Pais GC, Burke TR, Pommier Y, Neamati N, Gellert M
Effect of HIV integrase inhibitors on the RAG1/2 recombinase.
Proc Natl Acad Sci U S A 99: 134-7 (2001)
PM ID: 11756686 PMC117527
186: Lau R, Wang FF, Jeffery GG, Marty V, Kuniyoshi J, Bade E, Ryback ME, Weber JS
Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma.
J Immunother 24: 66-78 (2001 Jan-Feb)
PM ID: 11211150
187: Lindberg J, Fernandez MA, Ropp JD, Hamm-Alvarez SF
Nocodazole treatment of CV-1 cells enhances nuclear/perinuclear accumulation of lipid-DNA complexes and increases gene expression.
Pharm Res 18: 246-9 (2002)
PM ID: 11405299
188: Tatlidil R, Conti PS, Conti PS
Gastric and colonic bypass grafts: FDG positron emission tomographic patterns.
Clin Nucl Med 26: 955-6 (2002)
PM ID: 11595859
189: Rojsitthisak P, Romero RM, Haworth IS
Extrahelical cytosine bases in DNA duplexes containing d[GCC](n).d[GCC](n) repeats: detection by a mechlorethamine crosslinking reaction.
Nucleic Acids Res 29: 4716-23 (2002)
PM ID: 11713322 PMC92524
190: Samant S, Robbins KT, Kumar PG, Ma JZ, Vieira F, Hanchett C
Bone or cartilage invasion by advanced head and neck cancer: intra-arterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation.
Arch Otolaryngol Head Neck Surg 127: 1451-6 (2002)
PM ID: 11735813
191: Chao DH, Zisman A, Pantuck AJ, Gitlitz BJ, Freedland SJ, Said JW, Figlin RA, Belldegrun AS
Collecting duct renal cell carcinoma: clinical study of a rare tumor.
J Urol 167: 71-4 (2002)
PM ID: 11743278
192: Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Cancer 92: 2699-708 (2002)
PM ID: 11745206
193: Sposto R, Meadows AT, Chilcote RR, Steinherz PG, Kjeldsberg CR, Kadin ME, Krailo MD, Termuhlen AM, Morse M, Siegel SE
Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group.
Med Pediatr Oncol 37: 432-41 (2002)
PM ID: 11745871
194: Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ
A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.
Cancer Res 61: 8654-8 (2002)
PM ID: 11751380
195: Kumar PG, Walcot N, Carpenter R, Uppal R
Concomitant off-pump myocardial revascularization and pheochromocytoma resection.
Ann Thorac Surg 72: 2139-41 (2002)
PM ID: 11789820
196: Marchand C, Zhang XK, Pais GC, Cowansage K, Neamati N, Burke TR, Pommier Y
Structural determinants for HIV-1 integrase inhibition by beta-diketo acids.
J Biol Chem 277: 12596-603 (2002)
PM ID: 11805103
197: Yamada K, Kumar PG, Goldstraw P
Cervical mediastinoscopy after total laryngectomy and radiotherapy: its feasibility.
Eur J Cardiothorac Surg 21: 71-3 (2002)
PM ID: 11788260
198: Grossfeld GD, Carroll PR, Lindeman N, Meng M, Groshen S, Feng AC, Hawes D, Cote RJ
Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression.
Urology 59: 97-102 (2002)
PM ID: 11796289
199: Sinha UK, Chang KE, Shih CW
Reconstruction of pharyngeal defects using AlloDerm and sternocleidomastoid muscle flap.
Laryngoscope 111: 1910-6 (2002)
PM ID: 11801968
200: Usadel H, Brabender J, Danenberg KD, Jerónimo C, Harden S, Engles J, Danenberg PV, Yang S, Sidransky D
Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.
Cancer Res 62: 371-5 (2002)
PM ID: 11809682
201: Pollack IF, Finkelstein SD, Woods J, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Boyett JM, Finlay JL, Sposto R, Children's Cancer Group
Expression of p53 and prognosis in children with malignant gliomas.
N Engl J Med 346: 420-7 (2002)
PM ID: 11832530
202: Dhodapkar KM, Dunkel IJ, Gardner S, Sapp M, Thoron L, Finlay J
Preliminary results of dose intensive pre-irradiation chemotherapy in patients older than 10 years of age with high risk medulloblastoma and supratentorial primitive neuroectodermal tumors.
Med Pediatr Oncol 38: 47-8 (2002)
PM ID: 11835236
203: Kawakami K, Salonga D, Park JM, Danenberg KD, Uetake H, Brabender J, Omura K, Watanabe G, Danenberg PV
Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.
Clin Cancer Res 7: 4096-101 (2002)
PM ID: 11751507
204: Neamati N
A small-molecule antagonist of virion assembly.
Expert Opin Investig Drugs 10: 1767-70 (2002)
PM ID: 11785455
205: Hamm-Alvarez SF
Focus on "EGF receptor downregulation depends on a trafficking motif in the distal tyrosine kinase domain".
Am J Physiol Cell Physiol 282: C417-9 (2002)
PM ID: 11832326
206: Graefen M, Karakiewicz PI, Cagiannos I, Klein EA, Kupelian PA, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, de Kernion J, Cangiano T, Schröder FH, Wildhagen MF, Scardino PT, Kattan MW
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.
J Clin Oncol 20: 951-6 (2002)
PM ID: 11844816
207: Wagner HN, Wiseman GA, Marcus CS, Nabi HA, Nagle CE, Fink-Bennett DM, Lamonica DM, Conti PS
Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody.
J Nucl Med 43: 267-72 (2002)
PM ID: 11850494
208: Formenti SC, Spicer D, Skinner KA, Cohen D, Groshen S, Bettini AC, Naritoku WY, Press MF, Salonga D, Tsao-Wei DD, Danenberg K, Danenberg P
Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer.
Int J Radiat Oncol Biol Phys 52: 397-405 (2002)
PM ID: 11872285
209: Anderson CP, Seeger RC, Satake N, Monforte-Munoz HL, Keshelava N, Bailey HH, Reynolds CP
Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line.
J Pediatr Hematol Oncol 23: 500-5 (2002)
PM ID: 11878777
210: Sinha UK, Shih C, Chang KJ, Rice DH
Use of AlloDerm for coverage of radial forearm free flap donor site.
Laryngoscope 112: 230-4 (2002)
PM ID: 11889375
211: Huang SH, Triche TJ, Jong AY
Infectomics: genomics and proteomics of microbial infections.
Funct Integr Genomics 1: 331-44 (2002)
PM ID: 11957108
212: Sharifi J, Khawli LA, Hu P, King S, Epstein AL
Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors.
Hybrid Hybridomics 20: 305-12 (2002)
PM ID: 11839248
213: Zisman A, Pantuck AJ, Dorey F, Chao DH, Gitlitz BJ, Moldawer N, Lazarovici D, deKernion JB, Figlin RA, Belldegrun AS
Mathematical model to predict individual survival for patients with renal cell carcinoma.
J Clin Oncol 20: 1368-74 (2002)
PM ID: 11870181
214: Yang L, Leong PK, Chen JO, Patel N, Hamm-Alvarez SF, McDonough AA
Acute hypertension provokes internalization of proximal tubule NHE3 without inhibition of transport activity.
Am J Physiol Renal Physiol 282: F730-40 (2002)
PM ID: 11880335
215: Brabender J, Park JM, Metzger R, Schneider PM, Lord RV, Hölscher AH, Danenberg KD, Danenberg PV
Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer.
Ann Surg 235: 440-3 (2002)
PM ID: 11882767 PMC1422451
216: Luna MC, Chen X, Wong SG, Tsui J, Rucker N, Lee AS, Gomer CJ
Enhanced photodynamic therapy efficacy with inducible suicide gene therapy controlled by the grp promoter.
Cancer Res 62: 1458-61 (2002)
PM ID: 11888920
217: Pullarkat ST, Stoehlmacher J, Ghaderi V, Xiong YP, Ingles SA, Sherrod AE, Warren R, Tsao-Wei DD, Groshen S, Lenz HJ
Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy.
Pharmacogenomics J 1: 65-70 (2002)
PM ID: 11913730
218: Kanzaki A, Toi M, Neamati N, Miyashita H, Oubu M, Nakayama K, Bando H, Ogawa K, Mutoh M, Mori S, Terada K, Sugiyama T, Fukumoto M, Takebayashi Y
Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma.
Jpn J Cancer Res 93: 70-7 (2002)
PM ID: 11802810
219: Stoehlmacher J, Ingles SA, Park DJ, Zhang W, Lenz HJ
The -9Ala/-9Val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma.
Oncol Rep 9: 235-8 (2002)
PM ID: 11836586
220: Brabender J, Danenberg KD, Metzger R, Schneider PM, Lord RV, Groshen S, Tsao-Wei DD, Park JM, Salonga D, Hölscher AH, Danenberg PV
The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer.
Clin Cancer Res 8: 438-43 (2002)
PM ID: 11839661
221: Lin AH, Cannon PM
Use of pseudotyped retroviral vectors to analyze the receptor-binding pocket of hemagglutinin from a pathogenic avian influenza A virus (H7 subtype).
Virus Res 83: 43-56 (2002)
PM ID: 11864740
222: Qian L, Yang T, Chen HM, Xie J, Zeng H, Warren DW, Macveigh M, Meneray MA, Hamm-Alvarez SF, Mircheff AK
Heterotrimeric GTP-binding proteins in the lacrimal acinar cell endomembrane system.
Exp Eye Res 74: 7-22 (2002)
PM ID: 11878814
223: Weiner HL, Lichtenbaum RA, Wisoff JH, Snow RB, Souweidane MM, Bruce JN, Finlay JL
Delayed surgical resection of central nervous system germ cell tumors.
Neurosurgery 50: 727-33; discussion 733-4 (2002)
PM ID: 11904022
224: Cairo MS, Krailo MD, Morse M, Hutchinson RJ, Harris RE, Kjeldsberg CR, Kadin ME, Radel E, Steinherz LJ, Morris E, Finlay JL, Meadows AT
Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report.
Leukemia 16: 594-600 (2002)
PM ID: 11960338
225: Erdreich-Epstein A, Monforte HL, Lavey RS, Joshi S, Phillips JD, Villablanca JG
Successful multimodality therapy of recurrent multifocal juvenile granulosa cell tumor of the ovary.
J Pediatr Hematol Oncol 24: 229-33 (2002)
PM ID: 11990313
226: Minz S, Sharma HP, Kumar PG, Nirala KP, Shrivastava SK, Khandelwal C
Solid--cystic papillary tumor of pancreas.
Indian J Pathol Microbiol 44: 463-4 (2002)
PM ID: 12035367
227: Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr FG
PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
J Clin Oncol 20: 2672-9 (2002)
PM ID: 12039929
228: Katsamba PS, Bayramyan M, Haworth IS, Myszka DG, Laird-Offringa IA
Complex role of the beta 2-beta 3 loop in the interaction of U1A with U1 hairpin II RNA.
J Biol Chem 277: 33267-74 (2002)
PM ID: 12082087
229: Metelitsa LS, Gillies SD, Super M, Shimada H, Reynolds CP, Seeger RC
Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.
Blood 99: 4166-73 (2002)
PM ID: 12010822
230: Pollack IF, Hamilton RL, Burnham J, Holmes EJ, Finkelstein SD, Sposto R, Yates AJ, Boyett JM, Finlay JL
Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Neurosurgery 50: 1238-44; discussion 1244-5 (2002)
PM ID: 12015841
231: Maderna P, Cottell DC, Berlasconi G, Petasis NA, Brady HR, Godson C
Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases.
Am J Pathol 160: 2275-83 (2002)
PM ID: 12057930 PMC1850826
232: Monabati A, Rakei SM, Kumar PG, Taghipoor M, Rahimi A
Primary burkitt lymphoma of the brain in an immunocompetent patient. Case report.
J Neurosurg 96: 1127-9 (2002)
PM ID: 12066916
233: Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC, Lenz HJ
Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.
J Natl Cancer Inst 94: 936-42 (2002)
PM ID: 12072547
234: Gitlitz BJ, Figlin RA, Pantuck AJ, Belldegrun AS
Dendritic cell-based immunotherapy of renal cell carcinoma.
Curr Urol Rep 2: 46-52 (2002)
PM ID: 12084295
235: Babu KG, Lokanath D, Kumar PG, Harita S, Nimit N, Girish R, Bapsy PP
A difficult diagnosis?
Lancet Oncol 3: 332 (2002)
PM ID: 12107019
236: Brabender J, Lord RV, Wickramasinghe K, Metzger R, Schneider PM, Park JM, Hölscher AH, DeMeester TR, Danenberg KD, Danenberg PV
Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.
J Gastrointest Surg 6: 359-67 (2002)
PM ID: 12022988
237: Pais GC, Zhang XK, Marchand C, Neamati N, Cowansage K, Svarovskaia ES, Pathak VK, Tang Y, Nicklaus MC, Pommier Y, Burke TR
Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors.
J Med Chem 45: 3184-94 (2002)
PM ID: 12109903
238: Bhardwaj K, Bal MS, Kumar PG
Rectal schwannoma.
Indian J Gastroenterol 21: 116-7 (2002)
PM ID: 12118926
239: Ferrario A, von Tiehl K, Wong SG, Luna M, Gomer CJ
Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response.
Cancer Res 62: 3956-61 (2002)
PM ID: 12124326
240: Packer RJ, Biegel JA, Blaney S, Finlay J, Geyer JR, Heideman R, Hilden JM, Janss AJ, Kun L, Vezina G, Rorke LB, Smith M
Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.
J Pediatr Hematol Oncol 24: 337-42 (2002)
PM ID: 12142780
241: Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, Finn RS, Bornmann W, Thaler H, Conti PS, Blasberg RG
Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression.
J Nucl Med 43: 1072-83 (2002)
PM ID: 12163634
242: Mircheff AK, Xie J, Qian L, Hamm-Alvarez SF
Diverse perturbations may alter the lacrimal acinar cell autoantigenic spectra.
DNA Cell Biol 21: 435-42 (2002)
PM ID: 12167246
243: Dunkel IJ, Finlay JL
High-dose chemotherapy with autologous stem cell rescue for brain tumors.
Crit Rev Oncol Hematol 41: 197-204 (2002)
PM ID: 11856595
244: Grem JL, Danenberg KD, Kao V, Danenberg PV, Nguyen D
Biochemical and molecular effects of UCN-01 in combination with 5-fluorodeoxyuridine in A431 human epidermoid cancer cells.
Anticancer Drugs 13: 259-70 (2002)
PM ID: 11984070
245: Sinha UK, Johnson TE, Crockett DM, Vadapalli S, Gruen P
Three-layer reconstruction for large defects of the anterior skull base.
Laryngoscope 112: 424-7 (2002)
PM ID: 12148847
246: Graefen M, Karakiewicz PI, Cagiannos I, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Klein EA, Kupelian P, Skinner DG, Lieskovsky G, Bochner B, Huland H, Hammerer PG, Haese A, Erbersdobler A, Eastham JA, de Kernion J, Cangiano T, Schröder FH, Wildhagen MF, van der Kwast TH, Scardino PT, Kattan MW
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
J Clin Oncol 20: 3206-12 (2002)
PM ID: 12149292
247: Barr FG, Qualman SJ, Macris MH, Melnyk N, Lawlor ER, Strzelecki DM, Triche TJ, Bridge JA, Sorensen PH
Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.
Cancer Res 62: 4704-10 (2002)
PM ID: 12183429
248: Wang JG, Barsky LW, Shum CH, Jong A, Weinberg KI, Collins SJ, Triche TJ, Wu L
Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha.
J Biol Chem 277: 43369-76 (2002)
PM ID: 12213824
249: József L, Zouki C, Petasis NA, Serhan CN, Filep JG
Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.
Proc Natl Acad Sci U S A 99: 13266-71 (2002)
PM ID: 12235371 PMC130622
250: Yen Y, Chow WA, Leong LA, Margolin K, Morgan RJ, Raschko J, Shibata SI, Somlo G, Twardowski P, Frankel P, Longmate J, Synold TW, Newman EM, Lenz HJ, Gandara D, Doroshow JH
Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial.
Cancer Chemother Pharmacol 50: 353-9 (2002)
PM ID: 12439592
251: Jadvar H, Conti PS
Diagnostic utility of FDG PET in multiple myeloma.
Skeletal Radiol 31: 690-4 (2002)
PM ID: 12483429
252: Salonga DS, Danenberg KD, Grem JL, Park JM, Danenberg PV
Relative gene expression in normal and tumor tissue by quantitative RT-PCR.
Methods Mol Biol 191: 83-98 (2002)
PM ID: 11951611
253: Khawli LA, Biela BH, Hu P, Epstein AL
Stable, genetically engineered F(ab')(2) fragments of chimeric TNT-3 expressed in mammalian cells.
Hybrid Hybridomics 21: 11-8 (2002)
PM ID: 11991812
254: Raghavan D, Quinn DI, Skinner DG, Stein JP
Surgery and adjunctive chemotherapy for invasive bladder cancer.
Surg Oncol 11: 55-63 (2002)
PM ID: 12031868
255: Kumar PG, Judson I, Nicholson AG, Ladas GP
Mediastinal hemangioma: successful treatment by alpha-2a interferon and postchemotherapy resection.
J Thorac Cardiovasc Surg 124: 404-6 (2002)
PM ID: 12167806
256: Tatlidil R, Jadvar H, Bading JR, Conti PS
Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings.
Radiology 224: 783-7 (2002)
PM ID: 12202714
257: Nakayama K, Kanzaki A, Ogawa K, Miyazaki K, Neamati N, Takebayashi Y
Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP.
Int J Cancer 101: 488-95 (2002)
PM ID: 12216079
258: Erdreich-Epstein A, Tran LB, Bowman NN, Wang H, Cabot MC, Durden DL, Vlckova J, Reynolds CP, Stins MF, Groshen S, Millard M
Ceramide signaling in fenretinide-induced endothelial cell apoptosis.
J Biol Chem 277: 49531-7 (2002)
PM ID: 12388538
259: Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ
Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer.
Int J Colorectal Dis 17: 46-9 (2002)
PM ID: 12018454
260: Prakash GK, Mandal M, Schweizer S, Petasis NA, Olah GA
Stereoselective synthesis of anti-alpha-(difluoromethyl)-beta-amino alcohols by boronic acid based three-component condensation. Stereoselective preparation of (2S,3R)-difluorothreonine.
J Org Chem 67: 3718-23 (2002)
PM ID: 12027685
261: Leonard MO, Hannan K, Burne MJ, Lappin DW, Doran P, Coleman P, Stenson C, Taylor CT, Daniels F, Godson C, Petasis NA, Rabb H, Brady HR
15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure.
J Am Soc Nephrol 13: 1657-62 (2002)
PM ID: 12039996
262: Chen M, Kasahara N, Keene DR, Chan LS, Hoeffler WK, Finlay D, Barcova M, Cannon PM, Mazurek C, Woodley DT
Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
Nat Genet 32: 670-5 (2002)
PM ID: 12426566
263: Schofield D, Triche TJ
cDNA microarray analysis of global gene expression in sarcomas.
Curr Opin Oncol 14: 406-11 (2002)
PM ID: 12130925
264: Kumar PG, Kim HH, Zahtz GD, Valderrama E, Steele AM
Obstructive congenital epulis: prenatal diagnosis and perinatal management.
Laryngoscope 112: 1935-9 (2002)
PM ID: 12439158
265: Chen IJ, Neamati N, MacKerell AD
Structure-based inhibitor design targeting HIV-1 integrase.
Curr Drug Targets Infect Disord 2: 217-34 (2002)
PM ID: 12462126
266: Bodey B, Siegel SE, Kaiser HE
Restoration of the thymic cellular microenvironment following autologous bone marrow transplantation.
In Vivo 16: 127-40 (2003)
PM ID: 12073772
267: Lord RV, Brabender J, Gandara D, Alberola V, Camps C, Domine M, Cardenal F, Sánchez JM, Gumerlock PH, Tarón M, Sánchez JJ, Danenberg KD, Danenberg PV, Rosell R
Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.
Clin Cancer Res 8: 2286-91 (2003)
PM ID: 12114432
268: Kumar PG, Wiebe LI, Mannan RH, Zhang ZY, Xia H, McEwan AJ
[99mTc]Technetium labelled PnAo-azomycin glucuronides: a novel class of imaging markers of tissue hypoxia.
Appl Radiat Isot 57: 719-28 (2003)
PM ID: 12433047
269: Moody K, Charlson ME, Finlay J
The neutropenic diet: what's the evidence?
J Pediatr Hematol Oncol 24: 717-21 (2003)
PM ID: 12468911
270: Neamati N, Lin Z, Karki RG, Orr A, Cowansage K, Strumberg D, Pais GC, Voigt JH, Nicklaus MC, Winslow HE, Zhao H, Turpin JA, Yi J, Skalka AM, Burke TR, Pommier Y
Metal-dependent inhibition of HIV-1 integrase.
J Med Chem 45: 5661-70 (2003)
PM ID: 12477350
271: Weber JS, Sondak VK, Scotland RR, Phillip R, Wang FF, Rubio V, Stuge TB, Groshen SG, Gee C, Jeffery GG, Sian S, Lee PP
Granulocyte-macrophage-colony-stimulating factor added to a multipeptide vaccine for resected Stage II melanoma.
Cancer 97: 186-200 (2003)
PM ID: 12491520
272: Aguilar HC, Anderson WF, Cannon PM
Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R Peptide.
J Virol 77: 1281-91 (2003)
PM ID: 12502845 PMC140788
273: Mohanty AK, Singh G, Paramasivam M, Saravanan K, Jabeen T, Sharma S, Yadav S, Kaur P, Kumar PG, Srinivasan A, Singh TP
Crystal structure of a novel regulatory 40-kDa mammary gland protein (MGP-40) secreted during involution.
J Biol Chem 278: 14451-60 (2003)
PM ID: 12529329
274: Neamati N, Barchi JJ
New paradigms in drug design and discovery.
Curr Top Med Chem 2: 211-27 (2003)
PM ID: 11944817
275: Calverley DC, Brass E, Hacker MR, Tsao-Wei DD, Espina BM, Pullarkat VA, Hodis HN, Groshen S
Potential role of platelet FcgammaRIIA in collagen-mediated platelet activation associated with atherothrombosis.
Atherosclerosis 164: 261-7 (2003)
PM ID: 12204796
276: Pluymers W, Pais GC, Van Maele B, Pannecouque C, Fikkert V, Burke TR, De Clercq E, Witvrouw M, Neamati N, Debyser Z
Inhibition of human immunodeficiency virus type 1 integration by diketo derivatives.
Antimicrob Agents Chemother 46: 3292-7 (2003)
PM ID: 12234864 PMC128766
277: Cairo MS, Sposto R, Hoover-Regan ML, Meadows AT, Anderson JR, Siegel SE, Kadin ME, Kjeldsberg CR, Wilson JF, Perkins SL, Lones MA, Morris E, Finlay JL
Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience.
Am J Hematol 72: 53-63 (2003)
PM ID: 12508269
278: Baltayan A, Naritoku WY, Chaiwun B, Tsao-Wei DD, Groshen S, Hern RA, Gusterson BA, Taylor CR, Imam SA
LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ.
Anticancer Res 22: 2933-7 (2003)
PM ID: 12530020
279: Chantrain CF, Declerck YA, Groshen S, McNamara G
Computerized quantification of tissue vascularization using high-resolution slide scanning of whole tumor sections.
J Histochem Cytochem 51: 151-8 (2003)
PM ID: 12533523
280: Kumar PG, Watson S, Brain AN, Davenport PJ, McWilliam LJ, Banerjee SS, Bisset DL
Incomplete excision of basal cell carcinoma: a prospective multicentre audit.
Br J Plast Surg 55: 616-22 (2003)
PM ID: 12550113
281: Sinha UK, Gallagher LA
Effects of steel scalpel, ultrasonic scalpel, CO2 laser, and monopolar and bipolar electrosurgery on wound healing in guinea pig oral mucosa.
Laryngoscope 113: 228-36 (2003)
PM ID: 12567074
282: Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS
Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy.
J Urol 169: 909-16 (2003)
PM ID: 12576811
283: Hu P, Mizokami MM, Ruoff G, Khawli LA, Epstein AL
Generation of low-toxicity interleukin-2 fusion proteins devoid of vasopermeability activity.
Blood 101: 4853-61 (2003)
PM ID: 12609842
284: Press MF, Spaulding B, Groshen S, Kaminsky D, Hagerty M, Sherman L, Christensen K, Edwards DP
Comparison of different antibodies for detection of progesterone receptor in breast cancer.
Steroids 67: 799-813 (2003)
PM ID: 12123792
285: Lenz HJ, Anderson WF, Hall FL, Gordon EM
Clinical protocol. Tumor site specific phase I evaluation of safety and efficacy of hepatic arterial infusion of a matrix-targeted retroviral vector bearing a dominant negative cyclin G1 construct as intervention for colorectal carcinoma metastatic to liver.
Hum Gene Ther 13: 1515-37 (2003)
PM ID: 12215272
286: Mitchell S, Thomas G, Harvey K, Cottell D, Reville K, Berlasconi G, Petasis NA, Erwig L, Rees AJ, Savill J, Brady HR, Godson C
Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo.
J Am Soc Nephrol 13: 2497-507 (2003)
PM ID: 12239238
287: Khawli LA, Mizokami MM, Sharifi J, Hu P, Epstein AL
Pharmacokinetic characteristics and biodistribution of radioiodinated chimeric TNT-1, -2, and -3 monoclonal antibodies after chemical modification with biotin.
Cancer Biother Radiopharm 17: 359-70 (2003)
PM ID: 12396700
288: Chang R, Finlay J, Badmaev V, Singh RH, Chapman J
Brain cancer: a case of glioblastoma multiforme.
J Altern Complement Med 8: 551-8 (2003)
PM ID: 12470435
289: McManus BM, Yanagawa B, Rezai N, Luo H, Taylor L, Zhang M, Yuan JM, Buckley JD, Triche TJ, Schreiner GF, Yang D
Genetic determinants of coxsackievirus B3 pathogenesis.
Ann N Y Acad Sci 975: 169-79 (2003)
PM ID: 12538163
290: Ji Q, Chang LJ, VanDenBerg D, Stanczyk FZ, Stolz A
Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism.
Prostate 54: 275-89 (2003)
PM ID: 12539226
291: Stapfer M, Hu J, Wei D, Groshen S, Beart RW
Establishment of a nude mouse model of hepatic metastasis for evaluation of targeted retroviral gene delivery.
J Surg Oncol 82: 121-30; discussion 131 (2003)
PM ID: 12561068
292: Lord RV, Park JM, Wickramasinghe K, DeMeester SR, Oberg S, Salonga D, Singer JB, Peters JH, Danenberg KD, DeMeester TR, Danenberg PV
Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
J Thorac Cardiovasc Surg 125: 246-53 (2003)
PM ID: 12579092
293: Kumar PG, Chatura KR, Chandrasekhar HR
Minimally invasive hyalinising trabecular carcinoma.
Indian J Pathol Microbiol 43: 99-100 (2003)
PM ID: 12583432
294: Quinn JA, Reardon DA, Friedman AH, Rich JN, Sampson JH, Provenzale JM, McLendon RE, Gururangan S, Bigner DD, Herndon JE, Avgeropoulos N, Finlay J, Tourt-Uhlig S, Affronti ML, Evans B, Stafford-Fox V, Zaknoen S, Friedman HS
Phase II trial of temozolomide in patients with progressive low-grade glioma.
J Clin Oncol 21: 646-51 (2003)
PM ID: 12586801
295: Formenti SC, Volm M, Skinner KA, Spicer D, Cohen D, Perez E, Bettini AC, Groshen S, Gee C, Florentine B, Press MF, Danenberg P, Muggia FM
Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial.
J Clin Oncol 21: 864-70 (2003)
PM ID: 12610186
296: Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR, Ward RL, Hawkins NJ, Quinn DI, Russell PJ, Sutherland RL, Breit SN, Moskaluk CA, Frierson HF, Hampton GM
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.
Proc Natl Acad Sci U S A 100: 3410-5 (2003)
PM ID: 12624183 PMC152306
297: Crowe DL, Hacia JG, Hsieh CL, Sinha UK, Rice H
Molecular pathology of head and neck cancer.
Histol Histopathol 17: 909-14 (2003)
PM ID: 12168802
298: Neamati N
Dipyrimidine-based inhibitors of HIV-1 integrase.
Expert Opin Investig Drugs 12: 289-92 (2003)
PM ID: 12556222
299: Cairo MS, Sposto R, Perkins SL, Meadows AT, Hoover-Regan ML, Anderson JR, Siegel SE, Lones MA, Tedeschi-Blok N, Kadin ME, Kjeldsberg CR, Wilson JF, Sanger WG, Morris E, Krailo MD, Finlay JL
Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience.
Br J Haematol 120: 660-70 (2003)
PM ID: 12588354
300: Han KR, Pantuck AJ, Bui MH, Shvarts O, Freitas DG, Zisman A, Leibovich BC, Dorey FJ, Gitlitz BJ, Figlin RA, Belldegrun AS
Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma.
Urology 61: 314-9 (2003)
PM ID: 12597937
301: Jadvar H, Tatlidil R, Garcia AA, Conti PS
Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography.
Clin Radiol 58: 215-21 (2003)
PM ID: 12639527
302: Wang Y, Jerdeva G, Yarber FA, da Costa SR, Xie J, Qian L, Rose CM, Mazurek C, Kasahara N, Mircheff AK, Hamm-Alvarez SF
Cytoplasmic dynein participates in apically targeted stimulated secretory traffic in primary rabbit lacrimal acinar epithelial cells.
J Cell Sci 116: 2051-65 (2003)
PM ID: 12679381
303: Perelman N, Selvaraj SK, Batra SK, Luck LR, Erdreich-Epstein A, Coates TD, Kalra VK, Malik P
Placenta growth factor activates monocytes and correlates with sickle cell disease severity.
Blood 102: 1506-14 (2003)
PM ID: 12714517
304: Kaiser HE, Bodey V, Siegel SE, Bodey B
Racial differences in childhood tumors.
In Vivo 16: 417-22 (2003)
PM ID: 12494884
305: Bodey B, Siegel SE, Kaiser HE
MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression.
In Vivo 16: 583-8 (2003)
PM ID: 12494904
306: Bodey B, Siegel SE, Kaiser HE
Expression of proline-directed protein kinase, (p34cdc2/p58cyclin A), a novel cell proliferation marker in childhood brain tumors.
In Vivo 16: 589-94 (2003)
PM ID: 12494905
307: Fierro IM, Colgan SP, Bernasconi G, Petasis NA, Clish CB, Arita M, Serhan CN
Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
J Immunol 170: 2688-94 (2003)
PM ID: 12594298
308: Mircheff AK, Qian L, Xie J, Wang Y, Hamm-Alvarez SF
M3 receptor autoimmunity: losing tolerance to a familiar protein.
Adv Exp Med Biol 506: 51-8 (2003)
PM ID: 12613888
309: da Costa SR, Andersson S, Arber F, Okamoto CT, Hamm-Alvarez SF
Cytoskeletal participation in stimulated secretion and compensatory apical plasma membrane retrieval in lacrimal gland acinar cells.
Adv Exp Med Biol 506: 199-205 (2003)
PM ID: 12613908
310: Xie J, Qian L, Hamm-Alvarez SF, Mircheff AK
Epidermal growth factor traffic in lacrimal acinar cells.
Adv Exp Med Biol 506: 213-7 (2003)
PM ID: 12613910
311: Filep JG, Zouki C, Petasis NA, Hachicha M, Serhan CN
Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 modulate adhesion molecule expression on human leukocytes in whole blood and inhibit neutrophil-endothelial cell adhesion.
Adv Exp Med Biol 507: 223-8 (2003)
PM ID: 12664589
312: Iqbal S, Lenz HJ
Targeted therapy and pharmacogenomic programs.
Cancer 97: 2076-82 (2003)
PM ID: 12673699
313: Quinn DI, Henshall SM, Brenner PC, Kooner R, Golovsky D, O'Neill GF, Turner JJ, Delprado W, Grygiel JJ, Sutherland RL, Stricker PD
Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
Cancer 97: 1884-93 (2003)
PM ID: 12673714
314: Haas-Kogan DA, Swift PS, Selch M, Haase GM, Seeger RC, Gerbing RB, Stram DO, Matthay KK
Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study.
Int J Radiat Oncol Biol Phys 56: 28-39 (2003)
PM ID: 12694821
315: Kumar PG, Rehani MM, Kumar L, Sharma R, Bhatla N, Singh R, Sundaram KR
Potential of CT-scan based tumor volume as a response indicator in chemotherapy of advanced epithelial ovarian cancer.
Med Sci Monit 8: CR667-74 (2003)
PM ID: 12388918
316: Sinha UK, Saadat D, Doherty CM, Rice DH
Use of AlloDerm implant to prevent frey syndrome after parotidectomy.
Arch Facial Plast Surg 5: 109-12 (2003)
PM ID: 12533152
317: Sharifi J, Khawli LA, Hu P, Li JZ, Epstein AL
Generation of human interferon gamma and tumor Necrosis factor alpha chimeric TNT-3 fusion proteins.
Hybrid Hybridomics 21: 421-32 (2003)
PM ID: 12573106
318: Rajagopal A, Ramasamy R, Martin J, Kumar PG
Acute myeloid leukemia presenting as splenic rupture.
J Assoc Physicians India 50: 1435-7 (2003)
PM ID: 12583479
319: Calverley DC, Hacker MR, Loda KA, Brass E, Buchanan TA, Tsao-Wei DD, Groshen S
Increased platelet Fc receptor expression as a potential contributing cause of platelet hypersensitivity to collagen in diabetes mellitus.
Br J Haematol 121: 139-42 (2003)
PM ID: 12670344
320: Neamati N, Murthy M, Wang YX
Preparation of DNA-protein complexes suitable for spectroscopic analysis.
Methods Mol Med 85: 185-202 (2003)
PM ID: 12710209
321: Lenz HJ
Clinical update: proteasome inhibitors in solid tumors.
Cancer Treat Rev 29 Suppl 1: 41-8 (2003)
PM ID: 12738242
322: Epstein AL, Mizokami MM, Li JZ, Hu P, Khawli LA
Identification of a protein fragment of interleukin 2 responsible for vasopermeability.
J Natl Cancer Inst 95: 741-9 (2003)
PM ID: 12759392
323: Kuo DJ, Weiner HL, Wisoff J, Miller DC, Knopp EA, Finlay JL
Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas.
J Pediatr Hematol Oncol 25: 372-8 (2003)
PM ID: 12759623
324: Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, Gitlitz BJ, Figlin RA, Belldegrun AS
Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
J Urol 169: 2076-83 (2003)
PM ID: 12771723
325: Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, Gitlitz B, Belldegrun AS, Figlin RA
Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.
Cancer 97: 2995-3002 (2003)
PM ID: 12784334
326: Yang X, Groshen S, Formenti SC, Davidson NE, Press MF
P7 antigen expression in human breast cancer.
Clin Cancer Res 9: 201-6 (2003)
PM ID: 12538470
327: Brabender J, Usadel H, Metzger R, Schneider PM, Park JM, Salonga D, Tsao-Wei DD, Groshen S, Lord RV, Takebe N, Schneider S, Hölscher AH, Danenberg KD, Danenberg PV
Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome.
Clin Cancer Res 9: 223-7 (2003)
PM ID: 12538473
328: Metelitsa LS, Weinberg KI, Emanuel PD, Seeger RC
Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells.
Leukemia 17: 1068-77 (2003)
PM ID: 12764370
329: Mandola MV, Stoehlmacher J, Muller-Weeks S, Cesarone G, Yu MC, Lenz HJ, Ladner RD
A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity.
Cancer Res 63: 2898-904 (2003)
PM ID: 12782596
330: Kulkarni AA, Haworth IS, Lee VH
Transmembrane segment 5 of the dipeptide transporter hPepT1 forms a part of the substrate translocation pathway.
Biochem Biophys Res Commun 306: 177-85 (2003)
PM ID: 12788085
331: Choi SW, Bangaru BS, Wu CD, Finlay JL
Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine.
J Pediatr Hematol Oncol 25: 503-6 (2003)
PM ID: 12794533
332: Stein JP, Cai J, Groshen S, Skinner DG
Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
J Urol 170: 35-41 (2003)
PM ID: 12796639
333: Stoehlmacher J, Lenz HJ
Cyclooxygenase-2 inhibitors in colorectal cancer.
Semin Oncol 30: 10-6 (2003)
PM ID: 12802790
334: Bertolone SJ, Yates AJ, Boyett JM, Wallace D, Finlay JL, Children's Cancer Group
Combined modality therapy for poorly differentiated gliomas of the posterior fossa in children: a Children's Cancer Group report.
J Neurooncol 63: 49-54 (2003)
PM ID: 12814254
335: Kumar PG, Goldstraw P, Yamada K, Nicholson AG, Wells AU, Hansell DM, Dubois RM, Ladas GP
Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection.
J Thorac Cardiovasc Surg 125: 1321-7 (2003)
PM ID: 12830051
336: Lou H, Ookhtens M, Stolz A, Kaplowitz N
Chelerythrine stimulates GSH transport by rat Mrp2 (Abcc2) expressed in canine kidney cells.
Am J Physiol Gastrointest Liver Physiol 285: G1335-44 (2003)
PM ID: 12893631
337: Kawakami K, Ishida Y, Danenberg KD, Omura K, Watanabe G, Danenberg PV
Functional polymorphism of the thymidylate synthase gene in colorectal cancer accompanied by frequent loss of heterozygosity.
Jpn J Cancer Res 93: 1221-9 (2003)
PM ID: 12460463
338: Farrugia DC, Ford HE, Cunningham D, Danenberg KD, Danenberg PV, Brabender J, McVicar AD, Aherne GW, Hardcastle A, McCarthy K, Jackman AL
Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed.
Clin Cancer Res 9: 792-801 (2003)
PM ID: 12576452
339: Nguyen DC, Parsa B, Close A, Magnusson B, Crowe DL, Sinha UK
Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas.
Int J Oncol 22: 1285-90 (2003)
PM ID: 12738995
340: Stoehlmacher J, Lenz HJ
Implications of genetic testing in the management of colorectal cancer.
Am J Pharmacogenomics 3: 73-88 (2003)
PM ID: 12749725
341: Pollack IF, Boyett JM, Yates AJ, Burger PC, Gilles FH, Davis RL, Finlay JL, Children's Cancer Group
The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience.
Neuro Oncol 5: 197-207 (2003)
PM ID: 12816726 PMC1920685
342: Bading JR, Yoo PB, Fissekis JD, Alauddin MM, D'Argenio DZ, Conti PS
Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: a positron emission tomography study in rats.
Cancer Res 63: 3667-74 (2003)
PM ID: 12839957
343: Wu SQ, Weinberg KI, Joo WJ, Quinn JJ, Franklin JL, Siegel SE, Gaynon PS
Preponderant mitotic activity of nonleukemic cells plays an important role in failures to detect abnormal clone in childhood acute lymphoblastic leukemia.
J Pediatr Hematol Oncol 25: 520-5 (2003)
PM ID: 12847317
344: Ottaviano F, Finlay JL
Diabetes insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine.
J Pediatr Hematol Oncol 25: 575-7 (2003)
PM ID: 12847329
345: Einspahr JG, Krouse RS, Yochim JM, Danenberg PV, Danenberg KD, Bhattacharyya AK, Martínez ME, Alberts DS
Association between Cyclooxygenase expression and colorectal adenoma characteristics.
Cancer Res 63: 3891-3 (2003)
PM ID: 12873979
346: Henshall SM, Afar DE, Hiller J, Horvath LG, Quinn DI, Rasiah KK, Gish K, Willhite D, Kench JG, Gardiner-Garden M, Stricker PD, Scher HI, Grygiel JJ, Agus DB, Mack DH, Sutherland RL
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.
Cancer Res 63: 4196-203 (2003)
PM ID: 12874026
347: Raetz EA, Kim MK, Moos P, Carlson M, Bruggers C, Hooper DK, Foot L, Liu T, Seeger RC, Carroll WL
Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
Cancer 98: 841-53 (2003)
PM ID: 12910530
348: da Costa SR, Sou E, Xie J, Yarber FA, Okamoto CT, Pidgeon M, Kessels MM, Mircheff AK, Schechter JE, Qualmann B, Hamm-Alvarez SF
Impairing actin filament or syndapin functions promotes accumulation of clathrin-coated vesicles at the apical plasma membrane of acinar epithelial cells.
Mol Biol Cell 14: 4397-413 (2003)
PM ID: 12937279 PMC266760
349: Gitlitz BJ, Figlin RA, Kiertscher SM, Moldawer N, Rosen F, Roth MD
Phase I trial of granulocyte macrophage-colony stimulating factor and interleukin-4 as a combined immunotherapy for patients with cancer.
J Immunother 26: 171-8 (2003)
PM ID: 12616109
350: Alauddin MM, Louie AY, Shahinian A, Meade TJ, Conti PS
Receptor mediated uptake of a radiolabeled contrast agent sensitive to beta-galactosidase activity.
Nucl Med Biol 30: 261-5 (2003)
PM ID: 12745017
351: Sorger D, Patt M, Kumar PG, Wiebe LI, Barthel H, Seese A, Dannenberg C, Tannapfel A, Kluge R, Sabri O
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.
Nucl Med Biol 30: 317-26 (2003)
PM ID: 12745023
352: Ariel A, Chiang N, Arita M, Petasis NA, Serhan CN
Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
J Immunol 170: 6266-72 (2003)
PM ID: 12794159
353: Quek ML, Quinn DI, Daneshmand S, Stein JP
Molecular prognostication in bladder cancer--a current perspective.
Eur J Cancer 39: 1501-10 (2003)
PM ID: 12855255
354: Dolgopolov I, Andreeva L, Yankelevich M, Mscheidze D, Siegel SE, Mentkevich G
Delayed introduction of G-CSF after chemotherapy does not affect peripheral blood stem cell yield and engraftment kinetics in children with high-risk malignancies: retrospective study of 45 cases.
Am J Hematol 73: 225-9 (2003)
PM ID: 12879423
355: Reynolds CP, Matthay KK, Villablanca JG, Maurer BJ
Retinoid therapy of high-risk neuroblastoma.
Cancer Lett 197: 185-92 (2003)
PM ID: 12880980
356: Ramanathan RK, Clark JW, Kemeny NE, Lenz HJ, Gococo KO, Haller DG, Mitchell EP, Kardinal CG
Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer.
J Clin Oncol 21: 2904-11 (2003)
PM ID: 12885808
357: Kumar PG, Ladas GP, Judson I, Nicholson AG
Epithelioid hemangioendothelioma and other vascular mediastinal tumors: a role for alpha-2a interferon?
Ann Thorac Surg 76: 653; author reply 653 (2003)
PM ID: 12902133
358: Hu P, Yan J, Sharifi J, Bai T, Khawli LA, Epstein AL
Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis.
Cancer Res 63: 5046-53 (2003)
PM ID: 12941833
359: Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Lieskovsky G, Quinn DI, Raghavan D, Skinner DG
Natural history of surgically treated bladder carcinoma with extravesical tumor extension.
Cancer 98: 955-61 (2003)
PM ID: 12942562
360: Gitlitz BJ, Figlin RA
Cytokine-based therapy for metastatic renal cell cancer.
Urol Clin North Am 30: 589-600 (2003)
PM ID: 12953757
361: Fouladi M, Hunt DL, Pollack IF, Dueckers G, Burger PC, Becker LE, Yates AJ, Gilles FH, Davis RL, Boyett JM, Finlay JL
Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
Cancer 98: 1243-52 (2003)
PM ID: 12973849
362: Pollack IF, Finkelstein SD, Burnham J, Hamilton RL, Yates AJ, Holmes EJ, Boyett JM, Finlay JL
Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort.
Pediatr Neurosurg 39: 114-21 (2003)
PM ID: 12876389
363: Alauddin MM, Shahinian A, Gordon EM, Conti PS
Evaluation of 2'-deoxy-2'-flouro-5-methyl-1-beta-D-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivo.
Mol Imaging 1: 74-81 (2003)
PM ID: 12920847
364: Kiertscher SM, Gitlitz BJ, Figlin RA, Roth MD
Granulocyte/macrophage-colony stimulating factor and interleukin-4 expand and activate type-1 dendritic cells (DC1) when administered in vivo to cancer patients.
Int J Cancer 107: 256-61 (2003)
PM ID: 12949803
365: Henshall SM, Afar DE, Rasiah KK, Horvath LG, Gish K, Caras I, Ramakrishnan V, Wong MM, Jeffry U, Kench JG, Quinn DI, Turner JJ, Delprado W, Lee CS, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Mack DH, Sutherland RL
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer.
Oncogene 22: 6005-12 (2003)
PM ID: 12955079
366: Kulkarni AA, Haworth IS, Uchiyama T, Lee VH
Analysis of transmembrane segment 7 of the dipeptide transporter hPepT1 by cysteine-scanning mutagenesis.
J Biol Chem 278: 51833-40 (2003)
PM ID: 14532279
367: Khawli LA, Biela BH, Hu P, Epstein AL
Comparison of recombinant derivatives of chimeric TNT-3 antibody for the radioimaging of solid tumors.
Hybrid Hybridomics 22: 1-9 (2003)
PM ID: 12713684
368: Kumar PG, Yamada K, Ladas GP, Goldstraw P
Mediastinoscopy and mediastinotomy after cardiac surgery: are safety and efficacy affected by prior sternotomy?
Ann Thorac Surg 76: 872-6; discussion 876-7 (2003)
PM ID: 12963219
369: Marback EF, Arias VE, Paranhos A, Soares FA, Murphree AL, Erwenne CM
Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma.
Br J Ophthalmol 87: 1224-8 (2003)
PM ID: 14507753 PMC1920792
370: Doroshow JH, Synold TW, Gandara D, Mani S, Remick SC, Mulkerin DL, Hamilton A, Sharma S, Ramanathan RK, Lenz HJ, Graham MM, Longmate J, Takimoto CH, Ivy P
Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group.
Semin Oncol 30: 14-9 (2003)
PM ID: 14523790
371: Lenz HJ
Pharmacogenomics in colorectal cancer.
Semin Oncol 30: 47-53 (2003)
PM ID: 14523795
372: Cagiannos I, Karakiewicz PI, Eastham JA, Ohori M, Rabbani F, Gerigk C, Reuter V, Graefen M, Hammerer PG, Erbersdobler A, Huland H, Kupelian P, Klein EA, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Morash CG, Scardino PT, Kattan MW
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
J Urol 170: 1798-803 (2003)
PM ID: 14532779
373: Brabender J, Lord RV, Metzger R, Park JM, Salonga D, Danenberg KD, Danenberg PV, Hölscher AH, Schneider PM
Differential SPARC mRNA expression in Barrett's oesophagus.
Br J Cancer 89: 1508-12 (2003)
PM ID: 14562024 PMC2394336
374: Sinha UK, Rhee J, Alcaraz N, Urken ML
Pressure-Specifying Sensory Device: quantitative sensory measurement in the oral cavity and oropharynx of normal adults.
Ear Nose Throat J 82: 682-4, 687-90 (2003)
PM ID: 14569703
375: Gitlitz BJ, Baker C, Chapman Y, Allen HJ, Bosserman LD, Patel R, Sanchez JD, Shapiro RM, Figlin RA
A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma.
Cancer 98: 1863-9 (2003)
PM ID: 14584068
376: Tai CK, Logg CR, Park JM, Anderson WF, Press MF, Kasahara N
Antibody-mediated targeting of replication-competent retroviral vectors.
Hum Gene Ther 14: 789-802 (2003)
PM ID: 12804141
377: Kumar N, Saxena YK, Rathi AK, Chitra R, Kumar PG
Host and risk factors for gestational trophoblastic disease: a hospital-based analysis from India.
Med Sci Monit 9: CR442-7 (2003)
PM ID: 14523334
378: Qian L, Wang Y, Xie J, Rose CM, Yang T, Nakamura T, Sandberg M, Zeng H, Schechter JE, Chow RH, Hamm-Alvarez SF, Mircheff AK
Biochemical changes contributing to functional quiescence in lacrimal gland acinar cells after chronic ex vivo exposure to a muscarinic agonist.
Scand J Immunol 58: 550-65 (2003)
PM ID: 14629627
379: Elias AD, Kumar PG, Herndon JE, Skarin AT, Sugarbaker DJ, Green MR
Radiotherapy versus chemotherapy plus radiotherapy in surgically treated IIIA N2 non-small-cell lung cancer.
Clin Lung Cancer 4: 95-103 (2003)
PM ID: 14653865
380: Pullarkat V, Lee PP, Scotland RR, Rubio V, Groshen S, Gee C, Lau RL, Snively J, Sian S, Woulfe SL, Wolfe RA, Weber JS
A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma.
Clin Cancer Res 9: 1301-12 (2004)
PM ID: 12684398
381: Park DJ, Stoehlmacher J, Lenz HJ
Tailoring chemotherapy in advanced colorectal cancer.
Curr Opin Pharmacol 3: 378-85 (2004)
PM ID: 12901946
382: Parker CJ, Shawcross SG, Li HY, Wang QY, Herrington CS, Kumar SR, MacKie RM, Prime W, Rennie IG, Sisley K, Kumar PG
Expression of PAX 3 alternatively spliced transcripts and identification of two new isoforms in human tumors of neural crest origin.
Int J Cancer 108: 314-20 (2004)
PM ID: 14639621
383: Stins MF, Pearce D, Di Cello F, Erdreich-Epstein A, Pardo CA, Sik Kim K
Induction of intercellular adhesion molecule-1 on human brain endothelial cells by HIV-1 gp120: role of CD4 and chemokine coreceptors.
Lab Invest 83: 1787-98 (2004)
PM ID: 14691297
384: Pagliarulo V, George B, Beil SJ, Groshen S, Laird PW, Cai J, Willey J, Cote RJ, Datar RH
Sensitivity and reproducibility of standardized-competitive RT-PCR for transcript quantification and its comparison with real time RT-PCR.
Mol Cancer 3: 5 (2004)
PM ID: 14741054 PMC344741
385: Jackson P, Ow K, Yardley G, Delprado W, Quinn DI, Yang JL, Russell PJ
Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression.
Prostate Cancer Prostatic Dis 6: 174-81 (2004)
PM ID: 12806379
386: Li JZ, Hu P, Khawli LA, Epstein AL
LEC/chTNT-3 fusion protein for the immunotherapy of experimental solid tumors.
J Immunother 26: 320-31 (2004)
PM ID: 12843794
387: Iqbal S, Lenz HJ
Molecular predictors of treatment and outcome in colorectal cancer.
Curr Gastroenterol Rep 5: 399-405 (2004)
PM ID: 12959721
388: Hecht JR, Blanke CD, Benson AB, Lenz HJ
Irinotecan and paclitaxel in metastatic adenocarcinoma of the esophagus and gastric cardia.
Oncology (Williston Park) 17: 13-5 (2004)
PM ID: 14569841
389: Stoehlmacher J, Goekkurt E, Lenz HJ
Pharmacogenetic aspects in treatment of colorectal cancer--an update.
Pharmacogenomics 4: 767-77 (2004)
PM ID: 14596640
390: Sinha UK, Kundra A, Scalia P, Smith DL, Parsa B, Masood R, Gill PS
Expression of EphB4 in head and neck squamous cell carcinoma.
Ear Nose Throat J 82: 866, 869-70, 887 (2004)
PM ID: 14661437
391: Li JZ, Hu P, Khawli LA, Epstein AL
Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
Cancer Res 63: 8384-92 (2004)
PM ID: 14679000
392: Abrey LE, Childs BH, Paleologos N, Kaminer L, Rosenfeld S, Salzman D, Finlay JL, Gardner S, Peterson K, Hu W, Swinnen L, Bayer R, Forsyth P, Stewart D, Smith AM, Macdonald DR, Weaver S, Ramsey DA, Nimer SD, DeAngelis LM, Cairncross JG
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma.
J Neurooncol 65: 127-34 (2004)
PM ID: 14686732
393: Half E, Broaddus R, Danenberg KD, Danenberg PV, Ayers GD, Sinicrope FA
HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors.
Int J Cancer 108: 540-8 (2004)
PM ID: 14696118
394: Jubran RF, Erdreich-Epstein A, Butturini AM, Murphree AL, Villablanca JG
Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experience.
J Pediatr Hematol Oncol 26: 31-4 (2004)
PM ID: 14707710
395: Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Cote RJ, Lieskovsky G, Quinn DI, Skinner DG
Microscopic and gross extravesical extension in pathological staging of bladder cancer.
J Urol 171: 640-5 (2004)
PM ID: 14713777
396: Cagiannos I, Karakiewicz PI, Graefen M, Eastham JA, Ohori M, Rabbani F, Reuter V, Wheeler TM, Kupelian P, Klein EA, Huland H, Hammerer PG, Erbersdobler A, Schroeder F, Wildhagen MF, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Morash CG, Scardino PT, Kattan MW
Is year of radical prostatectomy a predictor of outcome in prostate cancer?
J Urol 171: 692-6 (2004)
PM ID: 14713788
397: Robbins KT, Samant S, Vieira F, Kumar PG
Presurgical cytoreduction of oral cancer using intra-arterial cisplatin and limited concomitant radiation therapy (Neo-RADPLAT).
Arch Otolaryngol Head Neck Surg 130: 28-32 (2004)
PM ID: 14732764
398: James AC, Veitch JG, Zareh AR, Triche TJ
Sensitivity and specificity of five abundance estimators for high-density oligonucleotide microarrays.
Bioinformatics 20: 1060-5 (2004)
PM ID: 14764574
399: Chatterjee SJ, Datar R, Youssefzadeh D, George B, Goebell PJ, Stein JP, Young L, Shi SR, Gee C, Groshen S, Skinner DG, Cote RJ
Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma.
J Clin Oncol 22: 1007-13 (2004)
PM ID: 14981105
400: Biela BH, Khawli LA, Hu P, Epstein AL
Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT).
Cancer Biother Radiopharm 18: 339-53 (2004)
PM ID: 12954121
401: Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA, Chan LS, Van Dyke TE
Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators.
J Immunol 171: 6856-65 (2004)
PM ID: 14662892
402: Kuo CL, Assefa H, Kamath S, Brzozowski Z, Slawinski J, Saczewski F, Buolamwini JK, Neamati N
Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
J Med Chem 47: 385-99 (2004)
PM ID: 14711310
403: Chen X, Park R, Tohme M, Shahinian AH, Bading JR, Conti PS
MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide.
Bioconjug Chem 15: 41-9 (2004)
PM ID: 14733582
404: Broniscer A, Nicolaides TP, Dunkel IJ, Gardner SL, Johnson J, Allen JC, Sposto R, Finlay JL
High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors.
Pediatr Blood Cancer 42: 261-7 (2004)
PM ID: 14752864
405: Sinha UK, Young P, Hurvitz K, Crockett DM
Functional outcomes following palatal reconstruction with a folded radial forearm free flap.
Ear Nose Throat J 83: 45-8 (2004)
PM ID: 14986758
406: Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL
Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.
J Clin Oncol 22: 846-53 (2004)
PM ID: 14990640
407: Chantrain CF, Shimada H, Jodele S, Groshen S, Ye W, Shalinsky DR, Werb Z, Coussens LM, Declerck YA
Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment.
Cancer Res 64: 1675-86 (2004)
PM ID: 14996727
408: Karp CL, Flick LM, Park KW, Softic S, Greer TM, Keledjian R, Yang R, Uddin J, Guggino WB, Atabani SF, Belkaid Y, Xu Y, Whitsett JA, Accurso FJ, Wills-Karp M, Petasis NA
Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway.
Nat Immunol 5: 388-92 (2004)
PM ID: 15034576
409: Chambers EJ, Price EA, Bayramyan MC, Haworth IS
Computation of DNA backbone conformations.
J Biomol Struct Dyn 21: 111-25 (2004)
PM ID: 12854963
410: Jadvar H, Pinski JK, Conti PS
FDG PET in suspected recurrent and metastatic prostate cancer.
Oncol Rep 10: 1485-8 (2004)
PM ID: 12883728
411: Gitlitz BJ, Belldegrun AS, Zisman A, Chao DH, Pantuck AJ, Hinkel A, Mulders P, Moldawer N, Tso CL, Figlin RA
A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma.
J Immunother 26: 412-9 (2004)
PM ID: 12973030
412: Mizokami MM, Hu P, Khawli LA, Li JZ, Epstein AL
Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignancies.
Hybrid Hybridomics 22: 197-207 (2004)
PM ID: 14511565
413: Jadvar H, Kherbache HM, Pinski JK, Conti PS
Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma.
Clin Nephrol 60: 395-400 (2004)
PM ID: 14690256
414: Xie J, Qian L, Wang Y, Rose CM, Yang T, Nakamura T, Hamm-Alvarez SF, Mircheff AK
Novel biphasic traffic of endocytosed EGF to recycling and degradative compartments in lacrimal gland acinar cells.
J Cell Physiol 199: 108-25 (2004)
PM ID: 14978740
415: Slevin M, West D, Kumar PG, Rooney P, Kumar SR
Hyaluronan, angiogenesis and malignant disease.
Int J Cancer 109: 793-4; author reply 795-6 (2004)
PM ID: 14999792
416: Levitt RJ, Buckley JD, Blouin MJ, Schaub B, Triche TJ, Pollak M
Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.
Biochem Biophys Res Commun 316: 421-8 (2004)
PM ID: 15020235
417: Chen X, Park R, Hou Y, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Bading JR, Laug WE, Conti PS
MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide.
Eur J Nucl Med Mol Imaging 31: 1081-9 (2004)
PM ID: 15118844
418: Dayam R, Neamati N
Small-molecule HIV-1 integrase inhibitors: the 2001-2002 update.
Curr Pharm Des 9: 1789-802 (2004)
PM ID: 12871197
419: Schmittgen TD, Ju JF, Danenberg KD, Danenberg PV
Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.
Int J Oncol 23: 785-9 (2004)
PM ID: 12888918
420: Juhasz A, Frankel P, Cheng CY, Rivera H, Vishwanath R, Chiu A, Margolin K, Yen Y, Newman EM, Synold TW, Wilczynski S, Lenz HJ, Gandara D, Albain KS, Longmate J, Doroshow JH
Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products.
J Clin Lab Anal 17: 184-94 (2004)
PM ID: 12938148
421: Lara PN, Frankel P, Mack PC, Gumerlock PH, Galvin I, Martel CL, Longmate J, Doroshow JH, Lenz HJ, Lau DH, Gandara DR
Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: a california cancer consortium phase I and molecular correlative study.
Clin Cancer Res 9: 4356-62 (2004)
PM ID: 14555506
422: Gitlitz BJ, Figlin RA
Cell, gene and vaccine based strategies in kidney cancer.
Cancer Treat Res 116: 183-98 (2004)
PM ID: 14650833
423: Conti PS
Radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin): the role of the nuclear medicine physician.
Semin Nucl Med 34: 2-3 (2004)
PM ID: 14762737
424: Dhodapkar KM, Cirignano B, Chamian F, Zagzag D, Miller DC, Finlay JL, Steinman RM
Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion.
Int J Cancer 109: 893-9 (2004)
PM ID: 15027123
425: Ferrario A, Chantrain CF, von Tiehl K, Buckley S, Rucker N, Shalinsky DR, Shimada H, Declerck YA, Gomer CJ
The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model.
Cancer Res 64: 2328-32 (2004)
PM ID: 15059880
426: Girvigian MR, Astrahan MA, Lim JI, Murphree AL, Tsao-Wei DD, Petrovich Z
Episcleral plaque 125I radiotherapy with episcleral LCF hyperthermia: a prospective randomized trial.
Brachytherapy 2: 229-39 (2004)
PM ID: 15062131
427: Robbins KT, Doweck I, Samant S, Vieira F, Kumar PG
Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT).
Laryngoscope 114: 411-7 (2004)
PM ID: 15091211
428: Tikoo RK, Kupersmith MJ, Finlay JL
Treatment of refractory neurosarcoidosis with cladribine.
N Engl J Med 350: 1798-9 (2004)
PM ID: 15103013
429: Lara PN, Quinn DI, Margolin K, Meyers FJ, Longmate J, Frankel P, Mack PC, Turrell C, Valk P, Rao JY, Buckley P, Wun T, Gosselin R, Galvin I, Gumerlock PH, Lenz HJ, Doroshow JH, Gandara DR, California Cancer Consortium
SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition.
Clin Cancer Res 9: 4772-81 (2004)
PM ID: 14581348
430: Yu P, Neamati N, Tarasov S, He QY, Sheikh MS, Wang YX
Codon-optimized cloning, expression and characertization of the C-terminal region of human apoptotic protein GADD34 in Escherichia coli.
Cell Cycle 3: 75-9 (2004)
PM ID: 14657671
431: Garcia AA, O'Meara AT, Bahador A, Facio G, Jeffers S, Kim DY, Roman LD
Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer.
Gynecol Oncol 93: 493-8 (2004)
PM ID: 15099968
432: Brabender J, Marjoram P, Salonga D, Metzger R, Schneider PM, Park JM, Schneider S, Hölscher AH, Yin J, Meltzer SJ, Danenberg KD, Danenberg PV, Lord RV
A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
Oncogene 23: 4780-8 (2004)
PM ID: 15107828
433: Xie J, Qian L, Wang Y, Hamm-Alvarez SF, Mircheff AK
Role of the microtubule cytoskeleton in traffic of EGF through the lacrimal acinar cell endomembrane network.
Exp Eye Res 78: 1093-106 (2004)
PM ID: 15109916
434: Long YQ, Jiang XH, Dayam R, Sanchez TW, Shoemaker R, Sei S, Neamati N
Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase.
J Med Chem 47: 2561-73 (2004)
PM ID: 15115398
435: Zhang S, He QY, Peng H, Tedeschi-Blok N, Triche TJ, Wu L
MAT1-modulated cyclin-dependent kinase-activating kinase activity cross-regulates neuroblastoma cell G1 arrest and neurite outgrowth.
Cancer Res 64: 2977-83 (2004)
PM ID: 15126328
436: Suh RD, Goldin JG, Wallace AB, Sheehan RE, Heinze SB, Gitlitz BJ, Figlin RA
Metastatic renal cell carcinoma: CT-guided immunotherapy as a technically feasible and safe approach to delivery of gene therapy for treatment.
Radiology 231: 359-64 (2004)
PM ID: 15128982
437: Kumar PG, Perrotti M, Weiss R, Todd M, Goodin S, Cummings K, DiPaola RS
Phase I trial of weekly docetaxel with concurrent three-dimensional conformal radiation therapy in the treatment of unfavorable localized adenocarcinoma of the prostate.
J Clin Oncol 22: 1909-15 (2004)
PM ID: 15143084
438: Modak S, Gardner S, Dunkel IJ, Balmaceda C, Rosenblum MK, Miller DC, Halpern S, Finlay JL
Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
J Clin Oncol 22: 1934-43 (2004)
PM ID: 15143087
439: Panosyan EH, Grigoryan RS, Avramis IA, Seibel NL, Gaynon PS, Siegel SE, Fingert HJ, Avramis VI
Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961).
Anticancer Res 24: 1121-5 (2004)
PM ID: 15154634
440: Lenz HJ
The use and development of germline polymorphisms in clinical oncology.
J Clin Oncol 22: 2519-21 (2004)
PM ID: 15173210
441: Newell ME, Hoy JF, Cooper SG, DeGraaff B, Grulich AE, Bryant M, Millar JL, Brew BJ, Quinn DI
Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.
Cancer 100: 2627-36 (2004)
PM ID: 15197806
442: da Costa SR, Okamoto CT, Hamm-Alvarez SF
Actin microfilaments et al.--the many components, effectors and regulators of epithelial cell endocytosis.
Adv Drug Deliv Rev 55: 1359-83 (2004)
PM ID: 14597136
443: Lenz HJ
Molecular markers in gastrointestinal cancer: targeted therapy and tailored chemotherapy.
Onkologie 27: 12-4 (2004)
PM ID: 15017995
444: Hillenbrand A, Formentini A, Staib L, Sander S, Salonga D, Danenberg K, Danenberg P, Kornmann M
A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy.
Eur J Surg Oncol 30: 407-13 (2004)
PM ID: 15063894
445: Panosyan EH, Seibel NL, Martin-Aragon S, Gaynon PS, Avramis IA, Sather H, Franklin JL, Nachman J, Ettinger LJ, La M, Steinherz P, Cohen LJ, Siegel SE, Avramis VI, Children's Cancer Group Study CCG-1961
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.
J Pediatr Hematol Oncol 26: 217-26 (2004)
PM ID: 15087948
446: Balmaceda C, Finlay J
Current advances in the diagnosis and management of intracranial germ cell tumors.
Curr Neurol Neurosci Rep 4: 253-62 (2004)
PM ID: 15102352
447: Lones MA, Sanger WG, Le Beau MM, Heerema NA, Sposto R, Perkins SL, Buckley JD, Kadin ME, Kjeldsberg CR, Meadows A, Siegel SE, Finlay J, Bergeron S, Cairo MS, Children's Cancer Group Study CCG-E08
Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08.
J Pediatr Hematol Oncol 26: 169-78 (2004)
PM ID: 15125609
448: Lentz SE, Muderspach LI, Felix JC, Ye W, Groshen S, Amezcua CA
Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients.
Obstet Gynecol 103: 1204-10 (2004)
PM ID: 15172853
449: Ansari MS, Gupta NP, Kumar PG
von Hippel-Lindau disease with bilateral multiple renal cell carcinoma managed by right radical nephrectomy and left repeat partial nephrectomy.
Int Urol Nephrol 35: 471-3 (2004)
PM ID: 15198146
450: Wang Y, Xie J, Yarber FA, Mazurek C, Trousdale MD, Medina-Kauwe LK, Kasahara N, Hamm-Alvarez SF
Adenoviral capsid modulates secretory compartment organization and function in acinar epithelial cells from rabbit lacrimal gland.
Gene Ther 11: 970-81 (2004)
PM ID: 15029229
451: Chamberlain MC, Tsao-Wei DD, Groshen S
Temozolomide for treatment-resistant recurrent meningioma.
Neurology 62: 1210-2 (2004)
PM ID: 15079029
452: Bu X, Khankaldyyan V, Gonzales-Gomez I, Groshen S, Ye W, Zhuo S, Pons J, Stratton JR, Rosenberg S, Laug WE
Species-specific urokinase receptor ligands reduce glioma growth and increase survival primarily by an antiangiogenesis mechanism.
Lab Invest 84: 667-78 (2004)
PM ID: 15094713
453: Daneshmand S, Stein JP, Lesser T, Quek ML, Nichols PW, Miranda G, Cai J, Groshen S, Skinner EC, Skinner DG
Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder.
J Urol 172: 81-4 (2004)
PM ID: 15201742
454: Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S, Lenz HJ
A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.
Br J Cancer 91: 344-54 (2004)
PM ID: 15213713 PMC2409815
455: Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL
Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach.
Pediatr Blood Cancer 43: 126-33 (2004)
PM ID: 15236278
456: Hamoui N, Peters JH, Schneider S, Uchida K, Yang D, Vallböhmer D, Valboehmer D, Hagen JA, DeMeester SR, DeMeester TR, Danenberg K, Danenberg P
Increased acid exposure in patients with gastroesophageal reflux disease influences cyclooxygenase-2 gene expression in the squamous epithelium of the lower esophagus.
Arch Surg 139: 712-6; discussion 716-7 (2004)
PM ID: 15249402
457: Wolff JE, Finlay JL
High-dose chemotherapy in childhood brain tumors.
Onkologie 27: 239-45 (2004)
PM ID: 15249712
458: Kimura T, Holland WS, Kawaguchi T, Williamson SK, Chansky K, Crowley JJ, Doroshow JH, Lenz HJ, Gandara DR, Gumerlock PH
Mutant DNA in plasma of lung cancer patients: potential for monitoring response to therapy.
Ann N Y Acad Sci 1022: 55-60 (2004)
PM ID: 15251940
459: Kumar PG, Miller AI, Polverini PJ
p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway.
J Biol Chem 279: 43352-60 (2004)
PM ID: 15292252
460: Raghavan SC, Houston SI, Hegde BG, Langen R, Haworth IS, Lieber MR
Stability and strand asymmetry in the non-B DNA structure at the bcl-2 major breakpoint region.
J Biol Chem 279: 46213-25 (2004)
PM ID: 15328356
461: Chen X, Park R, Shahinian AH, Bading JR, Conti PS
Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation.
Nucl Med Biol 31: 11-9 (2004)
PM ID: 14741566
462: Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS
Synthesis of 2'-deoxy-2'-[18F]fluoro-5-bromo-1-beta-D-arabinofuranosyluracil ([18F]-FBAU) and 2'-deoxy-2'-[18F]fluoro-5-chloro-1-beta-D-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression.
Nucl Med Biol 31: 399-405 (2004)
PM ID: 15093809
463: Bading JR, Shahinian AH, Vail A, Bathija P, Koszalka GW, Koda RT, Alauddin MM, Fissekis JD, Conti PS
Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.
Nucl Med Biol 31: 407-18 (2004)
PM ID: 15093810
464: Metelitsa LS, Wu HW, Wang H, Yang Y, Warsi Z, Asgharzadeh S, Groshen S, Wilson SB, Seeger RC
Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2.
J Exp Med 199: 1213-21 (2004)
PM ID: 15123743 PMC2211904
465: Schneider S, Uchida K, Salonga D, Yochim JM, Danenberg KD, Danenberg PV
Quantitative determination of p16 gene expression by RT-PCR.
Methods Mol Biol 281: 91-103 (2004)
PM ID: 15220523
466: Hilden JM, Meerbaum S, Burger P, Finlay J, Janss A, Scheithauer BW, Walter AW, Rorke LB, Biegel JA
Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.
J Clin Oncol 22: 2877-84 (2004)
PM ID: 15254056
467: Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti PS
microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
J Nucl Med 45: 1390-7 (2004)
PM ID: 15299066
468: St John MA, Li YT, Zhou XJ, Denny P, Ho CM, Montemagno C, Shi W, Qi F, Wu BW, Sinha U, Jordan R, Wolinsky L, Park NH, Liu HM, Abemayor E, Wong DT
Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg 130: 929-35 (2004)
PM ID: 15313862
469: He QY, Peng H, Collins SJ, Triche TJ, Wu L
Retinoid-modulated MAT1 ubiquitination and CAK activity.
FASEB J 18: 1734-6 (2004)
PM ID: 15345685
470: Danenberg PV
Pharmacogenomics of thymidylate synthase in cancer treatment.
Front Biosci 9: 2484-94 (2004)
PM ID: 15353301
471: Uchida K, Hayashi K, Kawakami K, Schneider S, Yochim JM, Kuramochi H, Takasaki K, Danenberg KD, Danenberg PV
Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene.
Clin Cancer Res 10: 433-9 (2004)
PM ID: 14760062
472: Bodey B, Siegel SE, Kaiser HE
Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
In Vivo 18: 81-100 (2004)
PM ID: 15011756
473: Schneider S, Yochim JM, Brabender J, Uchida K, Danenberg KD, Metzger R, Schneider PM, Salonga D, Hölscher AH, Danenberg PV
Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer.
Clin Cancer Res 10: 1588-96 (2004)
PM ID: 15014008
474: Crowe DL, Parsa B, Sinha UK
Relationships between stem cells and cancer stem cells.
Histol Histopathol 19: 505-9 (2004)
PM ID: 15024711
475: Kumar PG, Ohkura K, Balzarini J, De Clercq E, Seki K, Wiebe LI
Synthesis and antiviral activity of novel fluorinated 2',3'-dideoxynucleosides.
Nucleosides Nucleotides Nucleic Acids 23: 7-29 (2004)
PM ID: 15043133
476: Brabender J, Lord RV, Metzger R, Park JM, Salonga D, Danenberg KD, Hölscher AH, Danenberg PV, Schneider PM
Role of retinoid X receptor mRNA expression in Barrett's esophagus.
J Gastrointest Surg 8: 413-22 (2004)
PM ID: 15120365
477: Park DJ, Lenz HJ
The role of proteasome inhibitors in solid tumors.
Ann Med 36: 296-303 (2004)
PM ID: 15224656
478: Andersson P, Serhan CN, Petasis NA, Palmblad J
Interactions between lipoxin A4, the stable analogue 16-phenoxy-lipoxin A4 and leukotriene B4 in cytokine generation by human monocytes.
Scand J Immunol 60: 249-56 (2004)
PM ID: 15320881
479: Lund BT, Ashikian N, Ta HQ, Chakryan Y, Manoukian K, Groshen S, Gilmore W, Cheema GS, Stohl W, Burnett ME, Ko D, Kachuck NJ, Weiner LP
Increased CXCL8 (IL-8) expression in Multiple Sclerosis.
J Neuroimmunol 155: 161-71 (2004)
PM ID: 15342208
480: Zhang J, Hu S, Schofield DE, Sorensen PH, Triche TJ
Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
Cancer Res 64: 6026-34 (2004)
PM ID: 15342383
481: Bomgaars L, Geyer JR, Franklin JL, Dahl G, Park JM, Winick NJ, Klenke R, Berg SL, Blaney SM
Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
J Clin Oncol 22: 3916-21 (2004)
PM ID: 15459213
482: Chen X, Park R, Shahinian AH, Tohme M, Khankaldyyan V, Bozorgzadeh MH, Bading JR, Moats RA, Laug WE, Conti PS
18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.
Nucl Med Biol 31: 179-89 (2004)
PM ID: 15013483
483: Whitehead RP, Benedetti JK, Abbruzzese JL, Ardalan B, Goodwin JW, Balcerzak SP, Samlowski WE, Lenz HJ, Macdonald JS
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.
Invest New Drugs 22: 335-41 (2004)
PM ID: 15122082
484: Sechi M, Angotzi G, Dallocchio R, Dessì A, Carta F, Sannia L, Mariani A, Fiori S, Sanchez TW, Movsessian L, Plasencia C, Neamati N
Design and synthesis of novel dihydroxyindole-2-carboxylic acids as HIV-1 integrase inhibitors.
Antivir Chem Chemother 15: 67-81 (2004)
PM ID: 15185725
485: Goebell PJ, Groshen S, Schmitz-Dräger BJ, Sylvester R, Kogevinas M, Malats N, Sauter G, Barton Grossman H, Waldman F, Cote RJ
The International Bladder Cancer Bank: proposal for a new study concept.
Urol Oncol 22: 277-84 (2004)
PM ID: 15283883
486: Clark PE, Stein JP, Groshen SG, Miranda G, Cai J, Lieskovsky G, Skinner DG
The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer.
J Urol 172: 1342-7 (2004)
PM ID: 15371837
487: Shimada H, Nakagawa A, Peters JH, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC
TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Cancer 101: 1873-81 (2004)
PM ID: 15386308
488: Sechi M, Derudas M, Dallocchio R, Dessì A, Bacchi A, Sannia L, Carta F, Palomba M, Ragab O, Chan CK, Shoemaker R, Sei S, Dayam R, Neamati N
Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors.
J Med Chem 47: 5298-310 (2004)
PM ID: 15456274
489: Roberts SS, Mori M, Pattee P, Lapidus J, Mathews R, O'Malley JP, Hsieh YC, Turner MA, Wang ZZ, Tian Q, Rodland MJ, Reynolds CP, Seeger RC, Nagalla SR
GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma.
J Clin Oncol 22: 4127-34 (2004)
PM ID: 15483022
490: Chen X, Conti PS, Moats RA
In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.
Cancer Res 64: 8009-14 (2004)
PM ID: 15520209
491: Heidel JD, Hu S, Liu XF, Triche TJ, Davis ME
Lack of interferon response in animals to naked siRNAs.
Nat Biotechnol 22: 1579-82 (2004)
PM ID: 15558046
492: Hamm-Alvarez SF, Xie J, Wang Y, Medina-Kauwe LK
Modulation of secretory functions in epithelia by adenovirus capsid proteins.
J Control Release 93: 129-40 (2004)
PM ID: 14636719
493: Li JZ, Hu P, Khawli LA, Yun A, Epstein AL
chTNT-3/hu IL-12 fusion protein for the immunotherapy of experimental solid tumors.
Hybrid Hybridomics 23: 1-10 (2004)
PM ID: 15000842
494: Pantuck AJ, van Ophoven A, Gitlitz BJ, Tso CL, Acres B, Squiban P, Ross ME, Belldegrun AS, Figlin RA
Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancer.
J Immunother 27: 240-53 (2004)
PM ID: 15076142
495: Makhija MT, Kasliwal RT, Kulkarni VM, Neamati N
De novo design and synthesis of HIV-1 integrase inhibitors.
Bioorg Med Chem 12: 2317-33 (2004)
PM ID: 15080929
496: Nakayama K, Kanzaki A, Terada K, Mutoh M, Ogawa K, Sugiyama T, Takenoshita S, Itoh K, Yaegashi N, Miyazaki K, Neamati N, Takebayashi Y
Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy.
Clin Cancer Res 10: 2804-11 (2004)
PM ID: 15102688
497: Mandola MV, Stoehlmacher J, Zhang W, Groshen S, Yu MC, Iqbal S, Lenz HJ, Ladner RD
A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels.
Pharmacogenetics 14: 319-27 (2004)
PM ID: 15115918
498: Warnecke-Eberz U, Metzger R, Miyazono F, Baldus SE, Neiss S, Brabender J, Schaefer HF, Doerfler W, Bollschweiler E, Dienes HP, Mueller RP, Danenberg PV, Hoelscher AH, Schneider PM
High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.
Clin Cancer Res 10: 3794-9 (2004)
PM ID: 15173087
499: Dong D, Dubeau L, Bading JR, Nguyen K, Luna M, Yu H, Gazit-Bornstein G, Gordon EM, Gomer CJ, Hall FL, Gambhir SS, Lee AS
Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors.
Hum Gene Ther 15: 553-61 (2004)
PM ID: 15212714
500: Alauddin MM, Shahinian A, Gordon EM, Conti PS
Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model.
Mol Imaging 3: 76-84 (2004)
PM ID: 15296672
501: Chen X, Tohme M, Park R, Hou Y, Bading JR, Conti PS
Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide.
Mol Imaging 3: 96-104 (2004)
PM ID: 15296674
502: Iqbal S, Lenz HJ
Integration of novel agents in the treatment of colorectal cancer.
Cancer Chemother Pharmacol 54 Suppl 1: S32-9 (2004)
PM ID: 15309512
503: Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS
Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
J Nucl Med 45: 1776-83 (2004)
PM ID: 15471848
504: Ji Q, Aoyama C, Nien YD, Liu PI, Chen PK, Chang LJ, Stanczyk FZ, Stolz A
Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling.
Cancer Res 64: 7610-7 (2004)
PM ID: 15492289
505: Qian L, Xie J, Rose CM, Sou E, Zeng H, Hamm-Alvarez SF, Mircheff AK
Altered traffic to the lysosome in an ex vivo lacrimal acinar cell model for chronic muscarinic receptor stimulation.
Exp Eye Res 79: 665-75 (2004)
PM ID: 15500825
506: Rajendra S, Mulcahy H, Patchett S, Kumar PG
The effect of H2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines.
Dig Dis Sci 49: 1634-40 (2004)
PM ID: 15573918
507: Iqbal S, Stoehlmacher J, Lenz HJ
Tailored chemotherapy for colorectal cancer: a new approach to therapy.
Cancer Invest 22: 762-73 (2004)
PM ID: 15581057
508: Noy A, Scadden DT, Lee JW, Dezube BJ, Aboulafia D, Tulpule A, Walmsley S, Gill P
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
J Clin Oncol 23: 990-8 (2004)
PM ID: 15598977
509: Sanderson K, Scotland RR, Lee PJ, Liu D, Groshen S, Snively J, Sian S, Nichol G, Davis T, Keler T, Yellin M, Weber JS
Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma.
J Clin Oncol 23: 741-50 (2004)
PM ID: 15613700
510: Brabender J, Metzger R, Salonga D, Danenberg KD, Danenberg PV, Hölscher AH, Schneider PM
Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis.
Carcinogenesis 26: 525-30 (2004)
PM ID: 15618235
511: Calverley DC, Varteresian T, Brass E, Tsao-Wei DD, Groshen S, Mack WJ, Buchanan TA, Hodis HN, Schreiber AD
Association between monocyte Fcgamma subclass expression and acute coronary syndrome.
Immun Ageing 1: 4 (2004)
PM ID: 15679933
512: Khawli LA, Alauddin MM, Hu P, Epstein AL
Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.
Cancer Biother Radiopharm 18: 931-40 (2005)
PM ID: 14969605
513: Brzozowski Z, Saczewski F, Sanchez TW, Kuo CL, Gdaniec M, Neamati N
Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines.
Bioorg Med Chem 12: 3663-72 (2005)
PM ID: 15186851
514: Garcia AA, Leichman L, Baranda J, Pandit L, Lenz HJ, Leichman CG
Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer.
Int J Gastrointest Cancer 34: 79-86 (2005)
PM ID: 15361639
515: Kobayashi C, Monforte-Munoz HL, Gerbing RB, Stram DO, Matthay KK, Lukens JN, Seeger RC, Shimada H
Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
Cancer 103: 174-80 (2005)
PM ID: 15549714
516: Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL, Finlay JL
Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
J Clin Oncol 22: 4881-7 (2005)
PM ID: 15611503
517: Aiello F, Brizzi A, Garofalo A, Grande F, Ragno G, Dayam R, Neamati N
Synthesis of novel thiazolothiazepine based HIV-1 integrase inhibitors.
Bioorg Med Chem 12: 4459-66 (2005)
PM ID: 15265496
518: Lenz HJ
Pharmacogenomics and colorectal cancer.
Ann Oncol 15 Suppl 4: iv173-7 (2005)
PM ID: 15477304
519: Cham D, Henderson R, Conti PS
Virchow's node on F-18 FDG PET/CT.
Clin Nucl Med 29: 770-2 (2005)
PM ID: 15483511
520: Bodey B, Bodey V, Siegel SE, Nasir A, Coppola D, Hakam A, Kaiser HE
Immunocytochemical detection of members of the caspase cascade of apoptosis in high-grade astrocytomas.
In Vivo 18: 593-602 (2005)
PM ID: 15523899
521: Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS
Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression.
J Nucl Med 45: 2063-9 (2005)
PM ID: 15585483
522: Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, Skinner DG
Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
Cancer 103: 546-52 (2005)
PM ID: 15630702
523: Dayam R, Sanchez TW, Clement O, Shoemaker R, Sei S, Neamati N
Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
J Med Chem 48: 111-20 (2005)
PM ID: 15634005
524: Lara PN, Twardowski P, Quinn DI
Angiogenesis-targeted therapies in prostate cancer.
Clin Prostate Cancer 3: 165-73 (2005)
PM ID: 15636683
525: Dogra PN, Kumar PG, Goel R, Dash SC
Long duration priapism in blast crisis of chronic myeloid leukemia.
J Assoc Physicians India 52: 170 (2005)
PM ID: 15656063
526: Erdreich-Epstein A, Tran LB, Cox OT, Huang EY, Laug WE, Shimada H, Millard M
Endothelial apoptosis induced by inhibition of integrins alphavbeta3 and alphavbeta5 involves ceramide metabolic pathways.
Blood 105: 4353-61 (2005)
PM ID: 15705795 PMC1895032
527: Karaman MW, Groshen S, Lee CC, Pike BL, Hacia JG
Comparisons of substitution, insertion and deletion probes for resequencing and mutational analysis using oligonucleotide microarrays.
Nucleic Acids Res 33: e33 (2005)
PM ID: 15722479 PMC549431
528: Chi G, Neamati N, Nair V
Inhibition of the strand transfer step of HIV-1 integrase by non-natural dinucleotides.
Bioorg Med Chem Lett 14: 4815-7 (2005)
PM ID: 15341930
529: Chen X, Liu S, Hou Y, Tohme M, Park R, Bading JR, Conti PS
MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides.
Mol Imaging Biol 6: 350-9 (2005)
PM ID: 15380745
530: Jadvar H, Gamie S, Ramanna L, Conti PS
Musculoskeletal system.
Semin Nucl Med 34: 254-61 (2005)
PM ID: 15493003
531: Jadvar H, Conti PS
The reproductive tract.
Semin Nucl Med 34: 262-73 (2005)
PM ID: 15493004
532: He Y, Das B, Baruchel S, Kumar PG, Wiebe LI, Reilly RM
Meta-[123I]iodobenzylguanidine is selectively radiotoxic to neuroblastoma cells at concentrations that spare cells of haematopoietic lineage.
Nucl Med Commun 25: 1125-30 (2005)
PM ID: 15577592
533: Piert M, Machulla HJ, Picchio M, Reischl G, Ziegler SF, Kumar PG, Wester HJ, Beck R, McEwan AJ, Wiebe LI, Schwaiger M
Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
J Nucl Med 46: 106-13 (2005)
PM ID: 15632040
534: Rose CM, Qian L, Hakim L, Wang Y, Jerdeva GY, Marchelletta RR, Nakamura T, Hamm-Alvarez SF, Mircheff AK
Accumulation of catalytically active proteases in lacrimal gland acinar cell endosomes during chronic ex vivo muscarinic receptor stimulation.
Scand J Immunol 61: 36-50 (2005)
PM ID: 15644121
535: Lenz HJ
Angiogenesis as a target in colorectal cancer therapy. Introduction.
Semin Oncol 31: 1-2 (2005)
PM ID: 15696023
536: Iqbal S, Lenz HJ
Angiogenesis inhibitors in the treatment of colorectal cancer.
Semin Oncol 31: 10-6 (2005)
PM ID: 15696025
537: Yu KJ, Roy D, Bayramyan M, Haworth IS, Lieber MR
Fine-structure analysis of activation-induced deaminase accessibility to class switch region R-loops.
Mol Cell Biol 25: 1730-6 (2005)
PM ID: 15713630 PMC549380
538: Robbins KT, Kumar PG, Harris JM, McCulloch T, Cmelak A, Sofferman R, Levine P, Weisman R, Wilson W, Weymuller E, Fu K
Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615.
J Clin Oncol 23: 1447-54 (2005)
PM ID: 15735120
539: Chen SP, Yu L, Jiang C, Zhao Y, Sun D, Li S, Liao G, Chen Y, Fu Q, Tao Q, Ye D, Hu P, Khawli LA, Taylor CR, Epstein AL, Ju DW
Pivotal study of iodine-131-labeled chimeric tumor necrosis treatment radioimmunotherapy in patients with advanced lung cancer.
J Clin Oncol 23: 1538-47 (2005)
PM ID: 15735129
540: Schneider S, Uchida K, Brabender J, Baldus SE, Yochim JM, Danenberg KD, Salonga D, Chen PC, Tsao-Wei DD, Groshen S, Hoelscher AH, Schneider PM, Danenberg PV
Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
J Am Coll Surg 200: 336-44 (2005)
PM ID: 15737843
541: Rentsendorj A, Agadjanian H, Chen X, Cirivello M, Macveigh M, Kedes L, Hamm-Alvarez SF, Medina-Kauwe LK
The Ad5 fiber mediates nonviral gene transfer in the absence of the whole virus, utilizing a novel cell entry pathway.
Gene Ther 12: 225-37 (2005)
PM ID: 15483666
542: Bodey B, Bodey V, Siegel SE, Kaiser HE
Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker.
In Vivo 18: 713-8 (2005)
PM ID: 15646811
543: Chen X, Plasencia C, Hou Y, Neamati N
Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
J Med Chem 48: 1098-106 (2005)
PM ID: 15715477
544: Abada P, Noble B, Cannon PM
Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.
J Virol 79: 3627-38 (2005)
PM ID: 15731257 PMC1075700
545: Sohara Y, Shimada H, Minkin C, Erdreich-Epstein A, Nolta JA, Declerck YA
Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells.
Cancer Res 65: 1129-35 (2005)
PM ID: 15734993
546: Sechi M, Sannia L, Carta F, Palomba M, Dallocchio R, Dessì A, Derudas M, Zawahir Z, Neamati N
Design of novel bioisosteres of beta-diketo acid inhibitors of HIV-1 integrase.
Antivir Chem Chemother 16: 41-61 (2005)
PM ID: 15739621
547: Deng J, Lee KW, Sanchez TW, Cui M, Neamati N, Briggs JM
Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors.
J Med Chem 48: 1496-505 (2005)
PM ID: 15743192
548: Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.
J Exp Med 201: 713-22 (2005)
PM ID: 15753205 PMC2212834
549: Stein JP, Clark PE, Miranda G, Cai J, Groshen S, Skinner DG
Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
J Urol 173: 1163-8 (2005)
PM ID: 15758728
550: Garcia AA, Pujari M, Jeffers S, Iqbal S, Lenz HJ, Beringer P, Louie SG
Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule.
Cancer Chemother Pharmacol 56: 75-82 (2005)
PM ID: 15809878
551: Raghavan SC, Chastain P, Lee JS, Hegde BG, Houston SI, Langen R, Hsieh CL, Haworth IS, Lieber MR
Evidence for a triplex DNA conformation at the bcl-2 major breakpoint region of the t(14;18) translocation.
J Biol Chem 280: 22749-60 (2005)
PM ID: 15840562
552: Kumar PG, Kratzke RA
Molecular prognostic markers in malignant mesothelioma.
Lung Cancer 49 Suppl 1: S53-60 (2005)
PM ID: 15950802
553: Kumar PG, Robbins KT
Treatment of advanced head and neck cancer with intra-arterial cisplatin and concurrent radiation therapy: the 'RADPLAT' protocol.
Curr Oncol Rep 3: 59-65 (2005)
PM ID: 11123871
554: Prakash GK, Panja C, Mathew T, Surampudi V, Petasis NA, Olah GA
ipso-nitration of arylboronic acids with chlorotrimethylsilane-nitrate salts.
Org Lett 6: 2205-7 (2005)
PM ID: 15200321
555: Dayam R, Neamati N
Active site binding modes of the beta-diketoacids: a multi-active site approach in HIV-1 integrase inhibitor design.
Bioorg Med Chem 12: 6371-81 (2005)
PM ID: 15556755
556: Kuramochi H, Vallböhmer D, Uchida K, Schneider S, Hamoui N, Shimizu D, Chandrasoma PT, DeMeester TR, Danenberg KD, Danenberg PV, Peters JH
Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma.
J Gastrointest Surg 8: 1007-16; discussion 1016-7 (2005)
PM ID: 15585388
557: Chu C, Okamoto CT, Hamm-Alvarez SF, Lee VH
Stable transfection of MDCK cells with epitope-tagged human PepT1.
Pharm Res 21: 1970-3 (2005)
PM ID: 15587917
558: Ji Q, Liu PI, Elshimali Y, Stolz A
Frequent loss of estrogen and progesterone receptors in human prostatic tumors determined by quantitative real-time PCR.
Mol Cell Endocrinol 229: 103-10 (2005)
PM ID: 15607534
559: Kumar PG, Rehani MM, Kumar L, Sharma R, Bhatla N, Chaudhry R, Thulkar S, Sundaram KR, Kumar N
Tumor marker CA-125 as an evaluator and response indicator in ovarian cancer: its quantitative correlation with tumor volume.
Med Sci Monit 11: CR84-9 (2005)
PM ID: 15668638
560: Goebell PJ, Groshen S, Schmitz-Dräger BJ, Sylvester R, Kogevinas M, Malats N, Sauter G, Grossman HB, Dinney CP, Waldman F, Cote RJ
Concepts for banking tissue in urologic oncology--the International Bladder Cancer Bank.
Clin Cancer Res 11: 413-5 (2005)
PM ID: 15701822
561: Zhang W, Park DJ, Lu B, Yang DY, Gordon M, Groshen S, Yun JE, Press OA, Vallböhmer D, Rhodes K, Lenz HJ
Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.
Clin Cancer Res 11: 600-5 (2005)
PM ID: 15701846
562: Liu D, O'Day SJ, Yang D, Boasberg P, Milford R, Kristedja T, Groshen S, Weber JS
Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study.
Clin Cancer Res 11: 1237-46 (2005)
PM ID: 15709194
563: Lara PN, Law LY, Wright JJ, Frankel P, Twardowski P, Lenz HJ, Lau DH, Kawaguchi T, Gumerlock PH, Doroshow JH, Gandara DR
Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial.
Anticancer Drugs 16: 317-21 (2005)
PM ID: 15711184
564: Garcia AA, Blessing JA, Lenz HJ, Darcy KM, Mannel RS, Miller DS, Husseinzadeh N, Gynecologic Oncology Group
Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: a Gynecologic Oncology Group study.
Gynecol Oncol 96: 810-7 (2005)
PM ID: 15721430
565: Conti PS
The future of radioimmunotherapy: a PET perspective.
Semin Oncol 32: S63-7 (2005)
PM ID: 15786028
566: Buscarini M, Quek ML, Gill P, Xia G, Quinn DI, Stein JP
Molecular prognostic factors in bladder cancer.
BJU Int 95: 739-42 (2005)
PM ID: 15794774
567: Quinn DI, Henshall SM, Sutherland RL
Molecular markers of prostate cancer outcome.
Eur J Cancer 41: 858-87 (2005)
PM ID: 15808955
568: Golubkov V, Garcia AA, Markland FS
Action of fenretinide (4-HPR) on ovarian cancer and endothelial cells.
Anticancer Res 25: 249-53 (2005)
PM ID: 15816545
569: Kardosh A, Wang W, Uddin J, Petasis NA, Hofman FM, Chen TC, Schönthal AH
Dimethyl-celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-inhibitory function, potently mimics the anti-tumor effects of celecoxib on Burkitt's lymphoma in vitro and in vivo.
Cancer Biol Ther 4: 571-82 (2005)
PM ID: 15846081
570: Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN
Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis.
Proc Natl Acad Sci U S A 102: 7671-6 (2005)
PM ID: 15890784 PMC1103706
571: Law MJ, Chambers EJ, Katsamba PS, Haworth IS, Laird-Offringa IA
Kinetic analysis of the role of the tyrosine 13, phenylalanine 56 and glutamine 54 network in the U1A/U1 hairpin II interaction.
Nucleic Acids Res 33: 2917-28 (2005)
PM ID: 15914668 PMC1140079
572: Wong SG, Luna M, Ferrario A, Gomer CJ
CHOP activation by photodynamic therapy increases treatment induced photosensitization.
Lasers Surg Med 35: 336-41 (2005)
PM ID: 15611953
573: Joshi MB, Shirota Y, Danenberg KD, Conlon DH, Salonga DS, Herndon JE, Danenberg PV, Harpole DH
High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.
Clin Cancer Res 11: 2215-21 (2005)
PM ID: 15788669
574: Konduri K, Sahota SS, Babbage G, Tong AW, Kumar PG, Newman JT, Stone MJ
Immunoglobulin M myeloma: evaluation of molecular features and cytokine expression.
Clin Lymphoma 5: 285-9 (2005)
PM ID: 15794867
575: Kumar PG, Verma A, Kishore D, Parhi LD, Joshi D, Misra S
Polyneuropathy with osteosclerotic myeloma--POEMS syndrome.
J Assoc Physicians India 52: 997-8 (2005)
PM ID: 15884463
576: Kumar PG, Pati J
Prostate cancer metastasizing to bone with normal PSA level: a lesson to learn.
Hosp Med 66: 244 (2005)
PM ID: 15889877
577: Vallböhmer D, Zhang W, Gordon M, Yang DY, Yun JE, Press OA, Rhodes KE, Sherrod AE, Iqbal S, Danenberg KD, Groshen S, Lenz HJ
Molecular determinants of cetuximab efficacy.
J Clin Oncol 23: 3536-44 (2005)
PM ID: 15908664
578: Jerdeva GV, Yarber FA, Trousdale MD, Rhodes CJ, Okamoto CT, Dartt DA, Hamm-Alvarez SF
Dominant-negative PKC-epsilon impairs apical actin remodeling in parallel with inhibition of carbachol-stimulated secretion in rabbit lacrimal acini.
Am J Physiol Cell Physiol 289: C1052-68 (2005)
PM ID: 15930141 PMC1414898 NIHMS7462
579: Gupta NP, Kumar PG, Goel R, Dinda AK
Renal sinus hemangioma simulating renal mass: a diagnostic challenge.
Int Urol Nephrol 36: 485-7 (2005)
PM ID: 15787321
580: Chen X, Sievers E, Hou Y, Park R, Tohme M, Bart R, Bremner R, Bading JR, Conti PS
Integrin alpha v beta 3-targeted imaging of lung cancer.
Neoplasia 7: 271-9 (2005)
PM ID: 15799827 PMC1501139
581: Haile RW, Yochim JM, Cortessis VK, Lin J, Levine AJ, Diep AT, Danenberg K, Danenberg P
A molecular/epidemiologic analysis of expression of cyclooxygenases 1 and 2, use of nonsteroidal antiinflammatory drugs, and risk of colorectal adenoma.
Clin Colorectal Cancer 4: 390-5 (2005)
PM ID: 15807932
582: Aparicio AM, Elkhouiery AB, Quinn DI
The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy.
Urol Clin North Am 32: 217-30, vii (2005)
PM ID: 15862619
583: Vallbohmer D, Lenz HJ
Epidermal growth factor receptor as a target for chemotherapy.
Clin Colorectal Cancer 5 Suppl 1: S19-27 (2005)
PM ID: 15871762
584: Kakimoto M, Uetake H, Osanai T, Shirota Y, Takagi Y, Takeshita E, Toriya Y, Danenberg K, Danenberg PV, Sugihara K
Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test.
Cancer Lett 223: 103-11 (2005)
PM ID: 15890242
585: Norris LS, Snodgrass SR, Miller DC, Wisoff J, Garvin J, Rorke LB, Finlay JL
Recurrent central nervous system medulloepithelioma: response and outcome following marrow-ablative chemotherapy with stem cell rescue.
J Pediatr Hematol Oncol 27: 264-6 (2005)
PM ID: 15891561
586: Nargund V, Al Hashmi D, Kumar PG, Gordon S, Otitie U, Ellison D, Carroll M, Baithun S, Britton KE
Imaging with radiolabelled monoclonal antibody (MUJ591) to prostate-specific membrane antigen in staging of clinically localized prostatic carcinoma: comparison with clinical, surgical and histological staging.
BJU Int 95: 1232-6 (2005)
PM ID: 15892807
587: Xia G, Kumar SR, Masood R, Zhu SH, Reddy RK, Krasnoperov V, Quinn DI, Henshall SM, Sutherland RL, Pinski JK, Daneshmand S, Buscarini M, Stein JP, Zhong C, Broek D, Roy-Burman P, Gill PS
EphB4 expression and biological significance in prostate cancer.
Cancer Res 65: 4623-32 (2005)
PM ID: 15930280
588: Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE, Triche TJ
EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
Cancer Res 65: 4633-44 (2005)
PM ID: 15930281
589: Quek ML, Nichols PW, Yamzon J, Daneshmand S, Miranda G, Cai J, Groshen S, Stein JP, Skinner DG
Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience.
J Urol 174: 93-6 (2005)
PM ID: 15947585
590: Quek ML, Stein JP, Nichols PW, Cai J, Miranda G, Groshen S, Daneshmand S, Skinner EC, Skinner DG
Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
J Urol 174: 103-6 (2005)
PM ID: 15947587
591: da Costa SR, Wu K, Veigh MM, Pidgeon M, Ding C, Schechter JE, Hamm-Alvarez SF
Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development.
Exp Eye Res 82: 33-45 (2005)
PM ID: 16005870 PMC1351294 NIHMS7461
592: Chamberlain MC, Tsao-Wei DD, Groshen S
Neoplastic meningitis-related encephalopathy: prognostic significance.
Neurology 63: 2159-61 (2005)
PM ID: 15596770
593: Zheng YT, Haworth IS, Zuo Z, Chow MS, Chow AH
Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
J Pharm Sci 94: 1079-89 (2005)
PM ID: 15793810
594: Khawli LA, Hu P, Epstein AL
NHS76/PEP2, a fully human vasopermeability-enhancing agent to increase the uptake and efficacy of cancer chemotherapy.
Clin Cancer Res 11: 3084-93 (2005)
PM ID: 15837764
595: Uchida K, Schneider S, Yochim JM, Kuramochi H, Hayashi K, Takasaki K, Yang D, Danenberg KD, Danenberg PV
Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy.
Clin Cancer Res 11: 3363-8 (2005)
PM ID: 15867236
596: Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, Skinner DG
Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients.
Cancer 104: 36-43 (2005)
PM ID: 15912515
597: Khurana RN, Samuel MA, Murphree AL, Loo RH, Tawansy KA
Subfoveal nodule in Coats' disease.
Clin Experiment Ophthalmol 33: 301-2 (2005)
PM ID: 15932538
598: Lenz HJ
Antiangiogenic agents in cancer therapy.
Oncology (Williston Park) 19: 17-25 (2005)
PM ID: 15934499
599: Xia G, Kumar SR, Masood R, Koss MN, Templeman C, Quinn DI, Zhu SH, Reddy RK, Krasnoperov V, Gill PS
Up-regulation of EphB4 in mesothelioma and its biological significance.
Clin Cancer Res 11: 4305-15 (2005)
PM ID: 15958611
600: Bodey B, Siegel SE, Kaiser HE
Immunocytochemical detection of members of the caspase cascade of apoptosis in childhood medulloblastomas.
In Vivo 19: 749-60 (2005)
PM ID: 15999545
601: Meadows DC, Mathews TB, North TW, Hadd MJ, Kuo CL, Neamati N, Gervay-Hague J
Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors.
J Med Chem 48: 4526-34 (2005)
PM ID: 15999991
602: Coleman RE, Delbeke D, Guiberteau MJ, Conti PS, Royal HD, Weinreb JC, Siegel BA, Federle MF, Townsend DW, Berland LL, American College of Radiology , Society of Nuclear Medicine , Society of Computed Body Tomography and Magnetic R
Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.
J Nucl Med 46: 1225-39 (2005)
PM ID: 16000293
603: Yanagawa B, Taylor L, Deisher TA, Ng R, Schreiner GF, Triche TJ, Yang D, McManus BM
Affymetrix oligonucleotide analysis of gene expression in the injured heart.
Methods Mol Med 112: 305-20 (2005)
PM ID: 16010026
604: London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner PS, Brodeur GM, Maris JM, Reynolds CP, Cohn SL
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
J Clin Oncol 23: 6459-65 (2005)
PM ID: 16116153
605: Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O'Leary MP, Gerbing RB, Matthay KK
Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
J Clin Oncol 23: 6474-80 (2005)
PM ID: 16116154
606: Lenz HJ
First Amsterdam, then Bethesda, now Melbourne?
J Clin Oncol 23: 6445-9 (2005)
PM ID: 16116155
607: Kardosh A, Soriano N, Liu YT, Uddin J, Petasis NA, Hofman FM, Chen TC, Schönthal AH
Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxib.
Blood 106: 4330-8 (2005)
PM ID: 16123214
608: Li YT, St John MA, Zhou XJ, Kim YM, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH, Wong DT
Salivary transcriptome diagnostics for oral cancer detection.
Clin Cancer Res 10: 8442-50 (2005)
PM ID: 15623624
609: Kumar PG, Benedict R, Urzua F, Fischbach C, Mooney D, Polverini P
Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis.
Lab Invest 85: 756-67 (2005)
PM ID: 15864318
610: Jubran RF, Finlay J
Central nervous system germ cell tumors: controversies in diagnosis and treatment.
Oncology (Williston Park) 19: 705-11; discussion 711-2, 715-7, 721 (2005)
PM ID: 15971448
611: Meeske KA, Siegel SE, Globe DR, Mack WJ, Bernstein L
Prevalence and correlates of fatigue in long-term survivors of childhood leukemia.
J Clin Oncol 23: 5501-10 (2005)
PM ID: 16110010
612: Chernofsky MR, Felix JC, Muderspach LI, Morrow CP, Ye W, Groshen SG, Roman LD
Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix.
Gynecol Oncol 100: 288-93 (2005)
PM ID: 16182347
613: Chamberlain MC, Tsao-Wei DD, Groshen S
Neoplastic meningitis-related encephalopathy.
J Neurooncol 72: 185-9 (2005)
PM ID: 15926000
614: Garland L, Gitlitz B, Ebbinghaus S, Pan H, de Haan H, Puri RK, Von Hoff D, Figlin R
Phase I trial of intravenous IL-4 pseudomonas exotoxin protein (NBI-3001) in patients with advanced solid tumors that express the IL-4 receptor.
J Immunother 28: 376-81 (2005)
PM ID: 16000956
615: Constantine C, Miller DC, Gardner S, Balmaceda C, Finlay J
Osseous metastasis of pineoblastoma: a case report and review of the literature.
J Neurooncol 74: 53-7 (2005)
PM ID: 16078108
616: Packer RJ, Krailo M, Mehta M, Warren K, Allen JC, Jakacki RI, Villablanca JG, Chiba A, Reaman GH
Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas.
Cancer 104: 1281-7 (2005)
PM ID: 16078267
617: Bodey B, Kaiser HE, Siegel SE
Epidermal growth factor receptor (EGFR) expression in childhood brain tumors.
In Vivo 19: 931-41 (2005)
PM ID: 16097449
618: Jadvar H, Xiankui L, Shahinian A, Park R, Tohme M, Pinski J, Conti PS
Glucose metabolism of human prostate cancer mouse xenografts.
Mol Imaging 4: 91-7 (2005)
PM ID: 16105512
619: Backhus LM, Petasis NA, Uddin J, Schönthal AH, Bart RD, Lin Y, Starnes VA, Bremner RM
Dimethyl celecoxib as a novel non-cyclooxygenase 2 therapy in the treatment of non-small cell lung cancer.
J Thorac Cardiovasc Surg 130: 1406-12 (2005)
PM ID: 16256796
620: Jin W, Kim BC, Tognon C, Lee HJ, Patel SK, Lannon CL, Maris JM, Triche TJ, Sorensen PH, Kim SJ
The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor.
Proc Natl Acad Sci U S A 102: 16239-44 (2005)
PM ID: 16258068 PMC1283417
621: Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK
Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Virology 339: 213-25 (2005)
PM ID: 15996703
622: Man TK, Chintagumpala M, Visvanathan J, Shen J, Perlaky L, Hicks J, Johnson M, Davino N, Murray J, Helman L, Meyer WH, Triche TJ, Wong KK, Lau CC
Expression profiles of osteosarcoma that can predict response to chemotherapy.
Cancer Res 65: 8142-50 (2005)
PM ID: 16166288
623: Brabender J, Marjoram P, Lord RV, Metzger R, Salonga D, Vallböhmer D, Schäfer H, Danenberg KD, Danenberg PV, Selaru FM, Baldus SE, Hölscher AH, Meltzer SJ, Schneider PM
The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
Cancer Epidemiol Biomarkers Prev 14: 2113-7 (2005)
PM ID: 16172218
624: Gormley RP, Madan R, Dulau AE, Xu D, Tamas EF, Bhattacharyya PK, LeValley A, Xue X, Kumar PG, Sparano J, Ramesh KH, Pulijaal V, Cannizzaro L, Walsh D, Ioachim HL, Ratech H
Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases.
Am J Clin Pathol 124: 790-8 (2005)
PM ID: 16203284
625: Raghavan D, Brandes LJ, Klapp K, Snyder T, Styles E, Tsao-Wei DD, Lieskovsky G, Quinn DI, Ramsey EW
Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastases.
J Urol 174: 1808-13; discussion 1813 (2005)
PM ID: 16217292
626: Minhas S, Kayes O, Hegarty P, Kumar PG, Freeman A, Ralph D
What surgical resection margins are required to achieve oncological control in men with primary penile cancer?
BJU Int 96: 1040-3 (2005)
PM ID: 16225525
627: Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue BR, Finlay JL, Goldwein JW, Heier LA, Johnson DL, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T, Children's Cancer Group
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
J Clin Oncol 23: 7621-31 (2005)
PM ID: 16234523
628: Vallböhmer D, Peters JH, Oh D, Kuramochi H, Shimizu D, DeMeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, DeMeester TR, Danenberg P
Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
Surgery 138: 701-6; discussion 706-7 (2005)
PM ID: 16269299
629: Chaudhari AJ, Darvas F, Bading JR, Moats RA, Conti PS, Smith DJ, Cherry SR, Leahy RM
Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging.
Phys Med Biol 50: 5421-41 (2005)
PM ID: 16306643
630: Miyoshi Y, Uemura H, Ishiguro H, Kitamura H, Nomura N, Danenberg PV, Kubota Y
Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer.
Prostate Cancer Prostatic Dis 8: 260-5 (2005)
PM ID: 15999119
631: Shimizu D, Ishikawa T, Ichikawa Y, Togo S, Hayasizaki Y, Okazaki Y, Danenberg PV, Shimada H
Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays.
Int J Oncol 27: 371-6 (2005)
PM ID: 16010417
632: Plasencia C, Dayam R, Wang QS, Pinski J, Burke TR, Quinn DI, Neamati N
Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines.
Mol Cancer Ther 4: 1105-13 (2005)
PM ID: 16020668
633: Zhang N, Khawli LA, Hu P, Epstein AL
Generation of rituximab polymer may cause hyper-cross-linking-induced apoptosis in non-Hodgkin's lymphomas.
Clin Cancer Res 11: 5971-80 (2005)
PM ID: 16115941
634: Popielarski SR, Hu-Lieskovan S, French SW, Triche TJ, Davis ME
A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results.
Bioconjug Chem 16: 1071-80 (2005)
PM ID: 16173782
635: Packer RJ, Krailo M, Mehta M, Warren K, Allen JC, Jakacki RI, Villablanca JG, Chiba A, Reaman GH
A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
Cancer 104: 1968-74 (2005)
PM ID: 16177987
636: Hu-Lieskovan S, Heidel JD, Bartlett DW, Davis ME, Triche TJ
Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma.
Cancer Res 65: 8984-92 (2005)
PM ID: 16204072
637: Park DJ, Zhang W, Stoehlmacher J, Tsao-Wei DD, Groshen S, Gil J, Yun JE, Sones E, Mallik N, Lenz HJ
ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.
Clin Adv Hematol Oncol 1: 162-6 (2005)
PM ID: 16224397
638: Ferrario A, Fisher AM, Rucker N, Gomer CJ
Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
Cancer Res 65: 9473-8 (2005)
PM ID: 16230411
639: Attiyeh EF, London WB, Mossé YP, Wang QS, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM, Children's Oncology Group
Chromosome 1p and 11q deletions and outcome in neuroblastoma.
N Engl J Med 353: 2243-53 (2005)
PM ID: 16306521
640: Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, Petasis NA, Levy BD, Serhan CN, Van Dyke TE
RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis.
FASEB J 20: 401-3 (2005)
PM ID: 16373400
641: Karp CL, Flick LM, Yang R, Uddin J, Petasis NA
Cystic fibrosis and lipoxins.
Prostaglandins Leukot Essent Fatty Acids 73: 263-70 (2006)
PM ID: 15979866
642: Moharram S, Zhou A, Kumar PG, Knaus EE, Wiebe LI
Radiosynthesis, in vitro cellular uptake and in vivo biodistribution of 3'-O-(3-benzenesulfonylfuroxan-4-yl)-5-[125I]iodo-2'-deoxyuridine, a nucleoside-based nitric oxide donor.
Nucl Med Biol 32: 641-5 (2006)
PM ID: 16026711
643: Kumar PG, McQuarrie SA, Zhou A, McEwan AJ, Wiebe LI
[131I]Iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice.
Nucl Med Biol 32: 647-53 (2006)
PM ID: 16026712
644: Clark JW, Eder JP, Ryan DP, Lathia C, Lenz HJ
Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors.
Clin Cancer Res 11: 5472-80 (2006)
PM ID: 16061863
645: Petasis NA, Akritopoulou-Zanze I, Fokin VV, Bernasconi G, Keledjian R, Yang R, Uddin J, Nagulapalli KC, Serhan CN
Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
Prostaglandins Leukot Essent Fatty Acids 73: 301-21 (2006)
PM ID: 16098719
646: Jerdeva GV, Wu K, Yarber FA, Rhodes CJ, Kalman D, Schechter JE, Hamm-Alvarez SF
Actin and non-muscle myosin II facilitate apical exocytosis of tear proteins in rabbit lacrimal acinar epithelial cells.
J Cell Sci 118: 4797-812 (2006)
PM ID: 16219687 PMC1482462 NIHMS7429
647: Lord RV, Brabender J, Wickramasinghe K, DeMeester SR, Holscher A, Schneider PM, Danenberg PV, DeMeester TR
Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
Surgery 138: 924-31 (2006)
PM ID: 16291394
648: Attar M, Ling KH, Tang-Liu DD, Neamati N, Lee VH
Cytochrome P450 3A expression and activity in the rabbit lacrimal gland: glucocorticoid modulation and the impact on androgen metabolism.
Invest Ophthalmol Vis Sci 46: 4697-706 (2006)
PM ID: 16303967
649: Bumm K, Grizzi F, Franceschini B, Koch M, Iro H, Wurm J, Ceva-Grimaldi G, Dimmler A, Cobos E, Dioguardi N, Sinha UK, Kast WM, Chiriva-Internati M
Sperm protein 17 expression defines 2 subsets of primary esthesioneuroblastoma.
Hum Pathol 36: 1289-93 (2006)
PM ID: 16311122
650: Liu A, Hu P, Khawli LA, Epstein AL
Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
Clin Cancer Res 11: 8492-502 (2006)
PM ID: 16322313
651: Garcia AA, Roman LD, Muderspach L, O'Meara AT, Facio G, Edwards SM, Burnett A
Phase I clinical trial of topotecan and pegylated liposomal doxorubicin.
Cancer Invest 23: 665-70 (2006)
PM ID: 16377584
652: Brzozowski Z, Saczewski F, Neamati N
Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxides.
Bioorg Med Chem 14: 2985-93 (2006)
PM ID: 16406643
653: Law MJ, Linde ME, Chambers EJ, Oubridge C, Katsamba PS, Nilsson L, Haworth IS, Laird-Offringa IA
The role of positively charged amino acids and electrostatic interactions in the complex of U1A protein and U1 hairpin II RNA.
Nucleic Acids Res 34: 275-85 (2006)
PM ID: 16407334 PMC1326249
654: Nair V, Uchil V, Neamati N
Beta-diketo acids with purine nucleobase scaffolds: novel, selective inhibitors of the strand transfer step of HIV integrase.
Bioorg Med Chem Lett 16: 1920-3 (2006)
PM ID: 16439124
655: Whitehead RP, McCoy S, Macdonald JS, Rivkin SE, Neubauer MA, Dakhil SR, Lenz HJ, Tanaka MS, Abbruzzese JL
Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study.
Invest New Drugs E publication ahead of print: (2006)
PM ID: 16444612
656: Iqbal S, Lenz HJ
Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
Expert Rev Anticancer Ther 4: 947-55 (2006)
PM ID: 15606325
657: Leichman CG, Benedetti JK, Zalupski MM, Hochster HS, Shields AF, Lenz HJ, Wade Iii JL, Bearden Iii JD, Macdonald JS
Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study.
Clin Colorectal Cancer 5: 119-23 (2006)
PM ID: 16098253
658: Zhang W, Stoehlmacher J, Park DJ, Yang D, Borchard E, Gil J, Tsao-Wei DD, Yun JE, Gordon M, Press OA, Rhodes K, Groshen S, Lenz HJ
Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer.
Clin Colorectal Cancer 5: 124-31 (2006)
PM ID: 16098254
659: Finlay JL, Zacharoulis S
The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical - and futuristic - perspective.
J Neurooncol 75: 253-66 (2006)
PM ID: 16195805
660: Quek ML, Simma-Chiang V, Stein JP, Pinski J, Quinn DI, Skinner DG
Postchemotherapy residual masses in advanced seminoma: current management and outcomes.
Expert Rev Anticancer Ther 5: 869-74 (2006)
PM ID: 16221056
661: Conti PS, White C, Pieslor P, Molina A, Aussie J, Foster P
The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry.
J Nucl Med 46: 1812-8 (2006)
PM ID: 16269594
662: Dayam R, Sanchez TW, Neamati N
Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.
J Med Chem 48: 8009-15 (2006)
PM ID: 16335925
663: Gordon MA, Gil J, Lu B, Zhang W, Yang D, Yun JE, Schneider S, Groshen S, Iqbal S, Press OA, Rhodes K, Lenz HJ
Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation.
Pharmacogenomics 7: 67-88 (2006)
PM ID: 16354126
664: Venook AP, Blanke CD, Niedzwiecki D, Lenz HJ, Taylor JR, Hollis DR, Sutherland S, Goldberg RM
Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma.
Clin Colorectal Cancer 5: 292-4 (2006)
PM ID: 16356309
665: Kuramochi H, Hayashi K, Uchida K, Miyakura S, Shimizu D, Vallböhmer D, Park SY, Danenberg KD, Takasaki K, Danenberg PV
Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer.
Clin Cancer Res 12: 29-33 (2006)
PM ID: 16397020
666: Matthay KK, Tan JC, Villablanca JG, Yanik GA, Veatch J, Franc BL, Twomey E, Horn B, Reynolds CP, Groshen S, Seeger RC, Maris JM
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
J Clin Oncol 24: 500-6 (2006)
PM ID: 16421427
667: Ajani JA, Lee FC, Singh DA, Haller DG, Lenz HJ, Benson AB, Yanagihara R, Phan AT, Yao JC, Strumberg D
Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.
J Clin Oncol 24: 663-7 (2006)
PM ID: 16446338
668: Deng J, Kelley JA, Barchi JJ, Sanchez TW, Dayam R, Pommier Y, Neamati N
Mining the NCI antiviral compounds for HIV-1 integrase inhibitors.
Bioorg Med Chem 14: 3785-92 (2006)
PM ID: 16460953
669: Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE, Zhang C, Mayer RJ
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
J Clin Oncol 24: 1395-403 (2006)
PM ID: 16505413
670: Ji Q, Aoyama C, Chen PK, Stolz A, Liu PX
Localization and altered expression of AKR1C family members in human ovarian tissues.
Mol Cell Probes 19: 261-6 (2006)
PM ID: 15979276
671: Medina-Kauwe LK, Xie J, Hamm-Alvarez SF
Intracellular trafficking of nonviral vectors.
Gene Ther 12: 1734-51 (2006)
PM ID: 16079885
672: Chamberlain MC, Tsao-Wei DD, Groshen S
Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytoma.
Cancer 106: 172-9 (2006)
PM ID: 16323194
673: Kumar PG, Verma A, Maiti S, Gargallo R, Chowdhury S
Tetraplex DNA transitions within the human c-myc promoter detected by multivariate curve resolution of fluorescence resonance energy transfer.
Biochemistry 44: 16426-34 (2006)
PM ID: 16342935
674: Nair V, Chi G, Ptak R, Neamati N
HIV integrase inhibitors with nucleobase scaffolds: discovery of a highly potent anti-HIV agent.
J Med Chem 49: 445-7 (2006)
PM ID: 16420027 PMC2518396 NIHMS63135
675: Ding C, Macveigh M, Pidgeon M, da Costa SR, Wu K, Hamm-Alvarez SF, Schechter JE
Unique ultrastructure of exorbital lacrimal glands in male NOD and BALB/c mice.
Curr Eye Res 31: 13-22 (2006)
PM ID: 16421015
676: Serhan CN, Gotlinger KH, Hong S, Lu Y, Siegelman J, Baer T, Yang R, Colgan SP, Petasis NA
Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes.
J Immunol 176: 1848-59 (2006)
PM ID: 16424216
677: Levine AM, Tulpule A, Quinn DI, Gorospe G, Smith DL, Hornor L, Boswell WD, Espina BM, Groshen SG, Masood R, Gill PS
Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy.
J Clin Oncol 24: 1712-9 (2006)
PM ID: 16520466
678: Abrey LE, Childs BH, Paleologos N, Kaminer L, Rosenfeld S, Salzman D, Finlay JL, Gardner S, Peterson K, Hu W, Swinnen L, Bayer R, Forsyth P, Stewart D, Smith AM, Macdonald DR, Weaver S, Ramsay DA, Nimer SD, DeAngelis LM, Cairncross JG
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
Neuro Oncol 8: 183-8 (2006)
PM ID: 16524945 PMC1871935
679: Wu K, Jerdeva GV, da Costa SR, Sou E, Schechter JE, Hamm-Alvarez SF
Molecular mechanisms of lacrimal acinar secretory vesicle exocytosis.
Exp Eye Res 83: 84-96 (2006)
PM ID: 16530759
680: Bonnans C, Fukunaga K, Keledjian R, Petasis NA, Levy BD
Regulation of phosphatidylinositol 3-kinase by polyisoprenyl phosphates in neutrophil-mediated tissue injury.
J Exp Med 203: 857-63 (2006)
PM ID: 16567384 PMC2118263
681: Levy BD, Hickey L, Morris AJ, Larvie M, Keledjian R, Petasis NA, Bannenberg G, Serhan CN
Novel polyisoprenyl phosphates block phospholipase D and human neutrophil activation in vitro and murine peritoneal inflammation in vivo.
Br J Pharmacol 146: 344-51 (2006)
PM ID: 16041402 PMC1440714 NIHMS7539
682: Xia G, Kumar SR, Stein JP, Singh J, Krasnoperov V, Zhu SH, Hassanieh L, Smith DL, Buscarini M, Broek D, Quinn DI, Weaver FA, Gill PS
EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.
Oncogene 25: 769-80 (2006)
PM ID: 16205642
683: Erdreich-Epstein A, Ganguly AK, Shi XH, Zimonjic DB, Shackleford GM
Androgen inducibility of Fgf8 in Shionogi carcinoma 115 cells correlates with an adjacent t(5;19) translocation.
Genes Chromosomes Cancer 45: 169-81 (2006)
PM ID: 16252261
684: Kumar PG, Duarte J, Pati J
Metastatic prostate cancer presenting as diplopia with regression of signs with hormone manipulation.
Br J Hosp Med (Lond) 66: 646 (2006)
PM ID: 16308964
685: Chen X, Park R, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Moats RA, Bading JR, Laug WE, Conti PS
Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide.
Mol Imaging Biol 8: 9-15 (2006)
PM ID: 16315003
686: Garcia AA, Iqbal S, Quinn DI, Edwards SM, Lenz HJ, Weber JS
Phase I clinical trial of weekly docetaxel and exisulind, a novel inducer of apoptosis.
Invest New Drugs 24: 79-83 (2006)
PM ID: 16379039
687: El-Khoueiry AB, Lenz HJ
Should continuous infusion 5-fluorouracil become the standard of care in the USA as it is in Europe?
Cancer Invest 24: 50-5 (2006)
PM ID: 16466993
688: Noble B, Abada P, Nunez-Iglesias J, Cannon PM
Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release.
J Virol 80: 2924-32 (2006)
PM ID: 16501101 PMC1395462
689: Deng J, Sanchez TW, Neamati N, Briggs JM
Dynamic pharmacophore model optimization: identification of novel HIV-1 integrase inhibitors.
J Med Chem 49: 1684-92 (2006)
PM ID: 16509584
690: Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, Cheung NK, Seeger RC, Evans AE, Ikegaki N
The MYCN enigma: significance of MYCN expression in neuroblastoma.
Cancer Res 66: 2826-33 (2006)
PM ID: 16510605
691: Odin E, Wettergren Y, Carlsson G, Danenberg PV, Termini A, Willén R, Gustavsson B
Expression and clinical significance of methylenetetrahydrofolate reductase in patients with colorectal cancer.
Clin Colorectal Cancer 5: 344-9 (2006)
PM ID: 16512993
692: Chamberlain MC, Tsao-Wei DD, Groshen S
Salvage chemotherapy with CPT-11 for recurrent meningioma.
J Neurooncol 78: 271-6 (2006)
PM ID: 16628476
693: Andersson SV, Hamm-Alvarez SF, Gierow JP
Integrin adhesion in regulation of lacrimal gland acinar cell secretion.
Exp Eye Res 83: 543-53 (2006)
PM ID: 16631165
694: Chang A, Cai J, Miranda G, Groshen S, Skinner DG, Stein JP
Usefulness of CA 125 as a preoperative prognostic marker for transitional cell carcinoma of the bladder.
J Urol 172: 2182-6 (2006)
PM ID: 15538227
695: Yu L, Ju DW, Chen W, Li T, Xu Z, Jiang C, Chen SP, Tao Q, Ye D, Hu P, Khawli LA, Taylor CR, Epstein AL
131I-chTNT radioimmunotherapy of 43 patients with advanced lung cancer.
Cancer Biother Radiopharm 21: 5-14 (2006)
PM ID: 16480326
696: Xia G, Kumar SR, Hawes D, Cai J, Hassanieh L, Groshen S, Zhu SH, Masood R, Quinn DI, Broek D, Stein JP, Gill PS
Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer.
J Urol 175: 1245-52 (2006)
PM ID: 16515971
697: Lara PN, Stadler WM, Longmate J, Quinn DI, Wexler J, Van Loan M, Twardowski P, Gumerlock PH, Vogelzang NJ, Vokes EE, Lenz HJ, Doroshow JH, Gandara DR
A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases.
Clin Cancer Res 12: 1556-63 (2006)
PM ID: 16533781
698: Vallböhmer D, Peters JH, Kuramochi H, Oh D, Yang D, Shimizu D, DeMeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, Danenberg PV, DeMeester TR
Molecular determinants in targeted therapy for esophageal adenocarcinoma.
Arch Surg 141: 476-81; discussion 481-2 (2006)
PM ID: 16702519
699: Pyrko P, Soriano N, Kardosh A, Liu YT, Uddin J, Petasis NA, Hofman FM, Chen CS, Chen TC, Schönthal AH
Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
Mol Cancer 5: 19 (2006)
PM ID: 16707021 PMC1479836
700: Bui HH, Schiewe AJ, von Grafenstein H, Haworth IS
Structural prediction of peptides binding to MHC class I molecules.
Proteins 63: 43-52 (2006)
PM ID: 16447245
701: Chamberlain MC, Tsao-Wei DD, Groshen S
Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis.
Cancer 106: 2021-7 (2006)
PM ID: 16583432
702: Vallböhmer D, Brabender J, Yang DY, Danenberg K, Schneider PM, Metzger R, Holscher AH, Danenberg PV
Sex differences in the predictive power of the molecular prognostic factor HER2/neu in patients with non-small-cell lung cancer.
Clin Lung Cancer 7: 332-7 (2006)
PM ID: 16640805
703: Pike BL, Groshen S, Hsu YH, Shai RM, Wang XD, Holtan N, Futscher BW, Hacia JG
Comparisons of PCR-based genome amplification systems using CpG island microarrays.
Hum Mutat 27: 589-96 (2006)
PM ID: 16652338
704: Moody K, Finlay J, Mancuso C, Charlson ME
Feasibility and safety of a pilot randomized trial of infection rate: neutropenic diet versus standard food safety guidelines.
J Pediatr Hematol Oncol 28: 126-33 (2006)
PM ID: 16679934
705: Siegel MJ, Finlay JL, Zacharoulis S
State of the art chemotherapeutic management of pediatric brain tumors.
Expert Rev Neurother 6: 765-79 (2006)
PM ID: 16734524
706: Arita M, Oh SF, Chonan T, Hong S, Elangovan S, Sun YP, Uddin J, Petasis NA, Serhan CN
Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions.
J Biol Chem 281: 22847-54 (2006)
PM ID: 16757471
707: Park DJ, Lenz HJ
Determinants of chemosensitivity in gastric cancer.
Curr Opin Pharmacol 6: 337-44 (2006)
PM ID: 16777480
708: Aiello F, Brizzi A, De Grazia O, Garofalo A, Grande F, Sinicropi MS, Dayam R, Neamati N
An approach to the stereo-controlled synthesis of polycyclic derivatives of l-4-thiazolidinecarboxylic acid active against HIV-1 integrase.
Eur J Med Chem 41: 914-7 (2006)
PM ID: 16781021
709: Al-Mawsawi LQ, Fikkert V, Dayam R, Witvrouw M, Burke TR, Borchers CH, Neamati N
Discovery of a small-molecule HIV-1 integrase inhibitor-binding site.
Proc Natl Acad Sci U S A 103: 10080-5 (2006)
PM ID: 16785440 PMC1502509
710: Reignier T, Oldenburg J, Noble B, Lamb E, Romanowski V, Buchmeier MJ, Cannon PM
Receptor use by pathogenic arenaviruses.
Virology 353: 111-20 (2006)
PM ID: 16797051
711: Crowe DL, Sinha UK
p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Head Neck 28: 15-23 (2006)
PM ID: 16302195
712: Artinyan A, Essani R, Lake J, Kaiser AM, Vukasin P, Danenberg P, Danenberg K, Haile R, Beart RW
Molecular predictors of lymph node metastasis in colon cancer: increased risk with decreased thymidylate synthase expression.
J Gastrointest Surg 9: 1216-21; discussion 1221 (2006)
PM ID: 16332476
713: Panigrahy A, Krieger MD, Gonzalez-Gomez I, Liu XS, McComb JG, Finlay JL, Nelson MD, Gilles FH, Blüml S
Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization.
AJNR Am J Neuroradiol 27: 560-72 (2006)
PM ID: 16551993
714: Kuramochi H, Hayashi K, Uchida K, Miyakura S, Shimizu D, Vallbohmer D, Park SY, Danenberg KD, Takasaki K, Danenberg PV
5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis.
Int J Cancer 119: 522-6 (2006)
PM ID: 16572420
715: Beer TM, Tangen CM, Nichols CR, Margolin KA, Dreicer R, Stephenson WT, Quinn DI, Raghavan D, Crawford ED
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies.
Cancer 106: 2624-9 (2006)
PM ID: 16688776
716: Quek ML, Daneshmand S, Rodrigo S, Cai J, Dorff TB, Groshen S, Skinner DG, Lieskovsky G, Pinski J
Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer.
Urology 67: 1247-52 (2006)
PM ID: 16697447
717: Flanagan ML, Khawli LA, Hu P, Epstein AL
H60/TNT-3 fusion protein activates NK cells in vitro and improves immunotherapeutic outcome in murine syngeneic tumor models.
J Immunother 29: 274-83 (2006)
PM ID: 16699370
718: Dziadziuszko R, Witta SE, Cappuzzo F, Park SY, Tanaka K, Danenberg PV, Barón AE, Crino L, Franklin WA, Bunn PA, Varella-Garcia M, Danenberg KD, Hirsch FR
Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer.
Clin Cancer Res 12: 3078-84 (2006)
PM ID: 16707605
719: Pagliarulo V, Hawes D, Brands FH, Groshen S, Cai J, Stein JP, Lieskovsky G, Skinner DG, Cote RJ
Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.
J Clin Oncol 24: 2735-42 (2006)
PM ID: 16782914
720: Rentsendorj A, Xie J, Macveigh M, Agadjanian H, Bass S, Kim DH, Rossi J, Hamm-Alvarez SF, Medina-Kauwe LK
Typical and atypical trafficking pathways of Ad5 penton base recombinant protein: implications for gene transfer.
Gene Ther 13: 821-36 (2006)
PM ID: 16482205
721: Shimizu D, Vallböhmer D, Kuramochi H, Uchida K, Schneider S, Chandrasoma PT, Shimada H, DeMeester TR, Danenberg KD, Peters JH, DeMeester SR, Danenberg PV
Increasing cyclooxygenase-2 (cox-2) gene expression in the progression of Barrett's esophagus to adenocarcinoma correlates with that of Bcl-2.
Int J Cancer 119: 765-70 (2006)
PM ID: 16550596
722: Vallböhmer D, Lenz HJ
[Predictive and prognostic factors in the neoadjuvant/adjuvant therapy of gastrointestinal tumors: wishful thinking or reality?]
Zentralbl Chir 131: 148-56 (2006)
PM ID: 16612782
723: Pinski J, Wang QS, Quek ML, Cole A, Cooc J, Danenberg K, Danenberg PV
Genistein-induced neuroendocrine differentiation of prostate cancer cells.
Prostate 66: 1136-43 (2006)
PM ID: 16652383
724: Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG
Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
J Urol 176: 493-8; discussion 498-9 (2006)
PM ID: 16813876
725: Children's Oncology Group (CCG 09709) , Villablanca JG, Krailo MD, Ames MM, Reid JM, Reaman GH, Reynolds CP, Reynolds PC
Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).
J Clin Oncol 24: 3423-30 (2006)
PM ID: 16849757
726: Pollack IF, Hamilton RL, Sobol RW, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL
O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
J Clin Oncol 24: 3431-7 (2006)
PM ID: 16849758
727: Li HY, Zawahir Z, Song LD, Long YQ, Neamati N
Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.
J Med Chem 49: 4477-86 (2006)
PM ID: 16854053
728: Dayam R, Aiello F, Deng J, Wu Y, Garofalo A, Chen X, Neamati N
Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents.
J Med Chem 49: 4526-34 (2006)
PM ID: 16854058
729: Vallböhmer D, DeMeester SR, Oh DS, Banki F, Kuramochi H, Shimizu D, Hagen JA, Danenberg KD, Danenberg PV, Chandrasoma PT, Peters JH, DeMeester TR
Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus.
Am J Gastroenterol 101: 1458-66 (2006)
PM ID: 16863546
730: Zawahir Z, Neamati N
Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome.
Bioorg Med Chem Lett 16: 5199-202 (2006)
PM ID: 16879966
731: Brzozowski Z, Saczewski F, Neamati N
Synthesis and anti-HIV-1 activity of a novel series of 1,4,2-benzodithiazine-dioxides.
Bioorg Med Chem Lett 16: 5298-302 (2006)
PM ID: 16908143
732: Wang JG, Barsky LW, Davicioni E, Weinberg KI, Triche TJ, Zhang XK, Wu L
Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RARalpha.
FASEB J 20: 2142-4 (2006)
PM ID: 16935935
733: Ajani JA, Safran H, Bokemeyer C, Shah MA, Lenz HJ, Van Cutsem E, Burris HA, Lebwohl D, Mullaney B
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane.
Invest New Drugs 24: 441-6 (2006)
PM ID: 16586011
734: Masood R, Kumar SR, Sinha UK, Crowe DL, Krasnoperov V, Reddy RK, Zozulya S, Singh J, Xia G, Broek D, Schönthal AH, Gill PS
EphB4 provides survival advantage to squamous cell carcinoma of the head and neck.
Int J Cancer 119: 1236-48 (2006)
PM ID: 16615113
735: Zhang W, Gordon M, Press OA, Rhodes K, Vallböhmer D, Yang DY, Park DJ, Fazzone W, Schultheis A, Sherrod AE, Iqbal S, Groshen S, Lenz HJ
Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.
Pharmacogenet Genomics 16: 475-83 (2006)
PM ID: 16788380
736: Liu A, Hu P, Khawli LA, Epstein AL
B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumors.
J Immunother 29: 425-35 (2006)
PM ID: 16799338
737: Sechi M, Bacchi A, Carcelli M, Compari C, Duce E, Fisicaro E, Rogolino D, Gates P, Derudas M, Al-Mawsawi LQ, Neamati N
From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes.
J Med Chem 49: 4248-60 (2006)
PM ID: 16821784
738: Davicioni E, Finckenstein FG, Shahbazian V, Buckley JD, Triche TJ, Anderson MJ
Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas.
Cancer Res 66: 6936-46 (2006)
PM ID: 16849537
739: Bodey B, Siegel SE, Kaiser HE
Up-regulation of VEGF expression and related neo-angiogenesis in childhood high-grade gliomas: implications for anti-angiogenic anti-neoplastic therapy.
In Vivo 20: 511-8 (2006)
PM ID: 16900782
740: Bodey B, Siegel SE, Kaiser HE
Cyclooxygenase-2 (COX-2) overexpression in childhood brain tumors.
In Vivo 20: 519-25 (2006)
PM ID: 16900783
741: Robinette D, Neamati N, Tomer KB, Borchers CH
Photoaffinity labeling combined with mass spectrometric approaches as a tool for structural proteomics.
Expert Rev Proteomics 3: 399-408 (2006)
PM ID: 16901199 PMC2266983 NIHMS13267
742: Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H, Matthay KK, Buckley JD, Ortega A, Seeger RC
Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification.
J Natl Cancer Inst 98: 1193-203 (2006)
PM ID: 16954472
743: Cai Q, Kusnetzow AK, Hubbell WL, Haworth IS, Gacho GP, Van Eps N, Hideg K, Chambers EJ, Qin PZ
Site-directed spin labeling measurements of nanometer distances in nucleic acids using a sequence-independent nitroxide probe.
Nucleic Acids Res 34: 4722-30 (2006)
PM ID: 16966338 PMC1635252
744: Ceppi P, Volante M, Novello S, Rapa I, Danenberg KD, Danenberg PV, Cambieri A, Selvaggi G, Saviozzi S, Calogero R, Papotti M, Scagliotti GV
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine.
Ann Oncol 17: 1818-25 (2006)
PM ID: 16980606
745: Xie J, Chiang L, Contreras J, Wu K, Garner JA, Medina-Kauwe LK, Hamm-Alvarez SF
Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini.
J Virol 80: 11833-51 (2006)
PM ID: 16987972 PMC1642591
746: Kulkarni AA, Davies DL, Links JS, Patel LN, Lee VH, Haworth IS
A charge pair interaction between Arg282 in transmembrane segment 7 and Asp341 in transmembrane segment 8 of hPepT1.
Pharm Res 24: 66-72 (2006)
PM ID: 17009102
747: Selvam S, Thomas PB, Hamm-Alvarez SF, Schechter JE, Stevenson D, Mircheff AK, Trousdale MD
Current status of gene delivery and gene therapy in lacrimal gland using viral vectors.
Adv Drug Deliv Rev 58: 1243-57 (2006)
PM ID: 17056149 PMC1773022 NIHMS14762
748: Haworth IS
Computational drug delivery.
Adv Drug Deliv Rev 58: 1271-3 (2006)
PM ID: 17069930
749: Lenz HJ
Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
Oncology (Williston Park) 20: 5-13 (2006)
PM ID: 16736978
750: Schneider S, Park DJ, Yang D, El-Khoueiry AB, Sherrod AE, Groshen S, Streeter O, Iqbal S, Danenberg KD, Lenz HJ
Gene expression in tumor-adjacent normal tissue is associated with recurrence in patients with rectal cancer treated with adjuvant chemoradiation.
Pharmacogenet Genomics 16: 555-63 (2006)
PM ID: 16847424
751: Pontes de Carvalho RA, Krausse ML, Murphree AL, Schmitt EE, Campochiaro PA, Maumenee IH
Delivery from episcleral exoplants.
Invest Ophthalmol Vis Sci 47: 4532-9 (2006)
PM ID: 17003449
752: Henshall SM, Horvath LG, Quinn DI, Eggleton SA, Grygiel JJ, Stricker PD, Biankin AV, Kench JG, Sutherland RL
Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy.
J Natl Cancer Inst 98: 1420-4 (2006)
PM ID: 17018789
753: Garcia AA, Blessing JA, Darcy KM, Lenz HJ, Zhang W, Hannigan E, Moore DH
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
Gynecol Oncol 104: 572-9 (2006)
PM ID: 17049588 PMC1858667 NIHMS19454
754: Shibata SI, Chow WA, Frankel P, Juhasz A, Leong LA, Lim D, Margolin K, Morgan RJ, Newman EM, Somlo G, Yen Y, Synold TW, Gandara D, Lenz HJ, Doroshow JH
A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression.
Cancer Chemother Pharmacol 59: 549-57 (2006)
PM ID: 17051371
755: Hong S, Lu Y, Yang R, Gotlinger KH, Petasis NA, Serhan CN
Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms.
J Am Soc Mass Spectrom 18: 128-44 (2006)
PM ID: 17055291 PMC2763184 NIHMS16191
756: Meadows DC, Sanchez TW, Neamati N, North TW, Gervay-Hague J
Ring substituent effects on biological activity of vinyl sulfones as inhibitors of HIV-1.
Bioorg Med Chem 15: 1127-37 (2006)
PM ID: 17074494 PMC1994090 NIHMS15547
757: Grande F, Aiello F, Grazia OD, Brizzi A, Garofalo A, Neamati N
Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.
Bioorg Med Chem 15: 288-94 (2006)
PM ID: 17085054
758: Osenga KL, Hank JA, Albertini MR, Gan J, Sternberg AG, Eickhoff J, Seeger RC, Matthay KK, Reynolds CP, Twist C, Krailo M, Adamson PC, Reisfeld RA, Gillies SD, Sondel PM, Children's Oncology Group
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group.
Clin Cancer Res 12: 1750-9 (2006)
PM ID: 16551859 PMC2587020 NIHMS73403
759: Ferrario A, Gomer CJ
Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model.
J Environ Pathol Toxicol Oncol 25: 251-9 (2006)
PM ID: 16566722
760: Vallböhmer D, Iqbal S, Yang DY, Rhodes KE, Zhang W, Gordon M, Fazzone W, Schultheis AM, Sherrod AE, Danenberg KD, Lenz HJ
Molecular determinants of irinotecan efficacy.
Int J Cancer 119: 2435-42 (2006)
PM ID: 16894565
761: Azuma M, Danenberg KD, Iqbal S, El-Khoueiry AB, Zhang W, Yang D, Koizumi W, Saigenji K, Danenberg PV, Lenz HJ
Epidermal growth factor receptor and epidermal growth factor receptor variant III gene expression in metastatic colorectal cancer.
Clin Colorectal Cancer 6: 214-8 (2006)
PM ID: 17026791
762: Sinha UK, Mazhar K, Chinn SB, Dhillon VK, Liu L, Masood R, Rice DH, Gill PS
The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg 132: 1053-9 (2006)
PM ID: 17043250
763: Lenz HJ, Van Cutsem E, Khambata-Ford S, Mayer RJ, Gold P, Stella P, Mirtsching B, Cohn AL, Pippas AW, Azarnia N, Tsuchihashi Z, Mauro DJ, Rowinsky EK
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
J Clin Oncol 24: 4914-21 (2006)
PM ID: 17050875
764: Pootrakul L, Datar RH, Shi SR, Cai J, Hawes D, Groshen SG, Lee AS, Cote RJ
Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer.
Clin Cancer Res 12: 5987-93 (2006)
PM ID: 17062670
765: Patil S, Kamath S, Sanchez TW, Neamati N, Schinazi RF, Buolamwini JK
Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors.
Bioorg Med Chem 15: 1212-28 (2006)
PM ID: 17158051
766: Dayam R, Deng J, Neamati N
HIV-1 integrase inhibitors: 2003-2004 update.
Med Res Rev 26: 271-309 (2006)
PM ID: 16496343
767: Vallböhmer D, DeMeester SR, Peters JH, Oh DS, Kuramochi H, Shimizu D, Hagen JA, Danenberg KD, Danenberg PV, DeMeester TR, Chandrasoma PT
Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.
Dis Esophagus 19: 260-6 (2006)
PM ID: 16866857
768: Vallböhmer D, Brabender J, Yang D, Schneider PM, Metzger R, Danenberg KD, Hölscher AH, Danenberg PV
DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
Clin Lung Cancer 8: 39-44 (2006)
PM ID: 16870044
769: Steinberg ML, Fremont A, Khan DC, Huang D, Knapp H, Karaman D, Forge N, Andre K, Chaiken LM, Streeter OE
Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges.
Cancer 107: 2669-77 (2006)
PM ID: 17078056
770: Finlay JL, Erdreich-Epstein A, Packer RJ
Progress in the treatment of childhood brain tumors: no room for complacency.
Pediatr Hematol Oncol 24: 79-84 (2006)
PM ID: 17130118
771: Wang Y, Chiu CT, Nakamura T, Walker AM, Petridou B, Trousdale MD, Hamm-Alvarez SF, Schechter JE, Mircheff AK
Elevated prolactin redirects secretory vesicle traffic in rabbit lacrimal acinar cells.
Am J Physiol Endocrinol Metab 292: E1122-34 (2006)
PM ID: 17164431
772: Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer.
Arch Pathol Lab Med 131: 18 (2006)
PM ID: 17228981
773: Rosenne E, Shakhar G, Melamed R, Schwartz Y, Erdreich-Epstein A, Ben-Eliyahu S
Inducing a mode of NK-resistance to suppression by stress and surgery: a potential approach based on low dose of poly I-C to reduce postoperative cancer metastasis.
Brain Behav Immun 21: 395-408 (2006)
PM ID: 17240115 PMC2565756 NIHMS22060
774: Gomer CJ, Ferrario A, Luna M, Rucker N, Wong SG
Photodynamic therapy: combined modality approaches targeting the tumor microenvironment.
Lasers Surg Med 38: 516-21 (2007)
PM ID: 16607618
775: Iagaru A, Masamed R, Singer PA, Conti PS
2-Deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and positron emission tomography/computed tomography diagnosis of patients with recurrent papillary thyroid cancer.
Mol Imaging Biol 8: 309-14 (2007)
PM ID: 16758370
776: Iagaru A, Chawla S, Menendez L, Conti PS
18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas.
Nucl Med Commun 27: 795-802 (2007)
PM ID: 16969262
777: Sanderson KM, Penson DF, Cai J, Groshen S, Stein JP, Lieskovsky G, Skinner DG
Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
J Urol 176: 2025-31; discussion 2031-2 (2007)
PM ID: 17070244
778: Lones MA, Heerema NA, Le Beau MM, Perkins SL, Kadin ME, Kjeldsberg CR, Sposto R, Meadows A, Siegel SE, Buckley JD, Finlay J, Abromowitch M, Cairo MS, Sanger WG
Complex secondary chromosome abnormalities in advanced stage anaplastic large cell lymphoma of children and adolescents: a report from CCG-E08.
Cancer Genet Cytogenet 171: 89-96 (2007)
PM ID: 17116485
779: Lones MA, Heerema NA, Le Beau MM, Sposto R, Perkins SL, Kadin ME, Kjeldsberg CR, Meadows A, Siegel SE, Buckley JD, Abromowitch M, Kersey JH, Bergeron S, Cairo MS, Sanger WG
Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08.
Cancer Genet Cytogenet 172: 1-11 (2007)
PM ID: 17175373
780: Tedeschi-Blok N, Buckley JD, Varma R, Triche TJ, Hinton DR
Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease.
Ophthalmology 114: 99-103 (2007)
PM ID: 17198853
781: Perry R, Gonzales I, Finlay J, Zacharoulis S
Primary peripheral primitive neuroectodermal tumors of the spinal cord: report of two cases and review of the literature.
J Neurooncol 81: 259-64 (2007)
PM ID: 17203398
782: Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS
In vivo evaluation of 2'-deoxy-2'-[(18)F]fluoro-5-iodo-1-beta-D-arabinofuranosyluracil ([18F]FIAU) and 2'-deoxy-2'-[18F]fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil ([18F]FEAU) as markers for suicide gene expression.
Eur J Nucl Med Mol Imaging 34: 822-9 (2007)
PM ID: 17206416
783: Kang TY, Nichols PW, Skinner E, Groshen S, Valin G, Ye W, Raghavan D
Functional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy influences the response.
BJU Int 99: 1024-7 (2007)
PM ID: 17244277
784: Sun YP, Oh SF, Uddin J, Yang R, Gotlinger KH, Campbell E, Colgan SP, Petasis NA, Serhan CN
Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation.
J Biol Chem 282: 9323-34 (2007)
PM ID: 17244615
785: Hyder DJ, Sung L, Pollack IF, Gilles FH, Yates AJ, Davis RL, Boyett JM, Finlay JL
Anaplastic mixed gliomas and anaplastic oligodendroglioma in children: results from the CCG 945 experience.
J Neurooncol 83: 1-8 (2007)
PM ID: 17252186
786: Vallböhmer D, Kuramochi H, Shimizu D, Danenberg KD, Lindebjerg J, Nielsen JN, Jakobsen A, Danenberg PV
Molecular factors of 5-fluorouracil metabolism in colorectal cancer: analysis of primary tumor and lymph node metastasis.
Int J Oncol 28: 527-33 (2007)
PM ID: 16391809
787: Armenian SH, La Via WV, Siegel SE, Mascarenhas L
Evaluation of persistent pulmonary infiltrates in pediatric oncology patients.
Pediatr Blood Cancer 48: 165-72 (2007)
PM ID: 16411212
788: Lu Y, Hong S, Yang R, Uddin J, Gotlinger KH, Petasis NA, Serhan CN
Identification of endogenous resolvin E1 and other lipid mediators derived from eicosapentaenoic acid via electrospray low-energy tandem mass spectrometry: spectra and fragmentation mechanisms.
Rapid Commun Mass Spectrom 21: 7-22 (2007)
PM ID: 17131464
789: Lenz HJ, Lee FC, Haller DG, Singh D, Benson AB, Strumberg D, Yanagihara R, Yao JC, Phan AT, Ajani JA
Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.
Cancer 109: 33-40 (2007)
PM ID: 17133415
790: Yang D, Schneider S, Azuma M, Iqbal S, El-Khoueiry AB, Groshen S, Agafitei D, Danenberg KD, Danenberg PV, Ladner RD, Lenz HJ
Gene expression levels of epidermal growth factor receptor, survivin, and vascular endothelial growth factor as molecular markers of lymph node involvement in patients with locally advanced rectal cancer.
Clin Colorectal Cancer 6: 305-11 (2007)
PM ID: 17241515
791: Al-Mawsawi LQ, Sechi M, Neamati N
Single amino acid substitution in HIV-1 integrase catalytic core causes a dramatic shift in inhibitor selectivity.
FEBS Lett 581: 1151-6 (2007)
PM ID: 17328897
792: Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS
Biodistribution and PET imaging of [(18)F]-fluoroadenosine derivatives.
Nucl Med Biol 34: 267-72 (2007)
PM ID: 17383576 PMC1905838 NIHMS21243
793: Whitehead RP, McCoy S, Macdonald JS, Rivkin SE, Neubauer MA, Dakhil SR, Lenz HJ, Tanaka MS, Abbruzzese JL, Southwest Oncology Group
Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study.
Invest New Drugs 24: 335-41 (2007)
PM ID: 16683076
794: Goldberg RM, Rothenberg ML, Van Cutsem E, Benson AB, Blanke CD, Diasio RB, Grothey A, Lenz HJ, Meropol NJ, Ramanathan RK, Becerra CH, Wickham R, Armstrong D, Viele C
The continuum of care: a paradigm for the management of metastatic colorectal cancer.
Oncologist 12: 38-50 (2007)
PM ID: 17227899
795: Deng J, Dayam R, Al-Mawsawi LQ, Neamati N
Design of second generation HIV-1 integrase inhibitors.
Curr Pharm Des 13: 129-41 (2007)
PM ID: 17269923
796: Deng J, Grande F, Neamati N
Small molecule inhibitors of Stat3 signaling pathway.
Curr Cancer Drug Targets 7: 91-107 (2007)
PM ID: 17305481
797: Pollack IF, Hamilton RL, James CD, Finkelstein SD, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL, Children's Oncology Group
Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
J Neurosurg 105: 418-24 (2007)
PM ID: 17328268
798: Nair S, Kumar PG, Ladas GP
Intratracheal metastasis secondary to soft tissue liposarcoma.
Singapore Med J 48: e81-3 (2007)
PM ID: 17342277
799: Oldenburg J, Reignier T, Flanagan ML, Hamilton GA, Cannon PM
Differences in tropism and pH dependence for glycoproteins from the Clade B1 arenaviruses: implications for receptor usage and pathogenicity.
Virology 364: 132-9 (2007)
PM ID: 17397892 PMC2743526 NIHMS25518
800: Kochupillai V, Kumar PG, Singh D, Aggarwal D, Bhardwaj N, Bhutani M, DAS SN
Effect of rhythmic breathing (Sudarshan Kriya and Pranayam) on immune functions and tobacco addiction.
Ann N Y Acad Sci 1056: 242-52 (2007)
PM ID: 16387692
801: Stein JP, Penson DF, Cai J, Miranda G, Skinner EC, Dunn MA, Groshen S, Lieskovsky G, Skinner DG
Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer.
J Urol 177: 876-81; discussion 881-2 (2007)
PM ID: 17296365
802: Iagaru A, Masamed R, Keesara S, Conti PS
Breast MRI and 18F FDG PET/CT in the management of breast cancer.
Ann Nucl Med 21: 33-8 (2007)
PM ID: 17373334
803: Abrey LE, Louis DN, Paleologos N, Lassman AB, Raizer JJ, Mason W, Finlay J, Macdonald DR, DeAngelis LM, Cairncross JG, Oligodendroglioma Study Group
Survey of treatment recommendations for anaplastic oligodendroglioma.
Neuro Oncol 9: 314-8 (2007)
PM ID: 17435180 PMC1907408
804: Zhang N, Sadun RE, Arias RS, Flanagan ML, Sachsman SM, Nien YC, Khawli LA, Hu P, Epstein AL
Targeted and untargeted CD137L fusion proteins for the immunotherapy of experimental solid tumors.
Clin Cancer Res 13: 2758-67 (2007)
PM ID: 17460060
805: Schiewe AJ, Haworth IS
Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
J Mol Graph Model 26: 667-75 (2007)
PM ID: 17493854
806: Deng J, Sanchez TW, Al-Mawsawi LQ, Dayam R, Yunes RA, Garofalo A, Bolger MB, Neamati N
Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore.
Bioorg Med Chem 15: 4985-5002 (2007)
PM ID: 17502148
807: Tawansy KA, Samuel MA, Shammas M, Murphree AL
Vitreoretinal complications of retinoblastoma treatment.
Retina 26: S47-52 (2007)
PM ID: 16946679
808: Iagaru A, Masamed R, Singer PA, Conti PS
Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT.
Mol Imaging Biol 9: 72-7 (2007)
PM ID: 17186139
809: Kang HG, Jenabi JM, Zhang J, Keshelava N, Shimada H, May WA, Ng T, Reynolds CP, Triche TJ, Sorensen PH
E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.
Cancer Res 67: 3094-105 (2007)
PM ID: 17409416
810: Jadvar H, Henderson RW, Conti PS
[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
J Comput Assist Tomogr 31: 223-8 (2007)
PM ID: 17414758
811: Pañares RL, Garcia AA
Bevacizumab in the management of solid tumors.
Expert Rev Anticancer Ther 7: 433-45 (2007)
PM ID: 17428164
812: Schenke-Layland K, Xie J, Heydarkhan-Hagvall S, Hamm-Alvarez SF, Stock UA, Brockbank KG, MacLellan WR
Optimized preservation of extracellular matrix in cardiac tissues: implications for long-term graft durability.
Ann Thorac Surg 83: 1641-50 (2007)
PM ID: 17462373
813: Margolin K, Synold TW, Lara PN, Frankel P, Lacey SF, Quinn DI, Baratta T, Dutcher JP, Xi B, Diamond DJ, Gandara DR
Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium.
J Cancer Res Clin Oncol 133: 705-11 (2007)
PM ID: 17508219
814: Cai Q, Kusnetzow AK, Hideg K, Price EA, Haworth IS, Qin PZ
Nanometer distance measurements in RNA using site-directed spin labeling.
Biophys J 93: 2110-7 (2007)
PM ID: 17526583 PMC1959523
815: Ku TK, Nguyen DC, Karaman MW, Gill P, Hacia JG, Crowe DL
Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
Mol Cancer Res 5: 351-62 (2007)
PM ID: 17426250
816: Pyrko P, Kardosh A, Liu YT, Soriano N, Xiong W, Chow RH, Uddin J, Petasis NA, Mircheff AK, Farley RA, Louie SG, Chen TC, Schönthal AH
Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib.
Mol Cancer Ther 6: 1262-75 (2007)
PM ID: 17431104
817: Turner JS, Cheung EM, George J, Quinn DI
Pain management, supportive and palliative care in patients with renal cell carcinoma.
BJU Int 99: 1305-12 (2007)
PM ID: 17441929
818: Butturini AM, Dorey FJ, Lange BJ, Henry DW, Gaynon PS, Fu CH, Franklin JL, Siegel SE, Seibel NL, Rogers PC, Sather H, Trigg ME, Bleyer WA, Carroll WL
Obesity and outcome in pediatric acute lymphoblastic leukemia.
J Clin Oncol 25: 2063-9 (2007)
PM ID: 17513811
819: Sablayrolles J, Jubera V, Guillen F, Garcia AA
Charge transfer emission of ytterbium-doped oxyborates.
Spectrochim Acta A Mol Biomol Spectrosc 69: 1010-9 (2007)
PM ID: 17644400
820: Zacharoulis S, Levy AS, Chi SN, Gardner S, Rosenblum M, Miller DC, Dunkel IJ, Diez B, Sposto R, Ji L, Asgharzadeh S, Hukin J, Belasco J, Dubowy R, Kellie SJ, Termuhlen AM, Finlay J
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Pediatr Blood Cancer 49: 34-40 (2007)
PM ID: 16874765
821: Dayam R, Al-Mawsawi LQ, Neamati N
HIV-1 integrase inhibitors: an emerging clinical reality.
Drugs R D 8: 155-68 (2007)
PM ID: 17472411
822: Venook AP, Blanke CD, Niedzwiecki D, Lenz HJ, Taylor JR, Hollis DR, Sutherland S, Goldberg RM
Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.
Clin Colorectal Cancer 6: 536-8 (2007)
PM ID: 17553204
823: Keshelava N, Davicioni E, Wan Z, Ji L, Sposto R, Triche TJ, Reynolds CP
Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
J Natl Cancer Inst 99: 1107-19 (2007)
PM ID: 17623797
824: Luo P, Wang A, Payne KJ, Peng H, Wang JG, Parrish YK, Rogerio JW, Triche TJ, He QY, Wu L
Intrinsic retinoic acid receptor alpha-cyclin-dependent kinase-activating kinase signaling involves coordination of the restricted proliferation and granulocytic differentiation of human hematopoietic stem cells.
Stem Cells 25: 2628-37 (2007)
PM ID: 17628022
825: Daneshmand S, Quek ML, Lin E, Lee CT, Cote RJ, Hawes D, Cai J, Groshen S, Lieskovsky G, Skinner DG, Lee AS, Pinski J
Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival.
Hum Pathol 38: 1547-52 (2007)
PM ID: 17640713
826: Tsou JA, Galler JS, Wali A, Ye W, Siegmund KD, Groshen S, Laird PW, Turla S, Koss MN, Pass HI, Laird-Offringa IA
DNA methylation profile of 28 potential marker loci in malignant mesothelioma.
Lung Cancer 58: 220-30 (2007)
PM ID: 17659810 PMC2752414 NIHMS33001
827: Schenke-Layland K, Xie J, Angelis E, Starcher B, Wu K, Riemann I, MacLellan WR, Hamm-Alvarez SF
Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome.
Matrix Biol 27: 53-66 (2007)
PM ID: 17689946 PMC2394184 NIHMS46424
828: Plasencia C, Martínez-Balibrea E, Martinez-Cardús A, Quinn DI, Abad A, Neamati N
Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
Int J Oncol 29: 225-35 (2007)
PM ID: 16773204
829: El Kebir D, József L, Khreiss T, Pan W, Petasis NA, Serhan CN, Filep JG
Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation.
J Immunol 179: 616-22 (2007)
PM ID: 17579083
830: Arias RS, Flanagan ML, Miller KD, Nien YC, Hu P, Gray D, Khawli LA, Epstein AL
RA8, a human anti-CD25 antibody against human Treg cells.
Hybridoma (Larchmt) 26: 119-30 (2007)
PM ID: 17600493
831: Wang Y, Chiu CT, Nakamura T, Walker AM, Petridou B, Trousdale MD, Hamm-Alvarez SF, Mircheff AK, Schechter JE
Traffic of endogenous, transduced, and endocytosed prolactin in rabbit lacrimal acinar cells.
Exp Eye Res 85: 749-61 (2007)
PM ID: 17904551 PMC2190296 NIHMS36252
832: Gadir N, Lee EJ, Garcia AA, Toschi A, Foster DA
Suppression of TGF-beta signaling by phospholipase D.
Cell Cycle 6: 2840-5 (2007)
PM ID: 18032924
833: Mori R, Ishikawa T, Ichikawa Y, Taniguchi K, Matsuyama R, Ueda M, Fujii Y, Endo I, Togo S, Danenberg PV, Shimada H
Human equilibrative nucleoside transporter 1 is associated with the chemosensitivity of gemcitabine in human pancreatic adenocarcinoma and biliary tract carcinoma cells.
Oncol Rep 17: 1201-5 (2007)
PM ID: 17390066
834: Jiang X, Castelao JE, Groshen S, Cortessis VK, Ross RK, Conti DV, Gago-Dominguez M
Alcohol consumption and risk of bladder cancer in Los Angeles County.
Int J Cancer 121: 839-45 (2007)
PM ID: 17440923
835: Sadun RE, Sachsman SM, Chen X, Christenson KW, Morris WZ, Hu P, Epstein AL
Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy.
Clin Cancer Res 13: 4016-25 (2007)
PM ID: 17606736
836: Liao CP, Zhong C, Saribekyan G, Bading JR, Park R, Conti PS, Moats RA, Berns A, Shi W, Zhou Z, Nikitin AY, Roy-Burman P
Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.
Cancer Res 67: 7525-33 (2007)
PM ID: 17671224
837: Zhang W, Gordon M, Schultheis AM, Yang DY, Nagashima F, Azuma M, Chang HM, Borucka E, Lurje G, Sherrod AE, Iqbal S, Groshen S, Lenz HJ
FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.
J Clin Oncol 25: 3712-8 (2007)
PM ID: 17704420
838: Zhang W, Press OA, Haiman CA, Yang DY, Gordon MA, Fazzone W, El-Khoueiry AB, Iqbal S, Sherrod AE, Lurje G, Lenz HJ
Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.
J Clin Oncol 25: 3726-31 (2007)
PM ID: 17704422
839: Saltz LB, Lenz HJ, Kindler HL, Hochster HS, Wadler S, Hoff PM, Kemeny NE, Hollywood EM, Gonen M, Quinones M, Morse M, Chen HX
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study.
J Clin Oncol 25: 4557-61 (2007)
PM ID: 17876013
840: Abdueva D, Wing MR, Schaub B, Triche TJ
Experimental comparison and evaluation of the Affymetrix exon and U133Plus2 GeneChip arrays.
PLoS One 2: e913 (2007)
PM ID: 17878948 PMC1976394
841: Al-Mawsawi LQ, Neamati N
Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy.
Trends Pharmacol Sci 28: 526-35 (2007)
PM ID: 17888520
842: Beumer JH, Parise RA, Newman EM, Doroshow JH, Synold TW, Lenz HJ, Egorin MJ
Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU).
Cancer Chemother Pharmacol 62: 363-8 (2007)
PM ID: 17899082
843: Dayam R, Al-Mawsawi LQ, Neamati N
Substituted 2-pyrrolinone inhibitors of HIV-1 integrase.
Bioorg Med Chem Lett 17: 6155-9 (2007)
PM ID: 17911021
844: Brzozowski Z, Slawinski J, Saczewski F, Sanchez TW, Neamati N
Synthesis, anti-HIV-1 integrase, and cytotoxic activities of 4-chloro-N-(4-oxopyrimidin-2-yl)-2-mercaptobenzenesulfonamide derivatives.
Eur J Med Chem 43: 1188-98 (2007)
PM ID: 17949860
845: Gilles FH, Tavaré CJ, Becker LE, Burger PC, Yates AJ, Pollack IF, Finlay JL
Pathologist interobserver variability of histologic features in childhood brain tumors: results from the CCG-945 study.
Pediatr Dev Pathol 11: 108-17 (2007)
PM ID: 17990938
846: Dunkel IJ, Lee TC, Shi W, Beaverson KL, Novetsky D, Lyden D, Finlay JL, McCormick B, Abramson DH
A phase II trial of carboplatin for intraocular retinoblastoma.
Pediatr Blood Cancer 49: 643-8 (2007)
PM ID: 17301956
847: Bui HH, Schiewe AJ, Haworth IS
WATGEN: an algorithm for modeling water networks at protein-protein interfaces.
J Comput Chem 28: 2241-51 (2007)
PM ID: 17471455
848: Tobin E, Denardo G, Zhang N, Epstein AL, Liu CW, Denardo S
Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell lines.
Leuk Lymphoma 48: 944-56 (2007)
PM ID: 17487739
849: Price EA, Sutch BT, Cai Q, Qin PZ, Haworth IS
Computation of nitroxide-nitroxide distances in spin-labeled DNA duplexes.
Biopolymers 87: 40-50 (2007)
PM ID: 17538992 PMC2430107 NIHMS52036
850: Vallböhmer D, Yang DY, Kuramochi H, Shimizu D, Danenberg KD, Lindebjerg J, Nielsen JN, Jakobsen A, Danenberg PV
DPD is a molecular determinant of capecitabine efficacy in colorectal cancer.
Int J Oncol 31: 413-8 (2007)
PM ID: 17611699
851: Zhang N, Khawli LA, Hu P, Epstein AL
Lym-1-induced apoptosis of non-Hodgkin's lymphomas produces regression of transplanted tumors.
Cancer Biother Radiopharm 22: 342-56 (2007)
PM ID: 17651040
852: Song LL, Ara T, Wu HW, Woo CW, Reynolds CP, Seeger RC, Declerck YA, Thiele CJ, Sposto R, Metelitsa LS
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma.
J Clin Invest 117: 2702-12 (2007)
PM ID: 17710228 PMC1940236
853: Peng H, Sohara Y, Moats RA, Nelson MD, Groshen SG, Ye W, Reynolds CP, Declerck YA
The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
Cancer Res 67: 9346-55 (2007)
PM ID: 17909043
854: Al-Mawsawi LQ, Dayam R, Taheri L, Witvrouw M, Debyser Z, Neamati N
Discovery of novel non-cytotoxic salicylhydrazide containing HIV-1 integrase inhibitors.
Bioorg Med Chem Lett 17: 6472-5 (2007)
PM ID: 17950601
855: Norouziyan F, Shen WC, Hamm-Alvarez SF
Tyrphostin A8 stimulates a novel trafficking pathway of apically endocytosed transferrin through Rab11-enriched compartments in Caco-2 cells.
Am J Physiol Cell Physiol 294: C7-21 (2007)
PM ID: 17959726
856: Parra V, Eisner V, Chiong M, Criollo A, Moraga F, Garcia AA, Härtel S, Jaimovich E, Zorzano A, Hidalgo C, Lavandero S
Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis.
Cardiovasc Res 77: 387-97 (2007)
PM ID: 18006463
857: Garcia AA, Olmo B, Lopez-Gonzalvez A, Cornejo L, Rupérez FJ, Barbas C
Capillary electrophoresis for short chain organic acids in faeces Reference values in a Mediterranean elderly population.
J Pharm Biomed Anal 46: 356-61 (2007)
PM ID: 18055154
858: Lee EJ, Nichols PW, Spicer D, Groshen S, Yu MC, Lee AS
GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer.
Cancer Res 66: 7849-53 (2007)
PM ID: 16912156
859: Sodir NM, Chen X, Park R, Nickel AE, Conti PS, Moats RA, Bading JR, Shibata D, Laird PW
Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice.
Cancer Res 66: 8430-8 (2007)
PM ID: 16951153
860: Lenz HJ
Management and preparedness for infusion and hypersensitivity reactions.
Oncologist 12: 601-9 (2007)
PM ID: 17522249
861: Weber EL, Cannon PM
Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
Hum Gene Ther 18: 849-60 (2007)
PM ID: 17767401
862: Castellani ML, Bhattacharya K, Tagen M, Kempuraj D, Perrella A, De Lutiis MA, Boucher W, Conti PS, Theoharides TC, Cerulli G, Salini V, Neri G
Anti-chemokine therapy for inflammatory diseases.
Int J Immunopathol Pharmacol 20: 447-53 (2007)
PM ID: 17880758
863: Falasca K, Ucciferri C, Manzoli L, Mancino P, Pizzigallo E, Conti PS, Vecchiet J
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy.
Int J Immunopathol Pharmacol 20: 519-27 (2007)
PM ID: 17880765
864: Saltz LB, Rosen LS, Marshall JL, Belt RJ, Hurwitz HI, Eckhardt SG, Bergsland EK, Haller DG, Lockhart AC, Rocha Lima CM, Huang X, DePrimo SE, Chow-Maneval E, Chao RC, Lenz HJ
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
J Clin Oncol 25: 4793-9 (2007)
PM ID: 17947727
865: Pruissen DM, Rosendaal FR, Gorter JW, Garcia AA, Kappelle LJ, Algra A, SPIRIT Study Group
Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.
J Neurol 254: 1660-5 (2007)
PM ID: 17994314
866: Reignier T, Oldenburg J, Flanagan ML, Hamilton GA, Martin VK, Cannon PM
Receptor use by the Whitewater Arroyo virus glycoprotein.
Virology 371: 439-46 (2007)
PM ID: 17997467 PMC2270610 NIHMS40343
867: Flanagan ML, Oldenburg J, Reignier T, Holt N, Hamilton GA, Martin VK, Cannon PM
New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1.
J Virol 82: 938-48 (2007)
PM ID: 18003730 PMC2224602
868: Panigrahy A, Nelson MD, Finlay JL, Sposto R, Krieger MD, Gilles FH, Blüml S
Metabolism of diffuse intrinsic brainstem gliomas in children.
Neuro Oncol 10: 32-44 (2007)
PM ID: 18003889 PMC2600836
869: Lam HD, Samuel MA, Rao NA, Murphree AL
Retinoblastoma presenting as Coats' disease.
Eye 22: 1196-7 (2007)
PM ID: 18049483
870: Conti PS, Bading JR, Mouton PP, Links JM, Alauddin MM, Fissekis JD, Ravert HT, Hilton J, Wong DF, Anderson JH
In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PET.
Nucl Med Biol 35: 131-41 (2007)
PM ID: 18158952
871: Rubio-Viqueira B, Jimeno A, Cusatis G, Zhang XK, Iacobuzio-Donahue C, Karikari C, Shi C, Danenberg K, Danenberg PV, Kuramochi H, Tanaka K, Singh S, Salimi-Moosavi H, Bouraoud N, Amador ML, Altiok S, Kulesza P, Yeo C, Messersmith W, Eshleman J, Hruban RH, Maitra A, Hidalgo M
An in vivo platform for translational drug development in pancreatic cancer.
Clin Cancer Res 12: 4652-61 (2007)
PM ID: 16899615
872: Vallböhmer D, Marjoram P, Kuramochi H, Shimizu D, Jung HS, DeMeester SR, Oh D, Chandrasoma PT, Danenberg KD, DeMeester TR, Danenberg PV, Peters JH
Towards the molecular characterization of disease: comparison of molecular and histological analysis of esophageal epithelia.
J Gastrointest Surg 11: 1095-104 (2007)
PM ID: 17623264
873: Ikegaki N, Gotoh T, Kung B, Riceberg JS, Kim DY, Zhao H, Rappaport EF, Hicks SL, Seeger RC, Tang XX
De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene.
Clin Cancer Res 13: 6001-9 (2007)
PM ID: 17947461
874: George B, Datar RH, Wu L, Cai J, Patten N, Beil SJ, Groshen S, Stein JP, Skinner DG, Jones PA, Cote RJ
p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer.
J Clin Oncol 25: 5352-8 (2007)
PM ID: 18048815
875: White CN, Hamilton EJ, Garcia AA, Wang D, Chia KK, Figtree GA, Rasmussen HH
Opposing effects of coupled and uncoupled NOS activity on the Na+-K+ pump in cardiac myocytes.
Am J Physiol Cell Physiol 294: C572-8 (2007)
PM ID: 18057120
876: Prat A, Parera M, Peralta S, Perez-Benavente MA, Garcia AA, Gil-Moreno A, Martinez-Palones JM, Roxana I, Baselga J, Del Campo JM
Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer.
Ann Oncol 19: 327-31 (2007)
PM ID: 18065408
877: Zwerner JP, Joo J, Warner KL, Christensen L, Hu-Lieskovan S, Triche TJ, May WA
The EWS/FLI1 oncogenic transcription factor deregulates GLI1.
Oncogene 27: 3282-91 (2007)
PM ID: 18084326
878: Dhall G, Finlay JL, Dunkel IJ, Ettinger LJ, Kellie SJ, Allen JC, Egeler RM, Arceci RJ
Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
Pediatr Blood Cancer 50: 72-9 (2008)
PM ID: 17455311
879: Ell K, Quon B, Quinn DI, Dwight-Johnson M, Wells AU, Lee PJ, Xie B
Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study.
Gen Hosp Psychiatry 29: 223-31 (2008)
PM ID: 17484939 PMC1868447 NIHMS17999
880: Zacharoulis S, Ji L, Pollack IF, Duffner P, Geyer R, Grill J, Schild S, Jaing TH, Massimino M, Finlay J, Sposto R
Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factors.
Pediatr Blood Cancer 50: 231-5 (2008)
PM ID: 17610266
881: Fangusaro JR, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R, Halpern S, Dubowy R, Comito M, Diez B, Kellie SJ, Hukin J, Rosenblum M, Dunkel IJ, Miller DC, Allen JC, Gardner S
Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
Pediatr Blood Cancer 50: 312-8 (2008)
PM ID: 17668858
882: Wong RM, Scotland RR, Lau RL, Wang CY, Korman AJ, Kast WM, Weber JS
Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs.
Int Immunol 19: 1223-34 (2008)
PM ID: 17898045
883: Wiseman GA, Conti PS, Vo K, Schilder RJ, Gordon LI, Emmanouilides C, Silverman DH, Witzig TE, Darif M, Molina A
Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
Clin Lymphoma Myeloma 7: 514-7 (2008)
PM ID: 18021468
884: Khawli LA, Hu P, Epstein AL
Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Handb Exp Pharmacol : 291-328 (2008)
PM ID: 18071951
885: Garcia AA, Hirte H, Fleming GF, Yang D, Tsao-Wei DD, Roman LD, Groshen S, Swenson SD, Markland FS, Gandara D, Scudder S, Morgan RJ, Chen HM, Lenz HJ, Oza AM
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
J Clin Oncol 26: 76-82 (2008)
PM ID: 18165643
886: Davies AM, Ruel C, Lara PN, Lau DH, Gumerlock PH, Bold RJ, Shibata SI, Lenz HJ, Schenkein DP, Gandara DR
The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study.
J Thorac Oncol 3: 68-74 (2008)
PM ID: 18166843
887: Evans E, Zhang W, Jerdeva G, Chen CY, Chen X, Hamm-Alvarez SF, Okamoto CT
Direct interaction between Rab3D and the polymeric immunoglobulin receptor and trafficking through regulated secretory vesicles in lacrimal gland acinar cells.
Am J Physiol Cell Physiol 294: C662-74 (2008)
PM ID: 18171724
888: Marachelian A, Butturini AM, Finlay J
Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors.
Bone Marrow Transplant 41: 167-72 (2008)
PM ID: 18176620
889: Pique-Regi R, Monso-Varona J, Ortega A, Seeger RC, Triche TJ, Asgharzadeh S
Sparse representation and Bayesian detection of genome copy number alterations from microarray data.
Bioinformatics 24: 309-18 (2008)
PM ID: 18203770 PMC2704547
890: Vafa M, Troye-Blomberg M, Anchang J, Garcia AA, Migot-Nabias F
Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants.
Malar J 7: 17 (2008)
PM ID: 18215251 PMC2267475
891: Banki F, Mason RJ, Hagen JA, DeMeester SR, Lipham JC, Danenberg K, Danenberg P, DeMeester TR
Plasma DNA: a molecular marker of surgical insult and postoperative recovery in esophageal cancer.
Eur Surg Res 40: 273-8 (2008)
PM ID: 18219202
892: Petasis NA, Keledjian R, Sun YP, Nagulapalli KC, Tjonahen E, Yang R, Serhan CN
Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties.
Bioorg Med Chem Lett 18: 1382-7 (2008)
PM ID: